@BOOK{noauthor_undated-gh,
  title     = "Tumor Microenvironment",
  publisher = "Springer International Publishing"
}

@ARTICLE{Potter1985-bt,
  title    = "History of the {BALB/c} family",
  author   = "Potter, M",
  journal  = "Curr. Top. Microbiol. Immunol.",
  volume   =  122,
  pages    = "1--5",
  year     =  1985,
  language = "en"
}

@ARTICLE{Rogers1985-mf,
  title    = "Qa2 expression in {BALB/c} sublines and a {BALB/cLAC} tumor",
  author   = "Rogers, M J and Galetto, G and Matthai, R and Potter, M",
  journal  = "Curr. Top. Microbiol. Immunol.",
  volume   =  122,
  pages    = "43--49",
  year     =  1985,
  language = "en"
}

@ARTICLE{Forman1978-lu,
  title    = "Identification of a new {CML} target antigen controlled by a gene
              associated with theQa-2 locus",
  author   = "Forman, James and Flaherty, Lorraine",
  abstract = "BALB/cBy anti-BALB/cJ spleen cells were tested in a secondary
              cellmediated lympholysis assay. The effector cells generated
              displayed a positive cytotoxic effect against Con A lymphoblasts
              from only those strains that were typed serologically as having
              theQa-2a allele. Confirmation that the target antigen is
              controlled by a locus closely associated with or identical toQa-2
              was obtained by the findings that target cells from B6.K2
              (Qa-2a,Qa-3a) mice were lysed by the effector cells, while those
              from theQa-2, 3 congenic strain B6.K1 (Qa-2b,Qa-3b) were not. The
              fact that target cells from aQa-2-positive/Qa-3-negative strain
              (DBA/1,Qa-2ai,Qa-3b) were killed indicates that the target
              antigen is controlled, at least in part, by theQa-2 locus, not
              the Qa-3.There is no observedH-2 genetic restriction for this
              cytotoxic effect, since target cells which have theQa-2a allele
              but differ from the stimulator cells at theH-2K, D, andI regions
              were lysed efficiently.",
  journal  = "Immunogenetics",
  volume   =  6,
  number   =  1,
  pages    = "227--233",
  month    =  dec,
  year     =  1978
}

@ARTICLE{Wang2022-ln,
  title    = "Mesenchymal stem cells attenuate acute lung injury in mice partly
              by suppressing alveolar macrophage activation in a
              {PGE2-dependent} manner",
  author   = "Wang, Gaojian and Zhang, Yaping and Hu, Nianqiang and Liu, Qinxue
              and Ma, Fengjie and Xie, Junran",
  abstract = "Mesenchymal stem cells (MSCs) have been demonstrated to attenuate
              acute lung injury (ALI). We also found that they can suppress the
              activation of alveolar macrophages (AMs), which can partly
              account for their therapeutic effects. MSCs do not inherently own
              immunosuppressive effects, when co-cultured with inflammatory
              immune cells, MSCs can be activated by inflammatory cytokines and
              meanwhile exert immunosuppressive effects. In order to further
              research, RNA sequencing (RNA-seq) of MSCs cultured before and
              after co-culturing with activated macrophages was performed. The
              data suggested a total of 5268 differentially expressed genes
              (DEGs) along the process. We used the data of 2754 upregulated
              DEGs to develop a signaling network of genes and the
              transcription factors targeting them in order to predict the
              altered functions of MSCs after exposure to inflammatory stimuli.
              This constructed network revealed some critical target genes and
              potential roles of MSCs under inflammatory conditions. According
              to the network, Ptgs2 was assumed to be an important gene
              participating in the immunosuppressive effects of MSCs. We also
              identified significant increases in the expression of COX2
              protein and the secretion of PGE2 from MSCs. The use of the COX2
              inhibitor NS-398 restrained the secretion of PGE2 and reversed
              the suppression of macrophage activation by MSCs in vitro. In
              addition, a selective antagonist of PGE2 binding receptor (EP4
              receptor), GW627368X, also reversed the inhibitory effects of
              MSCs on AMs and the protective effects in ALI mouse. In summary,
              the therapeutic effects of MSCs on ALI partly occur through
              suppressing AM activation via PGE2 binding to EP4 receptor.",
  journal  = "Inflammation",
  month    =  jun,
  year     =  2022,
  keywords = "Acute lung injury; Alveolar macrophage; Mesenchymal stem cell;
              Prostaglandin E2; RNA-sequence",
  language = "en"
}

@ARTICLE{Mandula2022-zh,
  title    = "Ablation of the endoplasmic reticulum stress kinase {PERK}
              induces paraptosis and type {I} interferon to promote anti-tumor
              {T} cell responses",
  author   = "Mandula, Jessica K and Chang, Shiun and Mohamed, Eslam and
              Jimenez, Rachel and Sierra-Mondragon, Rosa A and Chang, Darwin C
              and Obermayer, Alyssa N and Moran-Segura, Carlos M and Das,
              Satyajit and Vazquez-Martinez, Julio A and Prieto, Karol and
              Chen, Ann and Smalley, Keiran S M and Czerniecki, Brian and
              Forsyth, Peter and Koya, Richard C and Ruffell, Brian and
              Cubillos-Ruiz, Juan R and Munn, David H and Shaw, Timothy I and
              Conejo-Garcia, Jose R and Rodriguez, Paulo C",
  abstract = "Activation of unfolded protein responses (UPRs) in cancer cells
              undergoing endoplasmic reticulum (ER) stress promotes survival.
              However, how UPR in tumor cells impacts anti-tumor immune
              responses remains poorly described. Here, we investigate the role
              of the UPR mediator pancreatic ER kinase (PKR)-like ER kinase
              (PERK) in cancer cells in the modulation of anti-tumor immunity.
              Deletion of PERK in cancer cells or pharmacological inhibition of
              PERK in melanoma-bearing mice incites robust activation of
              anti-tumor T cell immunity and attenuates tumor growth. PERK
              elimination in ER-stressed malignant cells triggers
              SEC61$\beta$-induced paraptosis, thereby promoting immunogenic
              cell death (ICD) and systemic anti-tumor responses. ICD induction
              in PERK-ablated tumors stimulates type I interferon production in
              dendritic cells (DCs), which primes CCR2-dependent tumor
              trafficking of common-monocytic precursors and their intra-tumor
              commitment into monocytic-lineage inflammatory Ly6C+CD103+ DCs.
              These findings identify how tumor cell-derived PERK promotes
              immune evasion and highlight the potential of PERK-targeting
              therapies in cancer immunotherapy.",
  journal  = "Cancer Cell",
  volume   =  40,
  number   =  10,
  pages    = "1145--1160.e9",
  month    =  oct,
  year     =  2022,
  keywords = "PERK; immunogenic cell death; tumor immunity; type I IFN;
              unfolded protein responses",
  language = "en"
}

@ARTICLE{Lambert2017-op,
  title    = "Emerging Biological Principles of Metastasis",
  author   = "Lambert, Arthur W and Pattabiraman, Diwakar R and Weinberg,
              Robert A",
  abstract = "Metastases account for the great majority of cancer-associated
              deaths, yet this complex process remains the least understood
              aspect of cancer biology. As the body of research concerning
              metastasis continues to grow at a rapid rate, the biological
              programs that underlie the dissemination and metastatic outgrowth
              of cancer cells are beginning to come into view. In this review
              we summarize the cellular and molecular mechanisms involved in
              metastasis, with a focus on carcinomas where the most is known,
              and we highlight the general principles of metastasis that have
              begun to emerge.",
  journal  = "Cell",
  volume   =  168,
  number   =  4,
  pages    = "670--691",
  month    =  feb,
  year     =  2017,
  language = "en"
}

@ARTICLE{Dhainaut2022-ew,
  title    = "Spatial {CRISPR} genomics identifies regulators of the tumor
              microenvironment",
  author   = "Dhainaut, Maxime and Rose, Samuel A and Akturk, Guray and
              Wroblewska, Aleksandra and Nielsen, Sebastian R and Park, Eun
              Sook and Buckup, Mark and Roudko, Vladimir and Pia, Luisanna and
              Sweeney, Robert and Le Berichel, Jessica and Wilk, C Matthias and
              Bektesevic, Anela and Lee, Brian H and Bhardwaj, Nina and Rahman,
              Adeeb H and Baccarini, Alessia and Gnjatic, Sacha and Pe'er, Dana
              and Merad, Miriam and Brown, Brian D",
  abstract = "While CRISPR screens are helping uncover genes regulating many
              cell-intrinsic processes, existing approaches are suboptimal for
              identifying extracellular gene functions, particularly in the
              tissue context. Here, we developed an approach for spatial
              functional genomics called Perturb-map. We applied Perturb-map to
              knock out dozens of genes in parallel in a mouse model of lung
              cancer and simultaneously assessed how each knockout influenced
              tumor growth, histopathology, and immune composition. Moreover,
              we paired Perturb-map and spatial transcriptomics for unbiased
              analysis of CRISPR-edited tumors. We found that in Tgfbr2
              knockout tumors, the tumor microenvironment (TME) was converted
              to a fibro-mucinous state, and T cells excluded, concomitant with
              upregulated TGF$\beta$ and TGF$\beta$-mediated fibroblast
              activation, indicating that TGF$\beta$-receptor loss on cancer
              cells increased TGF$\beta$ bioavailability and its
              immunosuppressive effects on the TME. These studies establish
              Perturb-map for functional genomics within the tissue at
              single-cell resolution with spatial architecture preserved and
              provide insight into how TGF$\beta$ responsiveness of cancer
              cells can affect the TME.",
  journal  = "Cell",
  volume   =  185,
  number   =  7,
  pages    = "1223--1239.e20",
  month    =  mar,
  year     =  2022,
  keywords = "CRISPR screens; Socs1; TGF beta; cancer immunology; interferon
              gamma; lung cancer; spatial genomics; spatial transcriptomics;
              tumor clonality; tumor microenvironment",
  language = "en"
}

@ARTICLE{Nalio_Ramos2022-nw,
  title    = "Tissue-resident {FOLR2+} macrophages associate with {CD8+} {T}
              cell infiltration in human breast cancer",
  author   = "Nalio Ramos, Rodrigo and Missolo-Koussou, Yoann and
              Gerber-Ferder, Yohan and Bromley, Christian P and Bugatti, Mattia
              and N{\'u}{\~n}ez, Nicolas Gonzalo and Tosello Boari, Jimena and
              Richer, Wilfrid and Menger, Laurie and Denizeau, Jordan and
              Sedlik, Christine and Caudana, Pamela and Kotsias, Fiorella and
              Niborski, Leticia L and Viel, Sophie and Bohec, Myl{\`e}ne and
              Lameiras, Sonia and Baulande, Sylvain and Lesage, La{\"e}titia
              and Nicolas, Andr{\'e} and Meseure, Didier and Vincent-Salomon,
              Anne and Reyal, Fabien and Dutertre, Charles-Antoine and Ginhoux,
              Florent and Vimeux, Lene and Donnadieu, Emmanuel and Buttard,
              B{\'e}n{\'e}dicte and Galon, J{\'e}r{\^o}me and Zelenay, Santiago
              and Vermi, William and Guermonprez, Pierre and Piaggio, Eliane
              and Helft, Julie",
  abstract = "Macrophage infiltration is a hallmark of solid cancers, and
              overall macrophage infiltration correlates with lower patient
              survival and resistance to therapy. Tumor-associated macrophages,
              however, are phenotypically and functionally heterogeneous.
              Specific subsets of tumor-associated macrophage might be endowed
              with distinct roles on cancer progression and antitumor immunity.
              Here, we identify a discrete population of FOLR2+ tissue-resident
              macrophages in healthy mammary gland and breast cancer primary
              tumors. FOLR2+ macrophages localize in perivascular areas in the
              tumor stroma, where they interact with CD8+ T cells. FOLR2+
              macrophages efficiently prime effector CD8+ T cells ex vivo. The
              density of FOLR2+ macrophages in tumors positively correlates
              with better patient survival. This study highlights specific
              roles for tumor-associated macrophage subsets and paves the way
              for subset-targeted therapeutic interventions in
              macrophages-based cancer therapies.",
  journal  = "Cell",
  volume   =  185,
  number   =  7,
  pages    = "1189--1207.e25",
  month    =  mar,
  year     =  2022,
  keywords = "CD8(+) T lymphocytes; FOLR2; TREM2; breast cancer; single-cell
              RNA sequencing; tissue-resident macrophages;Human study",
  language = "en"
}

@ARTICLE{Richart2022-xb,
  title     = "{XIST} loss impairs mammary stem cell differentiation and
               increases tumorigenicity through Mediator hyperactivation",
  author    = "Richart, Laia and Picod-Chedotel, Mary-Loup and Wassef, Michel
               and Macario, Manon and Aflaki, Setareh and Salvador, Marion A
               and H{\'e}ry, Tiphaine and Dauphin, Aur{\'e}lien and Wicinski,
               Julien and Chevrier, V{\'e}ronique and Pastor, Sonia and
               Guittard, Geoffrey and Le Cam, Samuel and Kamhawi, Hanya and
               Castellano, R{\'e}my and Guasch, G{\'e}raldine and
               Charafe-Jauffret, Emmanuelle and Heard, Edith and Margueron,
               Rapha{\"e}l and Ginestier, Christophe",
  abstract  = "SummaryX inactivation (XCI) is triggered by upregulation of
               XIST, which coats the chromosome in cis, promoting formation of
               a heterochromatic domain (Xi). XIST role beyond initiation of
               XCI is only beginning to be elucidated. Here, we demonstrate
               that XIST loss impairs differentiation of human mammary stem
               cells (MaSCs) and promotes emergence of highly tumorigenic and
               metastatic carcinomas. On the Xi, XIST deficiency triggers
               epigenetic changes and reactivation of genes overlapping
               Polycomb domains, including Mediator subunit MED14. MED14
               overdosage results in increased Mediator levels and
               hyperactivation of the MaSC enhancer landscape and
               transcriptional program, making differentiation less favorable.
               We further demonstrate that loss of XIST and Xi transcriptional
               instability is common among human breast tumors of poor
               prognosis. We conclude that XIST is a gatekeeper of human
               mammary epithelium homeostasis, thus unveiling a paradigm in the
               control of somatic cell identity with potential consequences for
               our understanding of gender-specific malignancies.",
  journal   = "Cell",
  publisher = "Elsevier",
  volume    =  0,
  number    =  0,
  month     =  may,
  year      =  2022,
  keywords  = "XIST; X chromosome; transcriptional reactivation; polycomb;
               human mammary stem cell; homeostasis; differentiation; Mediator;
               enhancers; breast tumorigenesis",
  language  = "en"
}

@ARTICLE{Lu2022-dd,
  title     = "Spatially resolved epigenomic profiling of single cells in
               complex tissues",
  author    = "Lu, Tian and Ang, Cheen Euong and Zhuang, Xiaowei",
  abstract  = "SummaryThe recent development of spatial omics methods has
               enabled single-cell profiling of the transcriptome and 3D genome
               organization with high spatial resolution. Expanding the
               repertoire of spatial omics tools, a spatially resolved
               single-cell epigenomics method will accelerate understanding of
               the spatial regulation of cell and tissue functions. Here, we
               report a method for spatially resolved epigenomic profiling of
               single cells using in situ tagmentation and transcription
               followed by multiplexed imaging. We demonstrated the ability to
               profile histone modifications marking active promoters, putative
               enhancers, and silent promoters in individual cells, and
               generated high-resolution spatial atlas of hundreds of active
               promoters and putative enhancers in embryonic and adult mouse
               brains. Our results suggested putative promoter-enhancer pairs
               and enhancer hubs regulating developmentally important genes. We
               envision this approach will be generally applicable to spatial
               profiling of epigenetic modifications and DNA-binding proteins,
               advancing our understanding of how gene expression is
               spatiotemporally regulated by the epigenome.",
  journal   = "Cell",
  publisher = "Elsevier",
  volume    =  0,
  number    =  0,
  month     =  oct,
  year      =  2022,
  keywords  = "spatial epigenomic; single-cell epigenomics; MERFISH; epigenomic
               MERFISH; promoter; enhancer; enhancer hub; enhancer-promoter
               interaction; brain; development",
  language  = "en"
}

@ARTICLE{Swadling2020-um,
  title    = "Human Liver Memory {CD8+} {T} Cells Use Autophagy for Tissue
              Residence",
  author   = "Swadling, Leo and Pallett, Laura J and Diniz, Mariana O and
              Baker, Josephine M and Amin, Oliver E and Stegmann, Kerstin A and
              Burton, Alice R and Schmidt, Nathalie M and Jeffery-Smith, Anna
              and Zakeri, Nekisa and Suveizdyte, Kornelija and Froghi, Farid
              and Fusai, Giuseppe and Rosenberg, William M and Davidson, Brian
              R and Schurich, Anna and Simon, A Katharina and Maini, Mala K",
  abstract = "Tissue-resident memory T cells have critical roles in long-term
              pathogen and tumor immune surveillance in the liver. We
              investigate the role of autophagy in equipping human memory T
              cells to acquire tissue residence and maintain functionality in
              the immunosuppressive liver environment. By performing ex vivo
              staining of freshly isolated cells from human liver tissue, we
              find that an increased rate of basal autophagy is a hallmark of
              intrahepatic lymphocytes, particularly liver-resident CD8+ T
              cells. CD8+ T cells with increased autophagy are those best able
              to proliferate and mediate cytotoxicity and cytokine production.
              Conversely, blocking autophagy induction results in the
              accumulation of depolarized mitochondria, a feature of exhausted
              T cells. Primary hepatic stellate cells or the prototypic hepatic
              cytokine interleukin (IL)-15 induce autophagy in parallel with
              tissue-homing/retention markers. Inhibition of T cell autophagy
              abrogates tissue-residence programming. Thus, upregulation of
              autophagy adapts CD8+ T cells to combat mitochondrial
              depolarization, optimize functionality, and acquire tissue
              residence.",
  journal  = "Cell Rep.",
  volume   =  30,
  number   =  3,
  pages    = "687--698.e6",
  month    =  jan,
  year     =  2020,
  keywords = "IL-15; T cell; autophagy; hepatitis B virus; immunometabolism;
              liver; mitophagy; tissue-resident;Human study",
  language = "en"
}

@ARTICLE{Tacconi2021-ib,
  title       = "{CD169+} lymph node macrophages have protective functions in
                 mouse breast cancer metastasis",
  author      = "Tacconi, Carlotta and Commerford, Catharina D and Dieterich,
                 Lothar C and Schwager, Simon and He, Yuliang and Ikenberg,
                 Kristian and Friebel, Ekaterina and Becher, Burkhard and
                 Tugues, S{\`o}nia and Detmar, Michael",
  abstract    = "Although the contribution of macrophages to metastasis is
                 widely studied in primary tumors, the involvement of
                 macrophages in tumor-draining lymph nodes (LNs) in this
                 process is less clear. We find CD169+ macrophages as the
                 predominant macrophage subtype in naive LNs, which undergo
                 proliferative expansion in response to tumor stimuli. CD169+
                 LN macrophage depletion, using an anti-CSF-1R antibody or
                 clodronate-loaded liposomes, leads to increased metastatic
                 burden in two mouse breast cancer models. The expansion of
                 CD169+ macrophages is tightly connected to B cell expansion in
                 tumor-draining LNs, and B cell depletion abrogates the effect
                 of CD169+ macrophage absence on metastasis, indicating that
                 the CD169+ macrophage anti-metastatic effects require B cell
                 presence. These results reveal a protective role of CD169+ LN
                 macrophages in breast cancer metastasis and raise caution for
                 the use of drugs aiming at the depletion of tumor-associated
                 macrophages, which might simultaneously deplete macrophages in
                 tumor-draining LNs.",
  journal     = "Cell Rep.",
  volume      =  35,
  number      =  2,
  pages       = "108993",
  month       =  apr,
  year        =  2021,
  keywords    = "CD169+ macrophages; breast cancer metastasis; distant organ
                 metastasis; lymph node macrophages; tumor-associated
                 macrophages; tumor-draining lymph node",
  language    = "en",
  original_id = "79fb70b1-c278-0f80-af02-42f563e36698"
}

@ARTICLE{Christian2021-pr,
  title    = "Resident memory {T} cells in tumor-distant tissues fortify
              against metastasis formation",
  author   = "Christian, Laura S and Wang, Liuyang and Lim, Bryan and Deng,
              Dachuan and Wu, Haiyang and Wang, Xiao-Fan and Li, Qi-Jing",
  abstract = "As a critical machinery for rapid pathogen removal, resident
              memory T cells (TRMs) are locally generated after the initial
              encounter. However, their development accompanying tumorigenesis
              remains elusive. Using a murine breast cancer model, we show that
              TRMs develop in the tumor, the contralateral mammary mucosa, and
              the pre-metastatic lung. Single-cell RNA sequencing of TRMs
              reveals two phenotypically distinct populations representing
              their active versus quiescent phases. These TRMs in different
              tissue compartments share the same TCR clonotypes and
              transcriptomes with a subset of intratumoral effector/effector
              memory T cells (TEff/EMs), indicating their developmental
              ontogeny. Furthermore, CXCL16 is highly produced by tumor cells
              and CXCR6- TEff/EMs are the major subset preferentially egressing
              the tumor to form distant TRMs. Functionally, releasing CXCR6
              retention in the primary tumor amplifies tumor-derived TRMs in
              the lung and leads to superior protection against metastases.
              This immunologic fortification suggests a potential strategy to
              prevent metastasis in clinical oncology.",
  journal  = "Cell Rep.",
  volume   =  35,
  number   =  6,
  pages    = "109118",
  month    =  may,
  year     =  2021,
  keywords = "TCR-$\beta$ repertoire sequencing; breast cancer; metastasis;
              ontogeny; resident memory T cells; single-cell RNA sequencing;
              tumor immunology;Mouse study",
  language = "en"
}

@ARTICLE{Dean2023-is,
  title    = "The aryl hydrocarbon receptor cell intrinsically promotes
              resident memory {CD8+} {T} cell differentiation and function",
  author   = "Dean, Joseph W and Helm, Eric Y and Fu, Zheng and Xiong, Lifeng
              and Sun, Na and Oliff, Kristen N and Muehlbauer, Marcus and
              Avram, Dorina and Zhou, Liang",
  abstract = "The Aryl hydrocarbon receptor (Ahr) regulates the differentiation
              and function of CD4+ T cells; however, its cell-intrinsic role in
              CD8+ T cells remains elusive. Herein we show that Ahr acts as a
              promoter of resident memory CD8+ T cell (TRM) differentiation and
              function. Genetic ablation of Ahr in mouse CD8+ T cells leads to
              increased CD127-KLRG1+ short-lived effector cells and CD44+CD62L+
              T central memory cells but reduced granzyme-B-producing
              CD69+CD103+ TRM cells. Genome-wide analyses reveal that Ahr
              suppresses the circulating while promoting the resident memory
              core gene program. A tumor resident polyfunctional CD8+ T cell
              population, revealed by single-cell RNA-seq, is diminished upon
              Ahr deletion, compromising anti-tumor immunity. Human intestinal
              intraepithelial CD8+ T cells also highly express AHR that
              regulates in vitro TRM differentiation and granzyme B production.
              Collectively, these data suggest that Ahr is an important
              cell-intrinsic factor for CD8+ T cell immunity.",
  journal  = "Cell Rep.",
  volume   =  42,
  number   =  1,
  pages    = "111963",
  month    =  jan,
  year     =  2023,
  keywords = "CD8(+) T cell; CP: Immunology; aryl hydrocarbon receptor; cancer
              immunology; cytotoxicity; development; differentiation; mucosal
              immunology; tissue resident memory; tumor infiltrating
              lymphocyte;ARI CD8;Mouse study",
  language = "en"
}

@ARTICLE{Johnstone2015-zr,
  title    = "Emerging roles for {IL-11} signaling in cancer development and
              progression: Focus on breast cancer",
  author   = "Johnstone, Cameron N and Chand, Ashwini and Putoczki, Tracy L and
              Ernst, Matthias",
  abstract = "Interleukin (IL)-11 is a member of the IL-6 family of cytokines
              that is defined by the shared use of the GP130 signal transducing
              receptor subunit. In addition of its long recognized activities
              as a hemopoietic growth factor, IL-11 has an emerging role in
              epithelial cancer biology. Through the activation of the
              GP130-Janus kinase signaling cascade and associated transcription
              factor STAT3, IL-11 can confer many of the tumor intrinsic
              'hallmark' capabilities to neoplastic cells, if they express the
              ligand-specific IL-11R$\alpha$ receptor subunit. Accordingly,
              IL-11 signaling has recently been identified as a rate-limiting
              step for the growth tumors arising from the mucosa of the
              gastrointestinal tract. However, there is less appreciation for a
              potential role of IL-11 to support breast cancer progression,
              apart from its well documented capacity to facilitate bone
              metastasis. Here we review evidence that IL-11 expression in
              breast cancer correlates with poor disease outcome and discuss
              some of the molecular mechanisms that are likely to underpin
              these observations. These include the capacity of IL-11 to
              stimulate survival and proliferation of cancer cells alongside
              angiogenesis of the primary tumor and of metastatic progenies at
              distant organs. We review current strategies to interfere with
              IL-11 signaling and advocate that inhibition of IL-11 signaling
              may represent an emerging therapeutic opportunity for numerous
              cancers.",
  journal  = "Cytokine Growth Factor Rev.",
  volume   =  26,
  number   =  5,
  pages    = "489--498",
  month    =  oct,
  year     =  2015,
  keywords = "Cancer; IL-11; IL-6; Interleukin; STAT3",
  language = "en"
}

@ARTICLE{Konjar2022-wm,
  title    = "Heterogeneity of tissue resident memory {T} cells",
  author   = "Konjar, {\v S}pela and Ficht, Xenia and Iannacone, Matteo and
              Veldhoen, Marc",
  abstract = "Non-lymphoid organs, in mice and humans, contain CD8+
              tissue-resident memory T (TRM) cells. They play important roles
              in tissue homoeostasis as well as defence against infections and
              cancer. TRM cells have common characteristics that enables their
              tissue residency and function. However, the wide variety of
              tissues, some with continually exposure to invading microbes,
              distinct organ structures and functions, impose tissue-specific
              differences on TRM cells. Upon tissue-entry, they need to adapt
              to local circumstances by modifying their transcriptional
              machinery, enabling interactions with the - often specialised -
              surrounding cells and available metabolites. Heterogeneity
              amongst TRM cells may have implications for their defence
              function, organ-specific autoimmunity and chronic immune
              disorders. Here we indicate shared and unique TRM cell features
              within different tissues to provide a better understanding of
              their function and discuss possible future research directions.",
  journal  = "Immunol. Lett.",
  volume   =  245,
  pages    = "1--7",
  month    =  may,
  year     =  2022,
  keywords = "Human; Mouse; Mucosal immunology; Tissues; Trm cells;Review",
  language = "en"
}

@ARTICLE{Mackay2015-ee,
  title    = "T-box Transcription Factors Combine with the Cytokines
              {TGF-$\beta$} and {IL-15} to Control {Tissue-Resident} Memory {T}
              Cell Fate",
  author   = "Mackay, Laura K and Wynne-Jones, Erica and Freestone, David and
              Pellicci, Daniel G and Mielke, Lisa A and Newman, Dane M and
              Braun, Asolina and Masson, Frederick and Kallies, Axel and Belz,
              Gabrielle T and Carbone, Francis R",
  abstract = "Tissue-resident memory T (Trm) cells contribute to local immune
              protection in non-lymphoid tissues such as skin and mucosa, but
              little is known about their transcriptional regulation. Here we
              showed that CD8(+)CD103(+) Trm cells, independent of circulating
              memory T cells, were sufficient for protection against infection
              and described molecular elements that were crucial for their
              development in skin and lung. We demonstrated that the T-box
              transcription factors (TFs) Eomes and T-bet combined to control
              CD8(+)CD103(+) Trm cell formation, such that their coordinate
              downregulation was crucial for TGF-$\beta$ cytokine signaling.
              TGF-$\beta$ signaling, in turn, resulted in reciprocal T-box TF
              downregulation. However, whereas extinguishment of Eomes was
              necessary for CD8(+)CD103(+) Trm cell development, residual T-bet
              expression maintained cell surface interleukin-15 (IL-15)
              receptor $\beta$-chain (CD122) expression and thus IL-15
              responsiveness. These findings indicate that the T-box TFs
              control the two cytokines, TGF-$\beta$ and IL-15, which are
              pivotal for CD8(+)CD103(+) Trm cell development and survival.",
  journal  = "Immunity",
  volume   =  43,
  number   =  6,
  pages    = "1101--1111",
  month    =  dec,
  year     =  2015,
  keywords = "T-box transcription factors; TGF-$\beta$; Tissue-resident memory
              T cells; peripheral immunity;Mouse study",
  language = "en"
}

@ARTICLE{Zhu2017-om,
  title    = "{Tissue-Resident} Macrophages in Pancreatic Ductal Adenocarcinoma
              Originate from Embryonic Hematopoiesis and Promote Tumor
              Progression",
  author   = "Zhu, Yu and Herndon, John M and Sojka, Dorothy K and Kim, Ki-Wook
              and Knolhoff, Brett L and Zuo, Chong and Cullinan, Darren R and
              Luo, Jingqin and Bearden, Audrey R and Lavine, Kory J and
              Yokoyama, Wayne M and Hawkins, William G and Fields, Ryan C and
              Randolph, Gwendalyn J and DeNardo, David G",
  journal  = "Immunity",
  volume   =  47,
  number   =  3,
  pages    = "597",
  month    =  sep,
  year     =  2017,
  language = "en"
}

@ARTICLE{Li2019-gm,
  title    = "The Transcription Factor Bhlhe40 Programs Mitochondrial
              Regulation of Resident {CD8+} {T} Cell Fitness and Functionality",
  author   = "Li, Chaofan and Zhu, Bibo and Son, Young Min and Wang, Zheng and
              Jiang, Li and Xiang, Min and Ye, Zhenqing and Beckermann, Kathryn
              E and Wu, Yue and Jenkins, James W and Siska, Peter J and
              Vincent, Benjamin G and Prakash, Y S and Peikert, Tobias and
              Edelson, Brian T and Taneja, Reshma and Kaplan, Mark H and
              Rathmell, Jeffrey C and Dong, Haidong and Hitosugi, Taro and Sun,
              Jie",
  abstract = "Tissue-resident memory CD8+ T (Trm) cells share core residency
              gene programs with tumor-infiltrating lymphocytes (TILs).
              However, the transcriptional, metabolic, and epigenetic
              regulation of Trm cell and TIL development and function is
              largely undefined. Here, we found that the transcription factor
              Bhlhe40 was specifically required for Trm cell and TIL
              development and polyfunctionality. Local PD-1 signaling inhibited
              TIL Bhlhe40 expression, and Bhlhe40 was critical for TIL
              reinvigoration following anti-PD-L1 blockade. Mechanistically,
              Bhlhe40 sustained Trm cell and TIL mitochondrial fitness and a
              functional epigenetic state. Building on these findings, we
              identified an epigenetic and metabolic regimen that promoted Trm
              cell and TIL gene signatures associated with tissue residency and
              polyfunctionality. This regimen empowered the anti-tumor activity
              of CD8+ T cells and possessed therapeutic potential even at an
              advanced tumor stage in mouse models. Our results provide
              mechanistic insights into the local regulation of Trm cell and
              TIL function.",
  journal  = "Immunity",
  volume   =  51,
  number   =  3,
  pages    = "491--507.e7",
  month    =  sep,
  year     =  2019,
  keywords = "Bhlhe40; PD-L1; Tubastatin A; acetate; epigenetic; metabolism;
              mitochondria; tissue resident memory T cell; tumor-infiltrating
              lymphocytes;Mouse study",
  language = "en"
}

@ARTICLE{Mohamed2020-ip,
  title    = "The Unfolded Protein Response Mediator {PERK} Governs Myeloid
              {Cell-Driven} Immunosuppression in Tumors through Inhibition of
              {STING} Signaling",
  author   = "Mohamed, Eslam and Sierra, Rosa A and Trillo-Tinoco, Jimena and
              Cao, Yu and Innamarato, Patrick and Payne, Kyle K and de Mingo
              Pulido, Alvaro and Mandula, Jessica and Zhang, Shuzhong and
              Thevenot, Paul and Biswas, Subir and Abdalla, Sarah K and
              Costich, Tara Lee and H{\"a}nggi, Kay and Anadon, Carmen M and
              Flores, Elsa R and Haura, Eric B and Mehrotra, Shikhar and
              Pilon-Thomas, Shari and Ruffell, Brian and Munn, David H and
              Cubillos-Ruiz, Juan R and Conejo-Garcia, Jose R and Rodriguez,
              Paulo C",
  abstract = "The primary mechanisms supporting immunoregulatory polarization
              of myeloid cells upon infiltration into tumors remain largely
              unexplored. Elucidation of these signals could enable better
              strategies to restore protective anti-tumor immunity. Here, we
              investigated the role of the intrinsic activation of the PKR-like
              endoplasmic reticulum (ER) kinase (PERK) in the immunoinhibitory
              actions of tumor-associated myeloid-derived suppressor cells
              (tumor-MDSCs). PERK signaling increased in tumor-MDSCs, and its
              deletion transformed MDSCs into myeloid cells that activated CD8+
              T cell-mediated immunity against cancer. Tumor-MDSCs lacking PERK
              exhibited disrupted NRF2-driven antioxidant capacity and impaired
              mitochondrial respiratory homeostasis. Moreover, reduced NRF2
              signaling in PERK-deficient MDSCs elicited cytosolic
              mitochondrial DNA elevation and, consequently, STING-dependent
              expression of anti-tumor type I interferon. Reactivation of NRF2
              signaling, conditional deletion of STING, or blockade of type I
              interferon receptor I restored the immunoinhibitory potential of
              PERK-ablated MDSCs. Our findings demonstrate the pivotal role of
              PERK in tumor-MDSC functionality and unveil strategies to
              reprogram immunosuppressive myelopoiesis in tumors to boost
              cancer immunotherapy.",
  journal  = "Immunity",
  volume   =  52,
  number   =  4,
  pages    = "668--682.e7",
  month    =  apr,
  year     =  2020,
  keywords = "ER stress; MDSCs; NRF2; PERK; STING; tumor immunity; type I IFN;
              unfolded protein responses",
  language = "en"
}

@ARTICLE{Milner2020-wo,
  title    = "Heterogenous Populations of {Tissue-Resident} {CD8+} {T} Cells
              Are Generated in Response to Infection and Malignancy",
  author   = "Milner, J Justin and Toma, Clara and He, Zhaoren and Kurd, Nadia
              S and Nguyen, Quynh P and McDonald, Bryan and Quezada, Lauren and
              Widjaja, Christella E and Witherden, Deborah A and Crowl, John T
              and Shaw, Laura A and Yeo, Gene W and Chang, John T and Omilusik,
              Kyla D and Goldrath, Ananda W",
  abstract = "Tissue-resident memory CD8+ T cells (Trm) provide host protection
              through continuous surveillance of non-lymphoid tissues. Using
              single-cell RNA-sequencing (scRNA-seq) and genetic reporter mice,
              we identified discrete lineages of intestinal antigen-specific
              CD8+ T cells, including a Blimp1hiId3lo tissue-resident effector
              cell population most prominent in the early phase of acute viral
              and bacterial infections and a molecularly distinct Blimp1loId3hi
              tissue-resident memory population that subsequently accumulated
              at later infection time points. These Trm populations exhibited
              distinct cytokine production, secondary memory potential, and
              transcriptional programs including differential roles for
              transcriptional regulators Blimp1, T-bet, Id2, and Id3 in
              supporting and maintaining intestinal Trm. Extending our analysis
              to malignant tissue, we also identified discrete populations of
              effector-like and memory-like CD8+ T cell populations with
              tissue-resident gene-expression signatures that shared features
              of terminally exhausted and progenitor-exhausted T cells,
              respectively. Our findings provide insight into the development
              and functional heterogeneity of Trm cells, which has implications
              for enhancing vaccination and immunotherapy approaches.",
  journal  = "Immunity",
  volume   =  52,
  number   =  5,
  pages    = "808--824.e7",
  month    =  may,
  year     =  2020,
  keywords = "T cell; memory T cell; single-cell RNA-sequencing;
              tissue-resident memory T cells; tumor immunity;Mouse study",
  language = "en"
}

@ARTICLE{Bourdely2020-ub,
  title    = "Transcriptional and Functional Analysis of {CD1c+} Human
              Dendritic Cells Identifies a {CD163+} Subset Priming {CD8+CD103+}
              {T} Cells",
  author   = "Bourdely, Pierre and Anselmi, Giorgio and Vaivode, Kristine and
              Ramos, Rodrigo Nalio and Missolo-Koussou, Yoann and Hidalgo,
              Sofia and Tosselo, Jimena and Nu{\~n}ez, Nicolas and Richer,
              Wilfrid and Vincent-Salomon, Anne and Saxena, Alka and Wood,
              Kristie and Lladser, Alvaro and Piaggio, Eliane and Helft, Julie
              and Guermonprez, Pierre",
  abstract = "Dendritic cells (DCs) are antigen-presenting cells controlling T
              cell activation. In humans, the diversity, ontogeny, and
              functional capabilities of DC subsets are not fully understood.
              Here, we identified circulating CD88-CD1c+CD163+ DCs (called
              DC3s) as immediate precursors of inflammatory
              CD88-CD14+CD1c+CD163+Fc$\epsilon$RI+ DCs. DC3s develop via a
              specific pathway activated by GM-CSF, independent of
              cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors.
              Like classical DCs but unlike monocytes, DC3s drove activation of
              naive T cells. In vitro, DC3s displayed a distinctive ability to
              prime CD8+ T cells expressing a tissue homing signature and the
              epithelial homing alpha-E integrin (CD103) through transforming
              growth factor $\beta$ (TGF-$\beta$) signaling. In vivo, DC3s
              infiltrated luminal breast cancer primary tumors, and DC3
              infiltration correlated positively with CD8+CD103+CD69+
              tissue-resident memory T cells. Together, these findings define
              DC3s as a lineage of inflammatory DCs endowed with a strong
              potential to regulate tumor immunity.",
  journal  = "Immunity",
  volume   =  53,
  number   =  2,
  pages    = "335--352.e8",
  month    =  aug,
  year     =  2020,
  keywords = "DC progenitors; DC3s; T(RM); cDC2s; conventional DCs;
              inflammatory DCs; monocytes; mononuclear phagocytes;Human study",
  language = "en"
}

@ARTICLE{Dubrot2021-fb,
  title    = "In vivo screens using a selective {CRISPR} antigen removal
              lentiviral vector system reveal immune dependencies in renal cell
              carcinoma",
  author   = "Dubrot, Juan and Lane-Reticker, Sarah Kate and Kessler, Emily A
              and Ayer, Austin and Mishra, Gargi and Wolfe, Clara H and Zimmer,
              Margaret D and Du, Peter P and Mahapatra, Animesh and Ockerman,
              Kyle M and Davis, Thomas G R and Kohnle, Ian C and Pope, Hans W
              and Allen, Peter M and Olander, Kira E and Iracheta-Vellve, Arvin
              and Doench, John G and Haining, W Nicholas and Yates, Kathleen B
              and Manguso, Robert T",
  abstract = "CRISPR-Cas9 genome engineering has increased the pace of
              discovery for immunology and cancer biology, revealing potential
              therapeutic targets and providing insight into mechanisms
              underlying resistance to immunotherapy. However, endogenous
              immune recognition of Cas9 has limited the applicability of
              CRISPR technologies in vivo. Here, we characterized immune
              responses against Cas9 and other expressed CRISPR vector
              components that cause antigen-specific tumor rejection in several
              mouse cancer models. To avoid unwanted immune recognition, we
              designed a lentiviral vector system that allowed selective CRISPR
              antigen removal (SCAR) from tumor cells. The SCAR system reversed
              immune-mediated rejection of CRISPR-modified tumor cells in vivo
              and enabled high-throughput genetic screens in previously
              intractable models. A pooled in vivo screen using SCAR in a
              CRISPR-antigen-sensitive renal cell carcinoma revealed resistance
              pathways associated with autophagy and major histocompatibility
              complex class I (MHC class I) expression. Thus, SCAR presents a
              resource that enables CRISPR-based studies of tumor-immune
              interactions and prevents unwanted immune recognition of
              genetically engineered cells, with implications for clinical
              applications.",
  journal  = "Immunity",
  volume   =  54,
  number   =  3,
  pages    = "571--585.e6",
  month    =  mar,
  year     =  2021,
  keywords = "CRISPR; Natural Killer cells; antigen presentation; checkpoint
              blockade; immuno-oncology; immunotherapy; in vivo screen;
              lentiviral vectors; pooled screen; target discovery",
  language = "en"
}

@ARTICLE{Cheng2021-by,
  title    = "Non-terminally exhausted tumor-resident memory {HBV-specific} {T}
              cell responses correlate with relapse-free survival in
              hepatocellular carcinoma",
  author   = "Cheng, Yang and Gunasegaran, Bavani and Singh, Harsimran D and
              Dutertre, Charles-Antoine and Loh, Chiew Yee and Lim, Jia Qi and
              Crawford, Jeremy Chase and Lee, Hong Kai and Zhang, Xiaomeng and
              Lee, Bernett and Becht, Etienne and Lim, Wan Jun and Yeong, Joe
              and Chan, Chung Yip and Chung, Alexander and Goh, Brian K P and
              Chow, Pierce K H and Chan, Jerry K Y and Ginhoux, Florent and
              Tai, David and Chen, Jinmiao and Lim, Seng Gee and Zhai, Weiwei
              and Choo, Su Pin and Newell, Evan W",
  abstract = "Hepatocellular carcinoma (HCC) often develops following chronic
              hepatitis B virus (HBV) infection and responds poorly to immune
              checkpoint blockade. Here, we examined the antigen specificities
              of HCC-infiltrating T cells and their relevance to tumor control.
              Using highly multiplexed peptide-MHC tetramer staining of
              unexpanded cells from blood, liver, and tumor tissues from 46 HCC
              patients, we detected 91 different antigen-specific CD8+ T cell
              populations targeting HBV, neoantigen, tumor-associated, and
              disease-unrelated antigens. Parallel high-dimensional analysis
              delineated five distinct antigen-specific tissue-resident memory
              T (Trm) cell populations. Intratumoral and intrahepatic
              HBV-specific T cells were enriched for two Trm cell subsets that
              were PD-1loTOXlo, despite being clonally expanded. High
              frequencies of intratumoral terminally exhausted T cells were
              uncommon. Patients with tumor-infiltrating HBV-specific CD8+ Trm
              cells exhibited longer-term relapse-free survival. Thus,
              non-terminally exhausted HBV-specific CD8+ Trm cells show
              hallmarks of active involvement and effective antitumor response,
              implying that these cells could be harnessed for therapeutic
              purposes.",
  journal  = "Immunity",
  volume   =  54,
  number   =  8,
  pages    = "1825--1840.e7",
  month    =  aug,
  year     =  2021,
  keywords = "CD8; HBV; HCC; T cell exhaustion; TCR; Tex; Trm; highly
              multiplexed pMHC tetramer; mass cytometry; virus-specific T
              cell;Human study",
  language = "en"
}

@ARTICLE{Molodtsov2021-im,
  title    = "Resident memory {CD8+} {T} cells in regional lymph nodes mediate
              immunity to metastatic melanoma",
  author   = "Molodtsov, Aleksey K and Khatwani, Nikhil and Vella, Jennifer L
              and Lewis, Kathryn A and Zhao, Yanding and Han, Jichang and
              Sullivan, Delaney E and Searles, Tyler G and Preiss, Nicholas K
              and Shabaneh, Tamer B and Zhang, Peisheng and Hawkes, Aaron R and
              Malik, Brian T and Kolling, 4th, Fred W and Usherwood, Edward J
              and Wong, Sandra L and Phillips, Joseph D and Shirai, Keisuke and
              Angeles, Christina V and Yan, Shaofeng and Curiel, Tyler J and
              Huang, Yina H and Cheng, Chao and Turk, Mary Jo",
  abstract = "The nature of the anti-tumor immune response changes as primary
              tumors progress and metastasize. We investigated the role of
              resident memory (Trm) and circulating memory (Tcirm) cells in
              anti-tumor responses at metastatic locations using a mouse model
              of melanoma-associated vitiligo. We found that the
              transcriptional characteristics of tumor-specific CD8+ T cells
              were defined by the tissue of occupancy. Parabiosis revealed that
              tumor-specific Trm and Tcirm compartments persisted throughout
              visceral organs, but Trm cells dominated lymph nodes (LNs).
              Single-cell RNA-sequencing profiles of Trm cells in LN and skin
              were distinct, and T cell clonotypes that occupied both tissues
              were overwhelmingly maintained as Trm in LNs. Whereas Tcirm cells
              prevented melanoma growth in the lungs, Trm afforded long-lived
              protection against melanoma seeding in LNs. Expanded Trm
              populations were also present in melanoma-involved LNs from
              patients, and their transcriptional signature predicted better
              survival. Thus, tumor-specific Trm cells persist in LNs,
              restricting metastatic cancer.",
  journal  = "Immunity",
  volume   =  54,
  number   =  9,
  pages    = "2117--2132.e7",
  month    =  sep,
  year     =  2021,
  keywords = "CD69; CD8 T cells; CXCR6; Cancer; TCR; TRP-2; Trm; parabiosis;
              scRNA-seq; vitiligo;Mouse study",
  language = "en"
}

@ARTICLE{Barsch2022-ef,
  title    = "T-cell exhaustion and residency dynamics inform clinical outcomes
              in hepatocellular carcinoma",
  author   = "Barsch, Maryam and Sali{\'e}, Henrike and Schlaak, Alexandra
              Emilia and Zhang, Zhen and Hess, Moritz and Mayer, Lena Sophie
              and Tauber, Catrin and Otto-Mora, Patricia and Ohtani, Takuya and
              Nilsson, Tobias and Wischer, Lara and Winkler, Frances and Manne,
              Sasikant and Rech, Andrew and Schmitt-Graeff, Annette and
              Bronsert, Peter and Hofmann, Maike and Neumann-Haefelin,
              Christoph and Boettler, Tobias and Fichtner-Feigl, Stefan and van
              Boemmel, Florian and Berg, Thomas and Rimassa, Lorenza and Di
              Tommaso, Luca and Saeed, Anwaar and D'Alessio, Antonio and
              Pinato, David J and Bettinger, Dominik and Binder, Harald and
              John Wherry, E and Schultheiss, Michael and Thimme, Robert and
              Bengsch, Bertram",
  abstract = "BACKGROUND \& AIMS: Despite recent translation of immunotherapies
              into clinical practice, the immunobiology of hepatocellular
              carcinoma (HCC), in particular the role and clinical relevance of
              exhausted and liver-resident T cells remain unclear. We therefore
              dissected the landscape of exhausted and resident T cell
              responses in the peripheral blood and tumor microenvironment of
              patients with HCC. METHODS: Lymphocytes were isolated from the
              blood, tumor and tumor-surrounding liver tissue of patients with
              HCC (n = 40, n = 10 treated with anti-PD-1 therapy). Phenotype,
              function and response to anti-PD-1 were analyzed by mass and flow
              cytometry ex vivo and in vitro, tissue residence was further
              assessed by immunohistochemistry and imaging mass cytometry. Gene
              signatures were analyzed in silico. RESULTS: We identified
              significant enrichment of heterogeneous populations of exhausted
              CD8+ T cells (TEX) in the tumor microenvironment. Strong
              enrichment of severely exhausted CD8 T cells expressing multiple
              immune checkpoints in addition to PD-1 was linked to poor
              progression-free and overall survival. In contrast, PD-1 was also
              expressed on a subset of more functional and metabolically active
              CD103+ tissue-resident memory T cells (TRM) that expressed few
              additional immune checkpoints and were associated with better
              survival. TEX enrichment was independent of BCLC stage,
              alpha-fetoprotein levels or age as a variable for
              progression-free survival in our cohort. These findings were in
              line with in silico gene signature analysis of HCC tumor
              transcriptomes from The Cancer Genome Atlas. A higher baseline
              TRM/TEX ratio was associated with disease control in
              anti-PD-1-treated patients. CONCLUSION: Our data provide
              information on the role of peripheral and intratumoral TEX-TRM
              dynamics in determining outcomes in patients with HCC. The
              dynamics between exhausted and liver-resident T cells have
              implications for immune-based diagnostics, rational patient
              selection and monitoring during HCC immunotherapies. LAY SUMMARY:
              The role of the immune response in hepatocellular carcinoma (HCC)
              remains unclear. T cells can mediate protection against tumor
              cells but are frequently dysfunctional and exhausted in cancer.
              We found that patients with a predominance of exhausted CD8+ T
              cells (TEX) had poor survival compared to patients with a
              predominance of tissue-resident memory T cells (TRM). This
              correlated with the molecular profile, metabolic and functional
              status of these cell populations. The enrichment of TEX was
              independently associated with prognosis in addition to disease
              stage, age and tumor markers. A high TRM proportion was also
              associated with better outcomes following checkpoint therapy.
              Thus, these T-cell populations are novel biomarkers with
              relevance in HCC.",
  journal  = "J. Hepatol.",
  volume   =  77,
  number   =  2,
  pages    = "397--409",
  month    =  aug,
  year     =  2022,
  keywords = "Hepatocellular Carcinoma; PD-1; T-cell exhaustion; immune
              checkpoint blockade; immune profiling; mass cytometry;
              tissue-resident memory T cells;Human study",
  language = "en"
}

@ARTICLE{Wang2015-wq,
  title    = "{CD103+} Tumor Infiltrating Lymphocytes Predict a Favorable
              Prognosis in Urothelial Cell Carcinoma of the Bladder",
  author   = "Wang, Bo and Wu, Shaoxu and Zeng, Hong and Liu, Zhuowei and Dong,
              Wen and He, Wang and Chen, Xu and Dong, Xiaoliang and Zheng,
              Limin and Lin, Tianxin and Huang, Jian",
  abstract = "PURPOSE: CD8(+) TILs at different tumor sites have diverse
              clinical attributes, which might result from distinct tumor
              microenvironments that promote differentiation into distinct
              subsets. However, only a few markers have been identified that
              can define CD8(+) T-cell subsets. CD103 is a marker of tissue
              resident memory CD8(+) T cells. In this retrospective study we
              investigated the cellular source and clinical significance of
              CD103 expression in urothelial cell carcinoma of bladder tissues
              in situ. MATERIALS AND METHODS: Immunohistochemistry and
              immunofluorescence were used to identify the cellular source of
              CD103 in bladder urothelial cell carcinoma tissues. Kaplan-Meier
              analysis and Cox proportional hazards regression models were
              applied to estimate overall and recurrence-free survival in 302
              patients with bladder urothelial cell carcinoma. RESULTS: CD8(+)
              T cells but not natural killer cells accounted for most CD103
              expressing cells in bladder urothelial cell carcinoma tissues.
              Notably CD103(+) cells were predominantly located in intratumor
              regions rather than in associated stroma (p < 0.0001). The
              density of intratumor CD103(+) TILs was inversely associated with
              tumor size (p < 0.0001) and could represent a favorable
              prognostic predictor of overall and recurrence-free survival (p =
              0.002 and 0.011, respectively). Moreover, intratumor CD103(+)
              TILs were positively associated with the expression of cognate
              ligand E-cadherin in intratumor regions of bladder urothelial
              cell carcinoma tissues (p = 0.008). CONCLUSIONS: Our findings
              suggest that CD8(+) T cells might have a significant role in
              tumor immunity by expressing CD103 in intratumor regions of
              bladder urothelial cell carcinoma tissues. Intratumor CD103(+)
              TILs could potentially serve as a prognostic marker in patients
              with bladder urothelial cell carcinoma.",
  journal  = "J. Urol.",
  volume   =  194,
  number   =  2,
  pages    = "556--562",
  month    =  aug,
  year     =  2015,
  keywords = "CD8; antigens; carcinoma; lymphocytes; prognosis; tumor
              infiltrating; urinary bladder;Human study",
  language = "en"
}

@ARTICLE{Chang2018-fh,
  title    = "Coordination between Two Branches of the Unfolded Protein
              Response Determines Apoptotic Cell Fate",
  author   = "Chang, Tsun-Kai and Lawrence, David A and Lu, Min and Tan,
              Jenille and Harnoss, Jonathan M and Marsters, Scot A and Liu,
              Peter and Sandoval, Wendy and Martin, Scott E and Ashkenazi, Avi",
  abstract = "The kinases PERK and IRE1 alleviate endoplasmic reticulum (ER)
              stress by orchestrating the unfolded protein response (UPR). If
              stress mitigation fails, PERK promotes cell death by activating
              pro-apoptotic genes, including death receptor 5 (DR5).
              Conversely, IRE1-which harbors both kinase and endoribonuclease
              (RNase) modules-blocks apoptosis through regulated IRE1-dependent
              decay (RIDD) of DR5 mRNA. Under irresolvable ER stress, PERK
              activity persists, whereas IRE1 paradoxically attenuates, by
              mechanisms that remain obscure. Here, we report that PERK governs
              IRE1's attenuation through a phosphatase known as RPAP2 (RNA
              polymerase II-associated protein 2). RPAP2 reverses IRE1
              phosphorylation, oligomerization, and RNase activation. This
              inhibits IRE1-mediated adaptive events, including activation of
              the cytoprotective transcription factor XBP1s, and ER-associated
              degradation of unfolded proteins. Furthermore, RIDD termination
              by RPAP2 unleashes DR5-mediated caspase activation and drives
              cell death. Thus, PERK attenuates IRE1 via RPAP2 to abort failed
              ER-stress adaptation and trigger apoptosis.",
  journal  = "Mol. Cell",
  volume   =  71,
  number   =  4,
  pages    = "629--636.e5",
  month    =  aug,
  year     =  2018,
  keywords = "ISRIB; activated transcription factors; protein folding; protein
              translation; proteostasis; siRNA-based screening",
  language = "en"
}

@ARTICLE{Corgnac2020-nw,
  title    = "{CD103+CD8+} {TRM} Cells Accumulate in Tumors of
              {Anti-PD-1-Responder} Lung Cancer Patients and Are
              {Tumor-Reactive} Lymphocytes Enriched with Tc17",
  author   = "Corgnac, St{\'e}phanie and Malenica, Ines and Mezquita, Laura and
              Auclin, Edouard and Voilin, Elodie and Kacher, Jamila and Halse,
              Heloise and Grynszpan, Laetitia and Signolle, Nicolas and Dayris,
              Thibault and Leclerc, Marine and Droin, Nathalie and de
              Montpr{\'e}ville, Vincent and Mercier, Olaf and Validire, Pierre
              and Scoazec, Jean-Yves and Massard, Christophe and Chouaib, Salem
              and Planchard, David and Adam, Julien and Besse, Benjamin and
              Mami-Chouaib, Fathia",
  abstract = "Accumulation of CD103+CD8+ resident memory T (TRM) cells in human
              lung tumors has been associated with a favorable prognosis.
              However, the contribution of TRM to anti-tumor immunity and to
              the response to immune checkpoint blockade has not been clearly
              established. Using quantitative multiplex immunofluorescence on
              cohorts of non-small cell lung cancer patients treated with
              anti-PD-(L)1, we show that an increased density of CD103+CD8+
              lymphocytes in immunotherapy-naive tumors is associated with
              greatly improved outcomes. The density of CD103+CD8+ cells
              increases during immunotherapy in most responder, but not in
              non-responder, patients. CD103+CD8+ cells co-express CD49a and
              CD69 and display a molecular profile characterized by the
              expression of PD-1 and CD39. CD103+CD8+ tumor TRM, but not
              CD103-CD8+ tumor-infiltrating counterparts, express Aiolos,
              phosphorylated STAT-3, and IL-17; demonstrate enhanced
              proliferation and cytotoxicity toward autologous cancer cells;
              and frequently display oligoclonal expansion of TCR-$\beta$
              clonotypes. These results explain why CD103+CD8+ TRM are
              associated with better outcomes in anti-PD-(L)1-treated patients.",
  journal  = "Cell Rep Med",
  volume   =  1,
  number   =  7,
  pages    = "100127",
  month    =  oct,
  year     =  2020,
  keywords = "Aiolos, AhR, and T-bet transcription factors; CD103 integrin; CD8
              TRM cells; CTL; ICB response biomarkers; TCR repertoire; Tc17;
              anti-PD-1 immunotherapy; lung cancer; tumor-infiltrating
              lymphocytes;Human study",
  language = "en"
}

@ARTICLE{Nguyen2021-ia,
  title    = "A protocol for macrophage depletion and reconstitution in a mouse
              model of sepsis",
  author   = "Nguyen, Tivoli and Du, Jie and Li, Yan Chun",
  abstract = "Macrophages are key innate immune cells involved in a broad
              spectrum of physiological and pathological processes. Macrophage
              depletion with clodronate-liposomes is commonly used to
              investigate in vivo functions of macrophages in mice. Here, we
              describe a protocol that combines the depletion of resident
              macrophages with the reconstitution of the mice with in vitro
              differentiated, lentivirus-transduced bone marrow-derived
              macrophages (BMDMs) in the context of an experimental sepsis
              model. This experimental strategy is easily adapted to other
              experimental designs. For complete details on the use and
              execution of this protocol, please refer to Du et al. (2020).",
  journal  = "STAR Protoc",
  volume   =  2,
  number   =  4,
  pages    = "101004",
  month    =  dec,
  year     =  2021,
  keywords = "Cell Biology; Cell Differentiation; Flow Cytometry/Mass
              Cytometry; Immunology; Model Organisms",
  language = "en"
}

@ARTICLE{Nind1973-hc,
  title    = "Lymphocyte anergy in patients with carcinoma",
  author   = "Nind, A P and Nairn, R C and Rolland, J M and Guli, E P and
              Hughes, E S",
  abstract = "All of 10 patients with colonic carcinoma and 5 with malignant
              melanoma of skin showed no sign of immunoreactivity against the
              cultured tumour cells by the lymphocyte populations residing
              within the tumours. More than half of these patients did show
              cytotoxic reactivity by their blood lymphocytes. Possible
              cytotoxic reactivity by the regional lymph node lymphocytes was
              also investigated in 57 tumour cases (44 colonic, 13 melanoma,
              and including 12 of the 15 examined for intrinsic lymphocyte
              activity). One third of the cases showed positive blood
              lymphocyte immunoreactivity, but in only 4 tumours (3 colonic)
              did the node lymphocytes show any cytotoxicity against the tumour
              cells. This state of anergy of intrinsic and regional lymphocytes
              is presumably acquired during the development of the cancer and
              would permit local tumour spread and metastasis to lymph nodes.
              Its cause has not been identified but appears to be lymphocyte
              inhibition rather than selective change in lymphocyte population.
              In particular, no special pattern can be seen in the relative
              proportions of T and B cells in patients' blood, lymph node or
              intrinsic carcinoma lymphocytes.",
  journal  = "Br. J. Cancer",
  volume   =  28,
  number   =  2,
  pages    = "108--117",
  month    =  aug,
  year     =  1973,
  keywords = "ARI CD8;Human study",
  language = "en"
}

@ARTICLE{Pan2017-bd,
  title    = "Survival of tissue-resident memory {T} cells requires exogenous
              lipid uptake and metabolism",
  author   = "Pan, Youdong and Tian, Tian and Park, Chang Ook and Lofftus,
              Serena Y and Mei, Shenglin and Liu, Xing and Luo, Chi and
              O'Malley, John T and Gehad, Ahmed and Teague, Jessica E and
              Divito, Sherrie J and Fuhlbrigge, Robert and Puigserver, Pere and
              Krueger, James G and Hotamisligil, G{\"o}khan S and Clark,
              Rachael A and Kupper, Thomas S",
  abstract = "Tissue-resident memory T (TRM) cells persist indefinitely in
              epithelial barrier tissues and protect the host against
              pathogens. However, the biological pathways that enable the
              long-term survival of TRM cells are obscure. Here we show that
              mouse CD8+ TRM cells generated by viral infection of the skin
              differentially express high levels of several molecules that
              mediate lipid uptake and intracellular transport, including
              fatty-acid-binding proteins 4 and 5 (FABP4 and FABP5). We further
              show that T-cell-specific deficiency of Fabp4 and Fabp5
              (Fabp4/Fabp5) impairs exogenous free fatty acid (FFA) uptake by
              CD8+ TRM cells and greatly reduces their long-term survival in
              vivo, while having no effect on the survival of central memory T
              (TCM) cells in lymph nodes. In vitro, CD8+ TRM cells, but not
              CD8+ TCM cells, demonstrated increased mitochondrial oxidative
              metabolism in the presence of exogenous FFAs; this increase was
              not seen in Fabp4/Fabp5 double-knockout CD8+ TRM cells. The
              persistence of CD8+ TRM cells in the skin was strongly diminished
              by inhibition of mitochondrial FFA $\beta$-oxidation in vivo.
              Moreover, skin CD8+ TRM cells that lacked Fabp4/Fabp5 were less
              effective at protecting mice from cutaneous viral infection, and
              lung Fabp4/Fabp5 double-knockout CD8+ TRM cells generated by skin
              vaccinia virus (VACV) infection were less effective at protecting
              mice from a lethal pulmonary challenge with VACV. Consistent with
              the mouse data, increased FABP4 and FABP5 expression and enhanced
              extracellular FFA uptake were also demonstrated in human CD8+ TRM
              cells in normal and psoriatic skin. These results suggest that
              FABP4 and FABP5 have a critical role in the maintenance,
              longevity and function of CD8+ TRM cells, and suggest that CD8+
              TRM cells use exogenous FFAs and their oxidative metabolism to
              persist in tissue and to mediate protective immunity.",
  journal  = "Nature",
  volume   =  543,
  number   =  7644,
  pages    = "252--256",
  month    =  mar,
  year     =  2017,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Milner2017-rq,
  title    = "Runx3 programs {CD8+} {T} cell residency in non-lymphoid tissues
              and tumours",
  author   = "Milner, J Justin and Toma, Clara and Yu, Bingfei and Zhang, Kai
              and Omilusik, Kyla and Phan, Anthony T and Wang, Dapeng and
              Getzler, Adam J and Nguyen, Toan and Crotty, Shane and Wang, Wei
              and Pipkin, Matthew E and Goldrath, Ananda W",
  abstract = "Tissue-resident memory CD8+ T (TRM) cells are found at common
              sites of pathogen exposure, where they elicit rapid and robust
              protective immune responses. However, the molecular signals that
              control TRM cell differentiation and homeostasis are not fully
              understood. Here we show that mouse TRM precursor cells represent
              a unique CD8+ T cell subset that is distinct from the precursors
              of circulating memory cell populations at the levels of gene
              expression and chromatin accessibility. Using computational and
              pooled in vivo RNA interference screens, we identify the
              transcription factor Runx3 as a key regulator of TRM cell
              differentiation and homeostasis. Runx3 was required to establish
              TRM cell populations in diverse tissue environments, and
              supported the expression of crucial tissue-residency genes while
              suppressing genes associated with tissue egress and
              recirculation. Furthermore, we show that human and mouse
              tumour-infiltrating lymphocytes share a core tissue-residency
              gene-expression signature with TRM cells that is associated with
              Runx3 activity. In a mouse model of adoptive T cell therapy for
              melanoma, Runx3-deficient CD8+ tumour-infiltrating lymphocytes
              failed to accumulate in tumours, resulting in greater rates of
              tumour growth and mortality. Conversely, overexpression of Runx3
              enhanced tumour-specific CD8+ T cell abundance, delayed tumour
              growth, and prolonged survival. In addition to establishing Runx3
              as a central regulator of TRM cell differentiation, these results
              provide insight into the signals that promote T cell residency in
              non-lymphoid sites, which could be used to enhance vaccine
              efficacy or adoptive cell therapy treatments that target cancer.",
  journal  = "Nature",
  volume   =  552,
  number   =  7684,
  pages    = "253--257",
  month    =  dec,
  year     =  2017,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Ouzounova2017-ff,
  title       = "Monocytic and granulocytic myeloid derived suppressor cells
                 differentially regulate spatiotemporal tumour plasticity
                 during metastatic cascade",
  author      = "Ouzounova, Maria and Lee, Eunmi and Piranlioglu, Raziye and El
                 Andaloussi, Abdeljabar and Kolhe, Ravindra and Demirci, Mehmet
                 F and Marasco, Daniela and Asm, Iskander and Chadli, Ahmed and
                 Hassan, Khaled A and Thangaraju, Muthusamy and Zhou, Gang and
                 Arbab, Ali S and Cowell, John K and Korkaya, Hasan",
  abstract    = "It is widely accepted that dynamic and reversible tumour cell
                 plasticity is required for metastasis, however, in vivo steps
                 and molecular mechanisms are poorly elucidated. We demonstrate
                 here that monocytic (mMDSC) and granulocytic (gMDSC) subsets
                 of myeloid-derived suppressor cells infiltrate in the primary
                 tumour and distant organs with different time kinetics and
                 regulate spatiotemporal tumour plasticity. Using co-culture
                 experiments and mouse transcriptome analyses in syngeneic
                 mouse models, we provide evidence that tumour-infiltrated
                 mMDSCs facilitate tumour cell dissemination from the primary
                 site by inducing EMT/CSC phenotype. In contrast, pulmonary
                 gMDSC infiltrates support the metastatic growth by reverting
                 EMT/CSC phenotype and promoting tumour cell proliferation.
                 Furthermore, lung-derived gMDSCs isolated from tumour-bearing
                 animals enhance metastatic growth of already disseminated
                 tumour cells. MDSC-induced 'metastatic gene signature' derived
                 from murine syngeneic model predicts poor patient survival in
                 the majority of human solid tumours. Thus spatiotemporal MDSC
                 infiltration may have clinical implications in tumour
                 progression.",
  journal     = "Nat. Commun.",
  volume      =  8,
  pages       = "14979",
  month       =  apr,
  year        =  2017,
  language    = "en",
  original_id = "c082a089-f4f8-0f49-b4c5-f1e975faa17b"
}

@ARTICLE{Nizard2017-ay,
  title    = "Induction of resident memory {T} cells enhances the efficacy of
              cancer vaccine",
  author   = "Nizard, Mevyn and Roussel, H{\'e}l{\`e}ne and Diniz, Mariana O
              and Karaki, Soumaya and Tran, Thi and Voron, Thibault and
              Dransart, Estelle and Sandoval, Federico and Riquet, Marc and
              Rance, Bastien and Marcheteau, Elie and Fabre, Elizabeth and
              Mandavit, Marion and Terme, Magali and Blanc, Charlotte and
              Escudie, Jean-Baptiste and Gibault, Laure and Barthes, Fran{\c
              c}oise Le Pimpec and Granier, Clemence and Ferreira, Luis C S and
              Badoual, Cecile and Johannes, Ludger and Tartour, Eric",
  abstract = "Tissue-resident memory T cells (Trm) represent a new subset of
              long-lived memory T cells that remain in tissue and do not
              recirculate. Although they are considered as early immune
              effectors in infectious diseases, their role in cancer
              immunosurveillance remains unknown. In a preclinical model of
              head and neck cancer, we show that intranasal vaccination with a
              mucosal vector, the B subunit of Shiga toxin, induces local Trm
              and inhibits tumour growth. As Trm do not recirculate, we
              demonstrate their crucial role in the efficacy of cancer vaccine
              with parabiosis experiments. Blockade of TFG$\beta$ decreases the
              induction of Trm after mucosal vaccine immunization, resulting in
              the lower efficacy of cancer vaccine. In order to extrapolate
              this role of Trm in humans, we show that the number of Trm
              correlates with a better overall survival in lung cancer in
              multivariate analysis. The induction of Trm may represent a new
              surrogate biomarker for the efficacy of cancer vaccine. This
              study also argues for the development of vaccine strategies
              designed to elicit them.",
  journal  = "Nat. Commun.",
  volume   =  8,
  pages    = "15221",
  month    =  may,
  year     =  2017,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Enamorado2017-fx,
  title    = "Enhanced anti-tumour immunity requires the interplay between
              resident and circulating memory {CD8+} {T} cells",
  author   = "Enamorado, Michel and Iborra, Salvador and Priego, Elena and
              Cueto, Francisco J and Quintana, Juan A and Mart{\'\i}nez-Cano,
              Sarai and Mej{\'\i}as-P{\'e}rez, Ernesto and Esteban, Mariano and
              Melero, Ignacio and Hidalgo, Andr{\'e}s and Sancho, David",
  abstract = "The goal of successful anti-tumoural immunity is the development
              of long-term protective immunity to prevent relapse. Infiltration
              of tumours with CD8+ T cells with a resident memory (Trm)
              phenotype correlates with improved survival. However, the
              interplay of circulating CD8+ T cells and Trm cells remains
              poorly explored in tumour immunity. Using different vaccination
              strategies that fine-tune the generation of Trm cells or
              circulating memory T cells, here we show that, while both subsets
              are sufficient for anti-tumour immunity, the presence of Trm
              cells improves anti-tumour efficacy. Transferred central memory T
              cells (Tcm) generate Trm cells following viral infection or
              tumour challenge. Anti-PD-1 treatment promotes infiltration of
              transferred Tcm cells within tumours, improving anti-tumour
              immunity. Moreover, Batf3-dependent dendritic cells are essential
              for reactivation of circulating memory anti-tumour response. Our
              findings show the plasticity, collaboration and requirements for
              reactivation of memory CD8+ T cells subsets needed for optimal
              tumour vaccination and immunotherapy.",
  journal  = "Nat. Commun.",
  volume   =  8,
  pages    = "16073",
  month    =  jul,
  year     =  2017,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Mohammed2016-gq,
  title    = "Stromal cells control the epithelial residence of {DCs} and
              memory {T} cells by regulated activation of {TGF-$\beta$}",
  author   = "Mohammed, Javed and Beura, Lalit K and Bobr, Aleh and Astry,
              Brian and Chicoine, Brian and Kashem, Sakeen W and Welty, Nathan
              E and Igy{\'a}rt{\'o}, Botond Z and Wijeyesinghe, Sathi and
              Thompson, Emily A and Matte, Catherine and Bartholin, Laurent and
              Kaplan, Alesia and Sheppard, Dean and Bridges, Alina G and
              Shlomchik, Warren D and Masopust, David and Kaplan, Daniel H",
  abstract = "Cells of the immune system that reside in barrier epithelia
              provide a first line of defense against pathogens. Langerhans
              cells (LCs) and CD8(+) tissue-resident memory T cells (TRM cells)
              require active transforming growth factor-$\beta$1 (TGF-$\beta$)
              for epidermal residence. Here we found that integrins
              $\alpha$v$\beta$6 and $\alpha$v$\beta$8 were expressed in
              non-overlapping patterns by keratinocytes (KCs) and maintained
              the epidermal residence of LCs and TRM cells by activating latent
              TGF-$\beta$. Similarly, the residence of dendritic cells and TRM
              cells in the small intestine epithelium also required
              $\alpha$v$\beta$6. Treatment of the skin with ultraviolet
              irradiation decreased integrin expression on KCs and reduced the
              availability of active TGF-$\beta$, which resulted in LC
              migration. Our data demonstrated that regulated activation of
              TGF-$\beta$ by stromal cells was able to directly control
              epithelial residence of cells of the immune system through a
              novel mechanism of intercellular communication.",
  journal  = "Nat. Immunol.",
  volume   =  17,
  number   =  4,
  pages    = "414--421",
  month    =  apr,
  year     =  2016,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Ganesan2017-gp,
  title    = "Tissue-resident memory features are linked to the magnitude of
              cytotoxic {T} cell responses in human lung cancer",
  author   = "Ganesan, Anusha-Preethi and Clarke, James and Wood, Oliver and
              Garrido-Martin, Eva M and Chee, Serena J and Mellows, Toby and
              Samaniego-Castruita, Daniela and Singh, Divya and Seumois,
              Gr{\'e}gory and Alzetani, Aiman and Woo, Edwin and Friedmann,
              Peter S and King, Emma V and Thomas, Gareth J and Sanchez-Elsner,
              Tilman and Vijayanand, Pandurangan and Ottensmeier, Christian H",
  abstract = "Therapies that boost the anti-tumor responses of cytotoxic T
              lymphocytes (CTLs) have shown promise; however, clinical
              responses to the immunotherapeutic agents currently available
              vary considerably, and the molecular basis of this is unclear. We
              performed transcriptomic profiling of tumor-infiltrating CTLs
              from treatment-naive patients with lung cancer to define the
              molecular features associated with the robustness of anti-tumor
              immune responses. We observed considerable heterogeneity in the
              expression of molecules associated with activation of the T cell
              antigen receptor (TCR) and of immunological-checkpoint molecules
              such as 4-1BB, PD-1 and TIM-3. Tumors with a high density of CTLs
              showed enrichment for transcripts linked to tissue-resident
              memory cells (TRM cells), such as CD103, and CTLs from CD103hi
              tumors displayed features of enhanced cytotoxicity. A greater
              density of TRM cells in tumors was predictive of a better
              survival outcome in lung cancer, and this effect was independent
              of that conferred by CTL density. Here we define the 'molecular
              fingerprint' of tumor-infiltrating CTLs and identify potentially
              new targets for immunotherapy.",
  journal  = "Nat. Immunol.",
  volume   =  18,
  number   =  8,
  pages    = "940--950",
  month    =  aug,
  year     =  2017,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Nagarsheth2017-gk,
  title    = "Chemokines in the cancer microenvironment and their relevance in
              cancer immunotherapy",
  author   = "Nagarsheth, Nisha and Wicha, Max S and Zou, Weiping",
  abstract = "The tumour microenvironment is the primary location in which
              tumour cells and the host immune system interact. Different
              immune cell subsets are recruited into the tumour
              microenvironment via interactions between chemokines and
              chemokine receptors, and these populations have distinct effects
              on tumour progression and therapeutic outcomes. In this Review,
              we focus on the main chemokines that are found in the human
              tumour microenvironment; we elaborate on their patterns of
              expression, their regulation and their roles in immune cell
              recruitment and in cancer and stromal cell biology, and we
              consider how they affect cancer immunity and tumorigenesis. We
              also discuss the potential of targeting chemokine networks, in
              combination with other immunotherapies, for the treatment of
              cancer.",
  journal  = "Nat. Rev. Immunol.",
  volume   =  17,
  number   =  9,
  pages    = "559--572",
  month    =  sep,
  year     =  2017,
  language = "en"
}

@ARTICLE{Jin2022-cq,
  title    = "{CD103+CD8+} tissue-resident memory {T} cell infiltration
              predicts clinical outcome and adjuvant therapeutic benefit in
              muscle-invasive bladder cancer",
  author   = "Jin, Kaifeng and Yu, Yanze and Zeng, Han and Liu, Zhaopei and
              You, Runze and Zhang, Hongyi and Liu, Chunnan and Su, Xiaohe and
              Yan, Sen and Chang, Yuan and Xu, Le and Xu, Jiejie and Zhu, Yu
              and Wang, Zewei",
  abstract = "BACKGROUND: CD103+CD8+ tissue-resident memory T (TRM) cells,
              associated with better overall survival among various
              malignancies, are thought to activate anti-tumour immune response
              and affect therapeutic sensitivity including both immunotherapy
              and adjuvant chemotherapy (ACT). METHODS: Totally 650
              muscle-invasive bladder cancer (MIBC) patients from three
              independent cohorts were included in this study for survival and
              cisplatin-based ACT response analysis. Another public data set
              consisting of 195 patients from IMvigor210 trial receiving PD-L1
              blockade were involved in the assessment of immunotherapeutic
              response. Fifty-nine fresh tumour tissues were used to evaluate
              immune infiltration of CD103+CD8+ TRM cells. RESULTS: Patients
              with high CD103+CD8+ TRM cells infiltration, but not CD8+ T
              cells, are more likely to benefit from immunotherapy and ACT. The
              presence of TRM cells is highly associated with an enhanced
              IFN$\gamma$-enriched and T cell-inflamed anti-tumour
              microenvironment. Elevated CD103+CD8+ TRM cells infiltration
              correlated with superior ACT response in mismatch repair (MMR),
              homologous recombination (HR), PIK3CA/AKT and RAS/RAF pathway
              proficient or histone modification and cell cycle pathway
              deficient patients. CONCLUSIONS: CD103+CD8+ TRM cells played a
              crucial role in anti-tumour immunity and served as an ideal
              prognostic biomarker. It could be treated as a superior companion
              predictor for treatment response to PD-L1 inhibitor and ACT
              within MIBC patients.",
  journal  = "Br. J. Cancer",
  volume   =  126,
  number   =  11,
  pages    = "1581--1588",
  month    =  jun,
  year     =  2022,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Duhen2018-rt,
  title    = "Co-expression of {CD39} and {CD103} identifies tumor-reactive
              {CD8} {T} cells in human solid tumors",
  author   = "Duhen, Thomas and Duhen, Rebekka and Montler, Ryan and Moses,
              Jake and Moudgil, Tarsem and de Miranda, Noel F and Goodall,
              Cheri P and Blair, Tiffany C and Fox, Bernard A and McDermott,
              Jason E and Chang, Shu-Ching and Grunkemeier, Gary and Leidner,
              Rom and Bell, Richard Bryan and Weinberg, Andrew D",
  abstract = "Identifying tumor antigen-specific T cells from cancer patients
              has important implications for immunotherapy diagnostics and
              therapeutics. Here, we show that CD103+CD39+ tumor-infiltrating
              CD8 T cells (CD8 TIL) are enriched for tumor-reactive cells both
              in primary and metastatic tumors. This CD8 TIL subset is found
              across six different malignancies and displays an exhausted
              tissue-resident memory phenotype. CD103+CD39+ CD8 TILs have a
              distinct T-cell receptor (TCR) repertoire, with T-cell clones
              expanded in the tumor but present at low frequencies in the
              periphery. CD103+CD39+ CD8 TILs also efficiently kill autologous
              tumor cells in a MHC-class I-dependent manner. Finally, higher
              frequencies of CD103+CD39+ CD8 TILs in patients with head and
              neck cancer are associated with better overall survival. Our data
              thus describe an approach for detecting tumor-reactive CD8 TILs
              that will help define mechanisms of existing immunotherapy
              treatments, and may lead to future adoptive T-cell cancer
              therapies.",
  journal  = "Nat. Commun.",
  volume   =  9,
  number   =  1,
  pages    = "2724",
  month    =  jul,
  year     =  2018,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Lee2018-ns,
  title       = "Macrophage-secreted interleukin-35 regulates cancer cell
                 plasticity to facilitate metastatic colonization",
  author      = "Lee, Chih-Chan and Lin, Jiunn-Chang and Hwang, Wei-Lun and
                 Kuo, Ying-Ju and Chen, Hung-Kai and Tai, Shyh-Kuan and Lin,
                 Chun-Chi and Yang, Muh-Hwa",
  abstract    = "A favorable interplay between cancer cells and the tumor
                 microenvironment (TME) facilitates the outgrowth of metastatic
                 tumors. Because of the distinct initiating processes between
                 primary and metastatic tumors, we investigate the differences
                 in tumor-associated macrophages (TAMs) from primary and
                 metastatic cancers. Here we show that dual expression of M1
                 and M2 markers is noted in TAMs from primary tumors, whereas
                 predominant expression of M2 markers is shown in metastatic
                 TAMs. At metastatic sites, TAMs secrete interleukin-35 (IL-35)
                 to facilitate metastatic colonization through activation of
                 JAK2-STAT6-GATA3 signaling to reverse epithelial-mesenchymal
                 transition (EMT) in cancer cells. In primary tumors,
                 inflammation-induced EMT upregulates IL12R$\beta$2, a subunit
                 of the IL-35 receptor, in cancer cells to help them respond to
                 IL-35 during metastasis. Neutralization of IL-35 or knockout
                 of IL-35 in macrophages reduces metastatic colonization. These
                 results indicate the distinct TMEs of primary and metastatic
                 tumors and provide potential targets for intercepting
                 metastasis.",
  journal     = "Nat. Commun.",
  volume      =  9,
  number      =  1,
  pages       = "3763",
  month       =  sep,
  year        =  2018,
  language    = "en",
  original_id = "64729fe5-d560-01d5-9796-7a5bece2296f"
}

@ARTICLE{Menares2019-op,
  title    = "Tissue-resident memory {CD8+} {T} cells amplify anti-tumor
              immunity by triggering antigen spreading through dendritic cells",
  author   = "Menares, Evelyn and G{\'a}lvez-Cancino, Felipe and
              C{\'a}ceres-Morgado, Pablo and Ghorani, Ehsan and L{\'o}pez,
              Ernesto and D{\'\i}az, Ximena and Saavedra-Almarza, Juan and
              Figueroa, Diego A and Roa, Eduardo and Quezada, Sergio A and
              Lladser, Alvaro",
  abstract = "Tissue-resident memory CD8+ T (Trm) cells mediate potent local
              innate and adaptive immune responses and play a central role
              against solid tumors. However, whether Trm cells cross-talk with
              dendritic cells (DCs) to support anti-tumor immunity remains
              unclear. Here we show that antigen-specific activation of skin
              Trm cells leads to maturation and migration to draining lymph
              nodes of cross-presenting dermal DCs. Tumor rejection mediated by
              Trm cells triggers the spread of cytotoxic CD8+ T cell responses
              against tumor-derived neo- and self-antigens via dermal DCs.
              These responses suppress the growth of intradermal tumors and
              disseminated melanoma lacking the Trm cell-targeted epitope.
              Moreover, analysis of RNA sequencing data from human melanoma
              tumors reveals that enrichment of a Trm cell gene signature
              associates with DC activation and improved survival. This work
              unveils the ability of Trm cells to amplify the breath of
              cytotoxic CD8+ T cell responses through DCs, thereby
              strengthening anti-tumor immunity.",
  journal  = "Nat. Commun.",
  volume   =  10,
  number   =  1,
  pages    = "4401",
  month    =  sep,
  year     =  2019,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Malenica2021-nb,
  title    = "{Integrin-$\alpha$V-mediated} activation of {TGF-$\beta$}
              regulates anti-tumour {CD8} {T} cell immunity and response to
              {PD-1} blockade",
  author   = "Malenica, Ines and Adam, Julien and Corgnac, St{\'e}phanie and
              Mezquita, Laura and Auclin, Edouard and Damei, Isabelle and
              Grynszpan, Laetitia and Gros, Gwendoline and de Montpr{\'e}ville,
              Vincent and Planchard, David and Th{\'e}ret, Nathalie and Besse,
              Benjamin and Mami-Chouaib, Fathia",
  abstract = "TGF-$\beta$ is secreted in the tumour microenvironment in a
              latent, inactive form bound to latency associated protein and
              activated by the integrin $\alpha$V subunit. The activation of
              latent TGF-$\beta$ by cancer-cell-expressed $\alpha$V re-shapes
              the tumour microenvironment, and this could affect patient
              responses to PD-1-targeting therapy. Here we show, using
              multiplex immunofluorescence staining in cohorts of anti-PD-1 and
              anti-PD-L1-treated lung cancer patients, that decreased
              expression of cancer cell $\alpha$V is associated with improved
              immunotherapy-related, progression-free survival, as well as with
              an increased density of CD8+CD103+ tumour-infiltrating
              lymphocytes. Mechanistically, tumour $\alpha$V regulates CD8 T
              cell recruitment, induces CD103 expression on activated CD8+ T
              cells and promotes their differentiation to granzyme B-producing
              CD103+CD69+ resident memory T cells via autocrine TGF-$\beta$
              signalling. Thus, our work provides the underlying principle of
              targeting cancer cell $\alpha$V for more efficient PD-1
              checkpoint blockade therapy.",
  journal  = "Nat. Commun.",
  volume   =  12,
  number   =  1,
  pages    = "5209",
  month    =  sep,
  year     =  2021,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Er2018-ps,
  title       = "Pericyte-like spreading by disseminated cancer cells activates
                 {YAP} and {MRTF} for metastatic colonization",
  author      = "Er, Ekrem Emrah and Valiente, Manuel and Ganesh, Karuna and
                 Zou, Yilong and Agrawal, Saloni and Hu, Jing and Griscom,
                 Bailey and Rosenblum, Marc and Boire, Adrienne and Brogi, Edi
                 and Giancotti, Filippo G and Schachner, Melitta and Malladi,
                 Srinivas and Massagu{\'e}, Joan",
  abstract    = "Metastatic seeding by disseminated cancer cells principally
                 occurs in perivascular niches. Here, we show that
                 mechanotransduction signalling triggered by the pericyte-like
                 spreading of disseminated cancer cells on host tissue
                 capillaries is critical for metastatic colonization.
                 Disseminated cancer cells employ L1CAM (cell adhesion molecule
                 L1) to spread on capillaries and activate the
                 mechanotransduction effectors YAP (Yes-associated protein) and
                 MRTF (myocardin-related transcription factor). This spreading
                 is robust enough to displace resident pericytes, which also
                 use L1CAM for perivascular spreading. L1CAM activates YAP by
                 engaging $\beta$1 integrin and ILK (integrin-linked kinase).
                 L1CAM and YAP signalling enables the outgrowth of
                 metastasis-initiating cells both immediately following their
                 infiltration of target organs and after they exit from a
                 period of latency. Our results identify an important step in
                 the initiation of metastatic colonization, define its
                 molecular constituents and provide an explanation for the
                 widespread association of L1CAM with metastatic relapse in the
                 clinic.",
  journal     = "Nat. Cell Biol.",
  volume      =  20,
  number      =  8,
  pages       = "966--978",
  month       =  aug,
  year        =  2018,
  language    = "en",
  original_id = "57903e11-369c-02ff-84ad-9a92c5dc38dd"
}

@ARTICLE{Park2019-ap,
  title    = "Tissue-resident memory {CD8+} {T} cells promote melanoma-immune
              equilibrium in skin",
  author   = "Park, Simone L and Buzzai, Anthony and Rautela, Jai and Hor, Jyh
              Liang and Hochheiser, Katharina and Effern, Maike and McBain,
              Nathan and Wagner, Teagan and Edwards, Jarem and McConville,
              Robyn and Wilmott, James S and Scolyer, Richard A and T{\"u}ting,
              Thomas and Palendira, Umaimainthan and Gyorki, David and Mueller,
              Scott N and Huntington, Nicholas D and Bedoui, Sammy and
              H{\"o}lzel, Michael and Mackay, Laura K and Waithman, Jason and
              Gebhardt, Thomas",
  abstract = "The immune system can suppress tumour development both by
              eliminating malignant cells and by preventing the outgrowth and
              spread of cancer cells that resist eradication1. Clinical and
              experimental data suggest that the latter mode of control-termed
              cancer-immune equilibrium1-can be maintained for prolonged
              periods of time, possibly up to several decades2-4. Although
              cancers most frequently originate in epithelial layers, the
              nature and spatiotemporal dynamics of immune responses that
              maintain cancer-immune equilibrium in these tissue compartments
              remain unclear. Here, using a mouse model of transplantable
              cutaneous melanoma5, we show that tissue-resident memory CD8+ T
              cells (TRM cells) promote a durable melanoma-immune equilibrium
              that is confined to the epidermal layer of the skin. A proportion
              of mice (~40\%) transplanted with melanoma cells remained free of
              macroscopic skin lesions long after epicutaneous inoculation, and
              generation of tumour-specific epidermal CD69+ CD103+ TRM cells
              correlated with this spontaneous disease control. By contrast,
              mice deficient in TRM formation were more susceptible to tumour
              development. Despite being tumour-free at the macroscopic level,
              mice frequently harboured melanoma cells in the epidermal layer
              of the skin long after inoculation, and intravital imaging
              revealed that these cells were dynamically surveyed by TRM cells.
              Consistent with their role in melanoma surveillance,
              tumour-specific TRM cells that were generated before melanoma
              inoculation conferred profound protection from tumour development
              independently of recirculating T cells. Finally, depletion of TRM
              cells triggered tumour outgrowth in a proportion (~20\%) of mice
              with occult melanomas, demonstrating that TRM cells can actively
              suppress cancer progression. Our results show that TRM cells have
              a fundamental role in the surveillance of subclinical melanomas
              in the skin by maintaining cancer-immune equilibrium. As such,
              they provide strong impetus for exploring these cells as targets
              of future anticancer immunotherapies.",
  journal  = "Nature",
  volume   =  565,
  number   =  7739,
  pages    = "366--371",
  month    =  jan,
  year     =  2019,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Jansen2019-dg,
  title    = "An intra-tumoral niche maintains and differentiates stem-like
              {CD8} {T} cells",
  author   = "Jansen, Caroline S and Prokhnevska, Nataliya and Master, Viraj A
              and Sanda, Martin G and Carlisle, Jennifer W and Bilen, Mehmet
              Asim and Cardenas, Maria and Wilkinson, Scott and Lake, Ross and
              Sowalsky, Adam G and Valanparambil, Rajesh M and Hudson, William
              H and McGuire, Donald and Melnick, Kevin and Khan, Amir I and
              Kim, Kyu and Chang, Yun Min and Kim, Alice and Filson,
              Christopher P and Alemozaffar, Mehrdad and Osunkoya, Adeboye O
              and Mullane, Patrick and Ellis, Carla and Akondy, Rama and Im, Se
              Jin and Kamphorst, Alice O and Reyes, Adriana and Liu, Yuan and
              Kissick, Haydn",
  abstract = "Tumour-infiltrating lymphocytes are associated with a survival
              benefit in several tumour types and with the response to
              immunotherapy1-8. However, the reason some tumours have high CD8
              T cell infiltration while others do not remains unclear. Here we
              investigate the requirements for maintaining a CD8 T cell
              response against human cancer. We find that CD8 T cells within
              tumours consist of distinct populations of terminally
              differentiated and stem-like cells. On proliferation, stem-like
              CD8 T cells give rise to more terminally differentiated,
              effector-molecule-expressing daughter cells. For many T cells to
              infiltrate the tumour, it is critical that this effector
              differentiation process occur. In addition, we show that these
              stem-like T cells reside in dense antigen-presenting-cell niches
              within the tumour, and that tumours that fail to form these
              structures are not extensively infiltrated by T cells. Patients
              with progressive disease lack these immune niches, suggesting
              that niche breakdown may be a key mechanism of immune escape.",
  journal  = "Nature",
  volume   =  576,
  number   =  7787,
  pages    = "465--470",
  month    =  dec,
  year     =  2019,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Caushi2021-um,
  title    = "Transcriptional programs of neoantigen-specific {TIL} in
              {anti-PD-1-treated} lung cancers",
  author   = "Caushi, Justina X and Zhang, Jiajia and Ji, Zhicheng and
              Vaghasia, Ajay and Zhang, Boyang and Hsiue, Emily Han-Chung and
              Mog, Brian J and Hou, Wenpin and Justesen, Sune and Blosser,
              Richard and Tam, Ada and Anagnostou, Valsamo and Cottrell, Tricia
              R and Guo, Haidan and Chan, Hok Yee and Singh, Dipika and Thapa,
              Sampriti and Dykema, Arbor G and Burman, Poromendro and
              Choudhury, Begum and Aparicio, Luis and Cheung, Laurene S and
              Lanis, Mara and Belcaid, Zineb and El Asmar, Margueritta and
              Illei, Peter B and Wang, Rulin and Meyers, Jennifer and Schuebel,
              Kornel and Gupta, Anuj and Skaist, Alyza and Wheelan, Sarah and
              Naidoo, Jarushka and Marrone, Kristen A and Brock, Malcolm and
              Ha, Jinny and Bush, Errol L and Park, Bernard J and Bott, Matthew
              and Jones, David R and Reuss, Joshua E and Velculescu, Victor E
              and Chaft, Jamie E and Kinzler, Kenneth W and Zhou, Shibin and
              Vogelstein, Bert and Taube, Janis M and Hellmann, Matthew D and
              Brahmer, Julie R and Merghoub, Taha and Forde, Patrick M and
              Yegnasubramanian, Srinivasan and Ji, Hongkai and Pardoll, Drew M
              and Smith, Kellie N",
  abstract = "PD-1 blockade unleashes CD8 T cells1, including those specific
              for mutation-associated neoantigens (MANA), but factors in the
              tumour microenvironment can inhibit these T cell responses.
              Single-cell transcriptomics have revealed global T cell
              dysfunction programs in tumour-infiltrating lymphocytes (TIL).
              However, the majority of TIL do not recognize tumour antigens2,
              and little is known about transcriptional programs of
              MANA-specific TIL. Here, we identify MANA-specific T cell clones
              using the MANA functional expansion of specific T cells assay3 in
              neoadjuvant anti-PD-1-treated non-small cell lung cancers
              (NSCLC). We use their T cell receptors as a 'barcode' to track
              and analyse their transcriptional programs in the tumour
              microenvironment using coupled single-cell RNA sequencing and T
              cell receptor sequencing. We find both MANA- and virus-specific
              clones in TIL, regardless of response, and MANA-, influenza- and
              Epstein-Barr virus-specific TIL each have unique transcriptional
              programs. Despite exposure to cognate antigen, MANA-specific TIL
              express an incompletely activated cytolytic program.
              MANA-specific CD8 T cells have hallmark transcriptional programs
              of tissue-resident memory (TRM) cells, but low levels of
              interleukin-7 receptor (IL-7R) and are functionally less
              responsive to interleukin-7 (IL-7) compared with
              influenza-specific TRM cells. Compared with those from responding
              tumours, MANA-specific clones from non-responding tumours express
              T cell receptors with markedly lower ligand-dependent signalling,
              are largely confined to HOBIThigh TRM subsets, and coordinately
              upregulate checkpoints, killer inhibitory receptors and
              inhibitors of T cell activation. These findings provide important
              insights for overcoming resistance to PD-1 blockade.",
  journal  = "Nature",
  volume   =  596,
  number   =  7870,
  pages    = "126--132",
  month    =  aug,
  year     =  2021,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Chu2021-bp,
  title     = "Tonic prime-boost of {STING} signalling mediates {Niemann-Pick}
               disease type {C}",
  author    = "Chu, Ting-Ting and Tu, Xintao and Yang, Kun and Wu, Jianjun and
               Repa, Joyce J and Yan, Nan",
  abstract  = "The classic mode of STING activation is through binding the
               cyclic dinucleotide 2'3'-cyclic GMP-AMP (cGAMP), produced by the
               DNA sensor cyclic GMP-AMP synthase (cGAS), which is important
               for the innate immune response to microbial infection and
               autoimmune disease. Modes of STING activation that are
               independent of cGAS are much less well understood. Here, through
               a spatiotemporally resolved proximity labelling screen followed
               by quantitative proteomics, we identify the lysosomal membrane
               protein Niemann-Pick type C1 (NPC1) as a cofactor in the
               trafficking of STING. NPC1 interacts with STING and recruits it
               to the lysosome for degradation in both human and mouse cells.
               Notably, we find that knockout of Npc1 'primes' STING signalling
               by physically linking or 'tethering' STING to SREBP2
               trafficking. Loss of NPC1 protein also 'boosts' STING signalling
               by blocking lysosomal degradation. Both priming and boosting of
               STING signalling are required for severe neurological disease in
               the Npc1-/- mouse. Genetic deletion of Sting1 (the gene that
               encodes STING) or Irf3, but not that of Cgas, significantly
               reduced the activation of microglia and relieved the loss of
               Purkinje neurons in the cerebellum of Npc1-/- mice, leading to
               improved motor function. Our study identifies a cGAS- and
               cGAMP-independent mode of STING activation that affects
               neuropathology and provides a therapeutic target for the
               treatment of Niemann-Pick disease type C.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  596,
  number    =  7873,
  pages     = "570--575",
  month     =  aug,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Savas2018-sf,
  title    = "Single-cell profiling of breast cancer {T} cells reveals a
              tissue-resident memory subset associated with improved prognosis",
  author   = "Savas, Peter and Virassamy, Balaji and Ye, Chengzhong and Salim,
              Agus and Mintoff, Christopher P and Caramia, Franco and Salgado,
              Roberto and Byrne, David J and Teo, Zhi L and Dushyanthen,
              Sathana and Byrne, Ann and Wein, Lironne and Luen, Stephen J and
              Poliness, Catherine and Nightingale, Sophie S and Skandarajah,
              Anita S and Gyorki, David E and Thornton, Chantel M and Beavis,
              Paul A and Fox, Stephen B and {Kathleen Cuningham Foundation
              Consortium for Research into Familial Breast Cancer (kConFab)}
              and Darcy, Phillip K and Speed, Terence P and Mackay, Laura K and
              Neeson, Paul J and Loi, Sherene",
  abstract = "The quantity of tumor-infiltrating lymphocytes (TILs) in breast
              cancer (BC) is a robust prognostic factor for improved patient
              survival, particularly in triple-negative and HER2-overexpressing
              BC subtypes1. Although T cells are the predominant TIL
              population2, the relationship between quantitative and
              qualitative differences in T cell subpopulations and patient
              prognosis remains unknown. We performed single-cell RNA
              sequencing (scRNA-seq) of 6,311 T cells isolated from human BCs
              and show that significant heterogeneity exists in the
              infiltrating T cell population. We demonstrate that BCs with a
              high number of TILs contained CD8+ T cells with features of
              tissue-resident memory T (TRM) cell differentiation and that
              these CD8+ TRM cells expressed high levels of immune checkpoint
              molecules and effector proteins. A CD8+ TRM gene signature
              developed from the scRNA-seq data was significantly associated
              with improved patient survival in early-stage triple-negative
              breast cancer (TNBC) and provided better prognostication than CD8
              expression alone. Our data suggest that CD8+ TRM cells contribute
              to BC immunosurveillance and are the key targets of modulation by
              immune checkpoint inhibition. Further understanding of the
              development, maintenance and regulation of TRM cells will be
              crucial for successful immunotherapeutic development in BC.",
  journal  = "Nat. Med.",
  volume   =  24,
  number   =  7,
  pages    = "986--993",
  month    =  jul,
  year     =  2018,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Da_Silva2017-ah,
  title    = "Reduced expression of the murine {HLA-G} homolog Qa-2 is
              associated with malignancy, epithelial-mesenchymal transition and
              stemness in breast cancer cells",
  author   = "da Silva, Ist{\'e}fani L and Montero-Montero, Luc{\'\i}a and
              Mart{\'\i}n-Villar, Ester and Martin-P{\'e}rez, Jorge and Sainz,
              Bruno and Renart, Jaime and Toscano Sim{\~o}es, Renata and Soares
              Veloso, {\'E}merson and Salviano Teixeira, Cl{\'a}udia and de
              Oliveira, M{\^o}nica C and Ferreira, Enio and Quintanilla, Miguel",
  abstract = "Qa-2 is believed to mediate a protective immune response against
              cancer; however, little is known about the role of Qa-2 in
              tumorigenesis. Here, we used 4T1 breast cancer cells to study the
              involvement of Qa-2 in tumor progression in a syngeneic host.
              Qa-2 expression was reduced during in vivo tumor growth and in
              cell lines derived from 4T1-induced tumors. Tumor-derived cells
              elicited an epithelial-mesenchymal transition associated with
              upregulation of Zeb1 and Twist1/2 and enhanced tumor initiating
              and invasive capacities. Furthermore, these cells showed
              increased stem characteristics, as demonstrated by upregulation
              of Hes1, Sox2 and Oct3/4, and enrichment of
              CD44high/CD24median/low cells. Remarkably, Qa-2 cell-surface
              expression was excluded from the CD44high/CD24median/low
              subpopulation. Tumor-derived cells showed increased Src activity,
              and treatment of these cells with the Src kinase inhibitor PP2
              enhanced Qa-2 but reduced Sox2 and CD44high/CD24median/low
              expression levels, suggesting that Src signaling, while
              positively associated with stemness, negatively regulates Qa-2
              expression in breast cancer. Finally, overexpression of the Qa-2
              family member Q7 on the cell surface slowed down in vivo tumor
              growth and reduced the metastatic potential of 4T1 cells. These
              results suggest an anti-malignant role for Qa-2 in breast cancer
              development, which appears to be absent from cancer stem cells.",
  journal  = "Sci. Rep.",
  volume   =  7,
  number   =  1,
  pages    = "6276",
  month    =  jul,
  year     =  2017,
  language = "en"
}

@ARTICLE{Dawod2020-or,
  title       = "Myeloid-derived suppressor cell depletion therapy targets
                 {IL-17A-expressing} mammary carcinomas",
  author      = "Dawod, Bassel and Liu, Jinghua and Gebremeskel, Simon and Yan,
                 Chi and Sappong, Antonia and Johnston, Brent and Hoskin, David
                 W and Marshall, Jean S and Wang, Jun",
  abstract    = "Triple-negative breast cancer (TNBC) is an invasive subtype of
                 breast cancer but paradoxically associated with increased
                 tumor-infiltrating leukocytes. The molecular and cellular
                 mechanisms underlying TNBC immunobiology are incompletely
                 understood. Interleukin (IL)-17A is a pro-inflammatory
                 cytokine that has both pro- and anti-tumor effects and found
                 in 40-80\% of TNBC samples. We report here that IL-17A mRNA
                 and protein are detectable in some human TNBC cell lines and
                 further upregulated by IL-23 and LPS stimulation. Furthermore,
                 the impact of tumor-derived IL-17A in host immune response and
                 tumor growth was examined using murine TNBC 4T1 mammary
                 carcinoma cells transduced with an adenoviral vector
                 expressing IL-17A (AdIL-17A) or control vector (Addl).
                 Compared to Addl-transduction, AdIL-17A-transduction enhanced
                 4T1 tumor growth and lung metastasis in vivo, which was
                 associated with a marked expansion of myeloid-derived
                 suppressor cells (MDSCs). However, AdIL-17A-transduction also
                 induced strong organ-specific and time-dependent immune
                 activation indicated by dynamic changes of NK cells, B cells,
                 CD4, and CD8 T cells in peripheral blood, lung, and tumor
                 site, as well as the plasma levels of IFN$\gamma$. Such
                 findings highlight that tumor-associated IL-17A induces
                 concurrent immune activation and immune suppression.
                 Administration of anti-Gr1 or anti-G-CSF antibody effectively
                 depleted MDSCs in vivo, markedly reducing the growth of
                 AdIL-17A-transduced 4T1 tumors, and eliminating lung
                 metastasis. Collectively, our study demonstrates that MDSC
                 depletion is an effective and practical approach for treating
                 IL-17A-enriched mammary carcinomas.",
  journal     = "Sci. Rep.",
  volume      =  10,
  number      =  1,
  pages       = "13343",
  month       =  aug,
  year        =  2020,
  language    = "en",
  original_id = "48b2be91-4d6d-0d9a-8919-fee5fea4fe44"
}

@ARTICLE{Losurdo2021-wa,
  title    = "Single-cell profiling defines the prognostic benefit of
              {CD39high} tissue resident memory {CD8+} {T} cells in
              luminal-like breast cancer",
  author   = "Losurdo, Agnese and Scirgolea, Caterina and Alvisi, Giorgia and
              Brummelman, Jolanda and Errico, Valentina and Di Tommaso, Luca
              and Pilipow, Karolina and Colombo, Federico Simone and Fernandes,
              Bethania and Peano, Clelia and Testori, Alberto and Tinterri,
              Corrado and Roncalli, Massimo and Santoro, Armando and Mazza,
              Emilia Maria Cristina and Lugli, Enrico",
  abstract = "Luminal-like breast cancer (BC) constitutes the majority of BC
              subtypes, but, differently from highly aggressive triple negative
              BC, is poorly infiltrated by the immune system. The quality of
              the immune infiltrate in luminal-like BCs has been poorly
              studied, thereby limiting further investigation of
              immunotherapeutic strategies. By using high-dimensional
              single-cell technologies, we identify heterogeneous behavior
              within the tissue-resident memory CD8+ T (Trm) cells infiltrating
              luminal-like tumors. A subset of CD127- CD39hi Trm cells,
              preferentially present in the tumor compared to the adjacent
              normal breast tissue or peripheral blood, retains enhanced
              degranulation capacity compared to the CD127+ CD39lo Trm
              counterpart ex vivo, and is specifically associated with positive
              prognosis. Nevertheless, such prognostic benefit is lost in the
              presence of highly-suppressive CCR8hi ICOShi IRF4+ effector
              Tregs. Thus, combinatorial strategies aiming at boosting Trm
              function and infiltration while relieving from Treg-mediated
              immunosuppression should be investigated to achieve proper tumor
              control in luminal-like BCs.",
  journal  = "Commun Biol",
  volume   =  4,
  number   =  1,
  pages    = "1117",
  month    =  sep,
  year     =  2021,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Han2021-lm,
  title    = "Resident and circulating memory {T} cells persist for years in
              melanoma patients with durable responses to immunotherapy",
  author   = "Han, Jichang and Zhao, Yanding and Shirai, Keisuke and Molodtsov,
              Aleksey and Kolling, Fred W and Fisher, Jan L and Zhang, Peisheng
              and Yan, Shaofeng and Searles, Tyler G and Bader, Justin M and
              Gui, Jiang and Cheng, Chao and Ernstoff, Marc S and Turk, Mary Jo
              and Angeles, Christina V",
  abstract = "While T-cell responses to cancer immunotherapy have been avidly
              studied, long-lived memory has been poorly characterized. In a
              cohort of metastatic melanoma survivors with exceptional
              responses to immunotherapy, we probed memory CD8+ T-cell
              responses across tissues, and across several years. Single-cell
              RNA sequencing revealed three subsets of resident memory T (TRM)
              cells shared between tumors and distant vitiligo-affected skin.
              Paired T-cell receptor sequencing further identified clonotypes
              in tumors that co-existed as TRM in skin and as effector memory T
              (TEM) cells in blood. Clonotypes that dispersed throughout tumor,
              skin, and blood preferentially expressed a IFNG / TNF-high
              signature, which had a strong prognostic value for melanoma
              patients. Remarkably, clonotypes from tumors were found in
              patient skin and blood up to nine years later, with skin
              maintaining the most focused tumor-associated clonal repertoire.
              These studies reveal that cancer survivors can maintain durable
              memory as functional, broadly-distributed TRM and TEM
              compartments.",
  journal  = "Nat Cancer",
  volume   =  2,
  number   =  3,
  pages    = "300--311",
  month    =  mar,
  year     =  2021,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Zeisberger2006-dg,
  title       = "Clodronate-liposome-mediated depletion of tumour-associated
                 macrophages: a new and highly effective antiangiogenic therapy
                 approach",
  author      = "Zeisberger, S M and Odermatt, B and Marty, C and
                 Zehnder-Fj{\"a}llman, A H M and Ballmer-Hofer, K and
                 Schwendener, R A",
  abstract    = "Tumour-associated macrophages, TAMs, play a pivotal role in
                 tumour growth and metastasis by promoting tumour angiogenesis.
                 Treatment with clodronate encapsulated in liposomes
                 (clodrolip) efficiently depleted these phagocytic cells in the
                 murine F9 teratocarcinoma and human A673 rhabdomyosarcoma
                 mouse tumour models resulting in significant inhibition of
                 tumour growth ranging from 75 to >92\%, depending on therapy
                 and schedule. Tumour inhibition was accompanied by a drastic
                 reduction in blood vessel density in the tumour tissue.
                 Vascular endothelial growth factor (VEGF) is one of the major
                 inducers of tumour angiogenesis and is also required for
                 macrophage recruitment. The strongest effects were observed
                 with the combination therapy of clodrolip and a
                 VEGF-neutralising antibody, whereas free clodronate was not
                 significantly active. Immunohistologic evaluation of the
                 tumours showed significant depletion of F4/80+ and MOMA-1+ and
                 a less pronounced depletion of CD11b+ TAMs. Blood vessel
                 staining (CD31) and quantification of the vessels as well as
                 TAMs and tumour-associated dendritic cells (TADCs) in the A673
                 model showed reduction rates of 85 to >94\%, even 9 days after
                 the end of therapy. In addition, CD11c+ TADCs, which have been
                 shown to potentially differentiate into endothelial-like cells
                 upon stimulation by tumour released growth and differentiation
                 factors, were similarly reduced by clodrolip or antibody
                 treatment. These results validate clodrolip therapy in
                 combination with angiogenesis inhibitors as a promising novel
                 strategy for an indirect cancer therapy aimed at the
                 haematopoietic precursor cells that stimulate tumour growth
                 and dissemination and as a tool to study the role of
                 macrophages and dendritic cells in tumorigenesis.",
  journal     = "Br. J. Cancer",
  volume      =  95,
  number      =  3,
  pages       = "272--281",
  month       =  aug,
  year        =  2006,
  language    = "en",
  original_id = "45d83228-e494-0f92-9ab9-1b784afbe395"
}

@ARTICLE{Skelton2001-uz,
  title    = "The enhanced green fluorescent protein ({eGFP}) is minimally
              immunogenic in {C57BL/6} mice",
  author   = "Skelton, D and Satake, N and Kohn, D B",
  journal  = "Gene Ther.",
  volume   =  8,
  number   =  23,
  pages    = "1813--1814",
  month    =  dec,
  year     =  2001,
  keywords = "mouse model",
  language = "en"
}

@ARTICLE{Mellor1985-gv,
  title    = "Structure and expression of genes encoding murine Qa-2 class {I}
              antigens",
  author   = "Mellor, A L and Antoniou, J and Robinson, P J",
  abstract = "DNA structural analysis of the Qa region in two BALB/c mouse
              substrains with different Qa-2 phenotypes reveals that a deletion
              of DNA has occurred in BALB/cBy (Qa-2-) mice relative to BALB/c
              (Qa-2+) mice. We propose that this deletion arises from unequal
              crossing-over and recombination between adjacent BALB/c class I
              genes and results in the generation of a hybrid class I gene in
              BALB/cBy mice. Furthermore, we suggest that this is a direct
              cause of the change in Qa-2 phenotype. Further support for this
              model was obtained from transfection experiments in which cloned
              genes from the equivalent part of the Qa region in C57BL/10 mice
              were introduced into L cells. Four C57BL/10 genes, arranged in
              two almost identical pairs, encode polypeptides that are
              precipitated from lysates of transfectants with anti-Qa-2/3
              antiserum. Although loss of one pair of these genes in BALB/c
              mice has no qualitative effect on Qa-2 phenotype, the loss of
              both pairs of genes via gene fusion leads to the loss of the
              Qa-2+ phenotype in BALB/cBy mice.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  82,
  number   =  17,
  pages    = "5920--5924",
  month    =  sep,
  year     =  1985,
  language = "en"
}

@ARTICLE{Xue2005-ed,
  title    = "Tumor Necrosis Factor $\alpha$ ({TNF$\alpha$}) Induces the
              Unfolded Protein Response ({UPR}) in a Reactive Oxygen Species
              ({ROS)-dependent} Fashion, and the {UPR} Counteracts {ROS}
              Accumulation by {TNF$\alpha$*}",
  author   = "Xue, Xin and Piao, Jiang-Hu and Nakajima, Akihito and
              Sakon-Komazawa, Sachiko and Kojima, Yuko and Mori, Kazutoshi and
              Yagita, Hideo and Okumura, Ko and Harding, Heather and Nakano,
              Hiroyasu",
  abstract = "Accumulation of unfolded proteins in the endoplasmic reticulum
              (ER) causes ER overload, resulting in ER stress. To cope with ER
              stress, mammalian cells trigger a specific response known as the
              unfolded protein response (UPR). Although recent studies have
              indicated cross-talk between ER stress and oxidative stress, the
              mechanistic link is not fully understood. By using murine
              fibrosarcoma L929 cells, in which tumor necrosis factor (TNF)
              $\alpha$ induces accumulation of reactive oxygen species (ROS)
              and cell death, we show that TNF$\alpha$ induces the UPR in a
              ROS-dependent fashion. In contrast to TNF$\alpha$, oxidative
              stresses by H2O2 or arsenite only induce eukaroytic initiation
              factor 2$\alpha$ phosphorylation, but not activation of PERK- or
              IRE1-dependent pathways, indicating the specificity of downstream
              signaling induced by various oxidative stresses. Conversely, the
              UPR induced by tunicamycin substantially suppresses
              TNF$\alpha$-induced ROS accumulation and cell death by inhibiting
              reduction of cellular glutathione levels. Collectively, some, but
              not all, oxidative stresses induce the UPR, and pre-emptive UPR
              counteracts TNF$\alpha$-induced ROS accumulation.",
  journal  = "J. Biol. Chem.",
  volume   =  280,
  number   =  40,
  pages    = "33917--33925",
  month    =  oct,
  year     =  2005
}

@ARTICLE{Kok2020-wh,
  title    = "A committed tissue-resident memory {T} cell precursor within the
              circulating {CD8+} effector {T} cell pool",
  author   = "Kok, Lianne and Dijkgraaf, Feline E and Urbanus, Jos and Bresser,
              Kaspar and Vredevoogd, David W and Cardoso, Rebeca F and
              Peri{\'e}, Le{\"\i}la and Beltman, Joost B and Schumacher, Ton N",
  abstract = "An increasing body of evidence emphasizes the role of
              tissue-resident memory T cells (TRM) in the defense against
              recurring pathogens and malignant neoplasms. However, little is
              known with regard to the origin of these cells and their kinship
              to other CD8+ T cell compartments. To address this issue, we
              followed the antigen-specific progeny of individual naive CD8+ T
              cells to the T effector (TEFF), T circulating memory (TCIRCM),
              and TRM pools by lineage-tracing and single-cell transcriptome
              analysis. We demonstrate that a subset of T cell clones possesses
              a heightened capacity to form TRM, and that enriched expression
              of TRM-fate-associated genes is already apparent in the
              circulating TEFF offspring of such clones. In addition, we
              demonstrate that the capacity to generate TRM is permanently
              imprinted at the clonal level, before skin entry. Collectively,
              these data provide compelling evidence for early stage TRM fate
              decisions and the existence of committed TRM precursor cells in
              the circulatory TEFF compartment.",
  journal  = "J. Exp. Med.",
  volume   =  217,
  number   =  10,
  month    =  oct,
  year     =  2020,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Evrard2022-zv,
  title    = "Sphingosine 1-phosphate receptor 5 ({S1PR5}) regulates the
              peripheral retention of tissue-resident lymphocytes",
  author   = "Evrard, Maximilien and Wynne-Jones, Erica and Peng, Changwei and
              Kato, Yu and Christo, Susan N and Fonseca, Raissa and Park,
              Simone L and Burn, Thomas N and Osman, Maleika and Devi, Sapna
              and Chun, Jerold and Mueller, Scott N and Kannourakis, George and
              Berzins, Stuart P and Pellicci, Daniel G and Heath, William R and
              Jameson, Stephen C and Mackay, Laura K",
  abstract = "Tissue-resident memory T (TRM) cells provide long-lasting immune
              protection. One of the key events controlling TRM cell
              development is the local retention of TRM cell precursors coupled
              to downregulation of molecules necessary for tissue exit.
              Sphingosine-1-phosphate receptor 5 (S1PR5) is a migratory
              receptor with an uncharted function in T cells. Here, we show
              that S1PR5 plays a critical role in T cell infiltration and
              emigration from peripheral organs, as well as being specifically
              downregulated in TRM cells. Consequentially, TRM cell development
              was selectively impaired upon ectopic expression of S1pr5,
              whereas loss of S1pr5 enhanced skin TRM cell formation by
              promoting peripheral T cell sequestration. Importantly, we found
              that T-bet and ZEB2 were required for S1pr5 induction and that
              local TGF-$\beta$ signaling was necessary to promote coordinated
              Tbx21, Zeb2, and S1pr5 downregulation. Moreover, S1PR5-mediated
              control of tissue residency was conserved across innate and
              adaptive immune compartments. Together, these results identify
              the T-bet-ZEB2-S1PR5 axis as a previously unappreciated mechanism
              modulating the generation of tissue-resident lymphocytes.",
  journal  = "J. Exp. Med.",
  volume   =  219,
  number   =  1,
  month    =  jan,
  year     =  2022,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Li2022-ys,
  title    = "In vivo labeling reveals continuous trafficking of {TCF-1+} {T}
              cells between tumor and lymphoid tissue",
  author   = "Li, Zhi and Tuong, Zewen K and Dean, Isaac and Willis, Claire and
              Gaspal, Fabrina and Fiancette, R{\'e}mi and Idris, Suaad and
              Kennedy, Bethany and Ferdinand, John R and Pe{\~n}alver, Ana and
              Cabantous, Mia and Murtuza Baker, Syed and Fry, Jeremy W and
              Carlesso, Gianluca and Hammond, Scott A and Dovedi, Simon J and
              Hepworth, Matthew R and Clatworthy, Menna R and Withers, David R",
  abstract = "Improving the efficacy of immune checkpoint therapies will
              require a better understanding of how immune cells are recruited
              and sustained in tumors. Here, we used the photoconversion of the
              tumor immune cell compartment to identify newly entering
              lymphocytes, determine how they change over time, and investigate
              their egress from the tumor. Combining single-cell
              transcriptomics and flow cytometry, we found that while a diverse
              mix of CD8 T cell subsets enter the tumor, all CD8 T cells
              retained within this environment for more than 72 h developed an
              exhausted phenotype, revealing the rapid establishment of this
              program. Rather than forming tumor-resident populations,
              non-effector subsets, which express TCF-1 and include memory and
              stem-like cells, were continuously recruited into the tumor, but
              this recruitment was balanced by concurrent egress to the
              tumor-draining lymph node. Thus, the TCF-1+ CD8 T cell niche in
              tumors is highly dynamic, with the circulation of cells between
              the tumor and peripheral lymphoid tissue to bridge systemic and
              intratumoral responses.",
  journal  = "J. Exp. Med.",
  volume   =  219,
  number   =  6,
  month    =  jun,
  year     =  2022,
  keywords = "Mouse study",
  language = "en"
}

@UNPUBLISHED{Zhang2020-an,
  title    = "{CECR2} Drives Breast Cancer Metastasis by Suppressing Macrophage
              Inflammatory Responses",
  author   = "Zhang, Meiling and Liu, Zongzhi Z and Aoshima, Keisuke and Zhang,
              Yangyi and An, Yongyan and Aoshima, Asako and Chan, Lok Hei and
              Lang, Sabine M and Sun, Hongyi and Tang, Zhenwei and Rutter, Sara
              J and Booth, Carmen J and Bossuyt, Veerle and Chen, Xiang and
              Morrow, Jon S and Pusztai, Lajos and Rimm, David L and Yin,
              Mingzhu and Yan, Qin",
  abstract = "Epigenetic and transcriptional changes are critical for
              metastasis, the major cause of cancer-related deaths. Metastatic
              tumor cells escape immune surveillance more efficiently than
              tumor cells in the primary sites, but the mechanisms controlling
              their immune evasion are poorly understood. We found that distal
              metastases are more immune inert with increased M2 macrophages
              compared to their matched primary tumors. Acetyl-lysine reader
              CECR2 is an epigenetic regulator upregulated in metastases and
              positively associated with M2 macrophages. CECR2 specifically
              promotes breast cancer metastasis in multiple mouse models, with
              more profound effect in the immunocompetent setting.
              Mechanistically, NF-$\kappa$B family member RELA recruits CECR2
              to activate CSF1 and CXCL1 , which are critical for
              macrophage-mediated immunosuppression at the metastatic sites.
              Furthermore, pharmacological inhibition of CECR2 bromodomain
              impedes NF-$\kappa$B-mediated immune suppression by macrophages
              and inhibits breast cancer metastasis. These results reveal novel
              therapeutic strategies to treat metastatic breast cancer.
              Statement of Significance Comparison of matched primary breast
              tumors and distal metastases show that metastases are more immune
              inert with increased tumor promoting macrophages. Depletion or
              pharmacological inhibition of CECR2 inhibits breast cancer
              metastasis by suppressing macrophage inflammatory responses,
              nominating CECR2 as a promising therapeutic target for cancer
              metastasis. \#\#\# Competing Interest Statement The authors have
              declared no competing interest.",
  journal  = "bioRxiv",
  pages    = "2020.09.10.291799",
  month    =  oct,
  year     =  2020,
  language = "en"
}

@UNPUBLISHED{Vergato2021-lm,
  title    = "{Type-I} interferon signaling is essential for robust metronomic
              chemo-immunogenic tumor regression in murine triple-negative
              breast cancer",
  author   = "Vergato, Cameron and Doshi, Kshama A and Roblyer, Darren and
              Waxman, David J",
  abstract = "Triple-negative breast cancer (TNBC) is characterized by poor
              prognosis and aggressive growth, with limited therapeutic options
              for many patients. Here, we use two syngeneic mouse TNBC models,
              4T1 and E0771, to investigate the chemo-immunogenic potential of
              cyclophosphamide and the mechanistic contributions of
              cyclophosphamide-activated type-I interferon (IFN) signaling to
              therapeutic activity. Chemically-activated cyclophosphamide
              induced robust IFN$\alpha$/$\beta$ receptor-1-dependent signaling
              linked to hundreds of IFN-stimulated gene responses in both TNBC
              lines. Further, in 4T1 tumors, cyclophosphamide given on a
              medium-dose, 6-day intermittent metronomic schedule induced
              strong IFN signaling but comparatively weak immune cell
              infiltration associated with long-term tumor growth stasis.
              Induction of IFN signaling was somewhat weaker in E0771 tumors
              but was followed by extensive downstream gene responses, robust
              immune cell infiltration and prolonged tumor regression. The
              immune dependence of these effective anti-tumor responses was
              established by CD8 T-cell immunodepletion, which blocked
              cyclophosphamide-induced E0771 tumor regression and led to tumor
              stasis followed by regrowth. Strikingly, IFN$\alpha$/$\beta$
              receptor-1 antibody blockade was even more effective in
              preventing E0771 immune cell infiltration and blocked the major
              tumor regression induced by cyclophosphamide treatment. Type-I
              IFN signaling is thus essential for the robust chemo-immunogenic
              response of these TNBC tumors to cyclophosphamide administered on
              a metronomic schedule. Significance TNBC has poor prognosis and
              few therapeutic options. We show that cyclophosphamide treatment
              can induces extensive tumor regression in syngeneic mouse models
              of TNBC via a chemo-immunogenic mechanism linked to type-I IFN
              production. Our findings establish that IFN signaling is
              essential for the robust anti-tumor actions of cyclophosphamide
              and suggest that treatment resistance may stem from silencing the
              IFN pathway. This suggests a new avenue for improving TNBC
              treatment efficacy. \#\#\# Competing Interest Statement The
              authors have declared no competing interest.",
  journal  = "bioRxiv",
  pages    = "2021.12.05.471293",
  month    =  dec,
  year     =  2021,
  language = "en"
}

@ARTICLE{Takahashi2015-kz,
  title    = "Mammary tissue microenvironment determines {T} cell-dependent
              breast cancer-associated inflammation",
  author   = "Takahashi, Kei and Nagai, Nao and Ogura, Keisuke and Tsuneyama,
              Koichi and Saiki, Ikuo and Irimura, Tatsuro and Hayakawa,
              Yoshihiro",
  abstract = "Although the importance of the host tissue microenvironment in
              cancer progression and metastasis has been established, the
              spatiotemporal process establishing a cancer metastasis-prone
              tissue microenvironment remains unknown. In this study, we aim to
              understand the immunological character of a metastasis-prone
              microenvironment in a murine 4T1 breast tumor model, by using the
              activation of nuclear factor-$\kappa$b (NF-$\kappa$B) in cancer
              cells as a sensor of inflammatory status and by monitoring its
              activity by bioluminescence imaging. By using a 4T1 breast cancer
              cell line stably expressing an NF-$\kappa$B/Luc2 reporter gene
              (4T1 NF-$\kappa$B cells), we observed significantly increased
              bioluminescence approximately 7 days after metastasis-prone
              orthotopic mammary fat-pad inoculation but not ectopic s.c.
              inoculation of 4T1 NF-$\kappa$B cells. Such in vivo NF-$\kappa$B
              activation within the fat-pad 4T1 tumor was diminished in
              immune-deficient SCID or nude mice, or T cell-depleted mice,
              suggesting the requirement of host T cell-mediated immune
              responses. Given the fat-pad 4T1 tumor expressed higher
              inflammatory mediators in a T cell-dependent mechanism compared
              to the s.c. tumor, our results imply the importance of the
              surrounding tissue microenvironment for inflaming tumors by
              collaborating with T cells to instigate metastatic spread of 4T1
              breast cancer cells.",
  journal  = "Cancer Sci.",
  volume   =  106,
  number   =  7,
  pages    = "867--874",
  month    =  jul,
  year     =  2015,
  keywords = "Breast cancer; T cell; imaging; inflammation; tissue
              microenvironment",
  language = "en"
}

@ARTICLE{Park2020-rx,
  title    = "Intratumoral {CD103-positive} tumour-infiltrating lymphocytes are
              associated with favourable prognosis in patients with
              triple-negative breast cancer",
  author   = "Park, Min H and Kwon, Sun Y and Choi, Jung E and Gong, Gyungyub
              and Bae, Young K",
  abstract = "AIMS: Cluster of differentiation 103 (CD103), a marker of tissue
              resident memory T cells, is expressed on subsets of CD8+ T
              lymphocytes. We investigated the prognostic significance of
              CD103+ intra-epithelial tumour-infiltrating lymphocytes (iTILs)
              in invasive breast cancer (IBC). METHODS AND RESULTS:
              Immunohistochemistry was performed for CD103, CD8 and TGF-$\beta$
              isoforms (1, 2 and 3) on tissue microarrays of 1187 IBC samples.
              CD103+ and CD8+ iTILs were present in 904 (76.2\%) and 854 (74\%)
              cases with an overall mean $\pm$ standard deviation of 38.2 $\pm$
              100.2/mm2 and 30.4 $\pm$ 89.7/mm2 , respectively. The numbers of
              CD103+ and CD8+ iTILs were positively correlated, and CD103+
              iTILs outnumbered CD8+ iTILs in HER2-positive and triple-negative
              breast cancer (TNBC). CD103+ and CD8+ iTIL densities were
              significantly higher in tumours of histological grade 3, absence
              of lymphovascular invasion, high Ki-67 index, high stromal TIL
              density or TGF-$\beta$3 expression. High CD103+ iTIL density was
              associated with better disease-free survival (DFS, P = 0.007),
              but no significant association was observed for overall survival
              (OS). Subgroup analysis by cancer molecular subtype showed that
              CD103+ iTIL count was prognostic only for TNBC (OS, P = 0.035;
              DFS, P = 0.009). CD8+ iTIL density was significant for DFS, but
              not for OS, in the entire cohort and TNBC. In multivariate
              analysis, CD103+ iTIL density was an independent prognostic
              factor of OS (P = 0.02) and DFS (P = 0.007) in TNBC, while CD8+
              iTIL density was not significant for survival. CONCLUSIONS: CD103
              iTIL density can serve as a predictor of good prognosis in
              patients with TNBC.",
  journal  = "Histopathology",
  volume   =  77,
  number   =  4,
  pages    = "560--569",
  month    =  oct,
  year     =  2020,
  keywords = "CD103; breast neoplasms; prognosis;Human study",
  language = "en"
}

@ARTICLE{Mair2021-ay,
  title    = "A lesson from the wild: The natural state of eosinophils is
              {Ly6Ghi}",
  author   = "Mair, Iris and Wolfenden, Andrew and Lowe, Ann E and Bennett,
              Alex and Muir, Andrew and Smith, Hannah and Fenn, Jonathan and
              Bradley, Janette E and Else, Kathryn J",
  abstract = "With a long history of promoting pathological inflammation,
              eosinophils are now emerging as important regulatory cells. Yet,
              findings from controlled laboratory experiments so far lack
              translation to animals, including humans, in their natural
              environment. In order to appreciate the breadth of eosinophil
              phenotype under non-laboratory, uncontrolled conditions, we
              exploit a free-living population of the model organism Mus
              musculus domesticus. Eosinophils were present at significantly
              higher proportions in the spleen and bone marrow of wild mice
              compared with laboratory mice. Strikingly, the majority of
              eosinophils of wild mice exhibited a unique Ly6Ghi phenotype
              seldom described in laboratory literature. Ly6G expression
              correlated with activation status in spleen and bone marrow, but
              not peritoneal exudate cells, and is therefore likely not an
              activation marker per se. Intermediate Ly6G expression was
              transiently induced in a small proportion of eosinophils from
              C57BL/6 laboratory mice during acute infection with the whipworm
              Trichuris muris, but not during low-dose chronic infection, which
              better represents parasite exposure in the wild. We conclude that
              the natural state of the eosinophil is not adequately reflected
              in the standard laboratory mouse, which compromises our attempts
              to dissect their functional relevance. Our findings emphasize the
              importance of studying the immune system in its natural context -
              alongside more mechanistic laboratory experiments - in order to
              capture the entirety of immune phenotypes and functions.",
  journal  = "Immunology",
  volume   =  164,
  number   =  4,
  pages    = "766--776",
  month    =  dec,
  year     =  2021,
  keywords = "Ly6G; ecoimmunology; eosinophils; flow cytometry; granulocytes;
              phenotype; wild mice",
  language = "en"
}

@ARTICLE{Franklin2014-vh,
  title       = "The cellular and molecular origin of tumor-associated
                 macrophages",
  author      = "Franklin, Ruth A and Liao, Will and Sarkar, Abira and Kim,
                 Myoungjoo V and Bivona, Michael R and Liu, Kang and Pamer,
                 Eric G and Li, Ming O",
  abstract    = "Long recognized as an evolutionarily ancient cell type
                 involved in tissue homeostasis and immune defense against
                 pathogens, macrophages are being rediscovered as regulators of
                 several diseases, including cancer. Here we show that in mice,
                 mammary tumor growth induces the accumulation of
                 tumor-associated macrophages (TAMs) that are phenotypically
                 and functionally distinct from mammary tissue macrophages
                 (MTMs). TAMs express the adhesion molecule Vcam1 and
                 proliferate upon their differentiation from inflammatory
                 monocytes, but do not exhibit an ``alternatively activated''
                 phenotype. TAM terminal differentiation depends on the
                 transcriptional regulator of Notch signaling, RBPJ; and TAM,
                 but not MTM, depletion restores tumor-infiltrating cytotoxic T
                 cell responses and suppresses tumor growth. These findings
                 reveal the ontogeny of TAMs and a discrete tumor-elicited
                 inflammatory response, which may provide new opportunities for
                 cancer immunotherapy.",
  journal     = "Science",
  volume      =  344,
  number      =  6186,
  pages       = "921--925",
  month       =  may,
  year        =  2014,
  language    = "en",
  original_id = "4a127a04-b489-0b82-ac9a-be97f6b1b905"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Ariotti2014-lg,
  title    = "{T} cell memory. Skin-resident memory {CD8} {T} cells trigger a
              state of tissue-wide pathogen alert",
  author   = "Ariotti, Silvia and Hogenbirk, Marc A and Dijkgraaf, Feline E and
              Visser, Lindy L and Hoekstra, Mirjam E and Song, Ji-Ying and
              Jacobs, Heinz and Haanen, John B and Schumacher, Ton N",
  abstract = "After an infection, pathogen-specific tissue-resident memory T
              cells (T(RM) cells) persist in nonlymphoid tissues to provide
              rapid control upon reinfection, and vaccination strategies that
              create T(RM) cell pools at sites of pathogen entry are therefore
              attractive. However, it is not well understood how T(RM) cells
              provide such pathogen protection. Here, we demonstrate that
              activated T(RM) cells in mouse skin profoundly alter the local
              tissue environment by inducing a number of broadly active
              antiviral and antibacterial genes. This ``pathogen alert'' allows
              skin T(RM) cells to protect against an antigenically unrelated
              virus. These data describe a mechanism by which tissue-resident
              memory CD8(+) T cells protect previously infected sites that is
              rapid, amplifies the activation of a small number of cells into
              an organ-wide response, and has the capacity to control escape
              variants.",
  journal  = "Science",
  volume   =  346,
  number   =  6205,
  pages    = "101--105",
  month    =  oct,
  year     =  2014,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Steinmetz1983-uf,
  title    = "Genes of the major histocompatibility complex in mouse and man",
  author   = "Steinmetz, M and Hood, L",
  abstract = "The genes of the major histocompatibility complex code for
              cell-surface molecules that play an important role in the
              generation of the immune response. These genes and molecules have
              been studied intensively over the last five decades by
              geneticists, biochemists, and immunologists, but only recently
              has the isolation of the genes by molecular biologists
              facilitated their precise characterization. Many surprising
              findings have been made concerning their structure, multiplicity,
              organization, function, and evolution.",
  journal  = "Science",
  volume   =  222,
  number   =  4625,
  pages    = "727--733",
  month    =  nov,
  year     =  1983,
  language = "en"
}

@ARTICLE{Mani2019-gy,
  title    = "Migratory {DCs} activate {TGF-$\beta$} to precondition na{\"\i}ve
              {CD8+} {T} cells for tissue-resident memory fate",
  author   = "Mani, Vinidhra and Bromley, Shannon K and {\"A}ij{\"o}, Tarmo and
              Mora-Buch, Rut and Carrizosa, Esteban and Warner, Ross D and
              Hamze, Moustafa and Sen, Debattama R and Chasse, Alexandra Y and
              Lorant, Alina and Griffith, Jason W and Rahimi, Rod A and
              McEntee, Craig P and Jeffrey, Kate L and Marangoni, Francesco and
              Travis, Mark A and Lacy-Hulbert, Adam and Luster, Andrew D and
              Mempel, Thorsten R",
  abstract = "Epithelial resident memory T (eTRM) cells serve as sentinels in
              barrier tissues to guard against previously encountered
              pathogens. How eTRM cells are generated has important
              implications for efforts to elicit their formation through
              vaccination or prevent it in autoimmune disease. Here, we show
              that during immune homeostasis, the cytokine transforming growth
              factor $\beta$ (TGF-$\beta$) epigenetically conditions resting
              na{\"\i}ve CD8+ T cells and prepares them for the formation of
              eTRM cells in a mouse model of skin vaccination. Na{\"\i}ve T
              cell conditioning occurs in lymph nodes (LNs), but not in the
              spleen, through major histocompatibility complex class
              I-dependent interactions with peripheral tissue-derived migratory
              dendritic cells (DCs) and depends on DC expression of
              TGF-$\beta$-activating $\alpha$V integrins. Thus, the preimmune T
              cell repertoire is actively conditioned for a specialized memory
              differentiation fate through signals restricted to LNs.",
  journal  = "Science",
  volume   =  366,
  number   =  6462,
  month    =  oct,
  year     =  2019,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Malik2017-sd,
  title    = "Resident memory {T} cells in the skin mediate durable immunity to
              melanoma",
  author   = "Malik, Brian T and Byrne, Katelyn T and Vella, Jennifer L and
              Zhang, Peisheng and Shabaneh, Tamer B and Steinberg, Shannon M
              and Molodtsov, Aleksey K and Bowers, Jacob S and Angeles,
              Christina V and Paulos, Chrystal M and Huang, Yina H and Turk,
              Mary Jo",
  abstract = "Tissue-resident memory T (TRM) cells have been widely
              characterized in infectious disease settings; however, their role
              in mediating immunity to cancer remains unknown. We report that
              skin-resident memory T cell responses to melanoma are generated
              naturally as a result of autoimmune vitiligo. Melanoma
              antigen-specific TRM cells resided predominantly in
              melanocyte-depleted hair follicles and were maintained without
              recirculation or replenishment from the lymphoid compartment.
              These cells expressed CD103, CD69, and CLA (cutaneous lymphocyte
              antigen), but lacked PD-1 (programmed cell death protein-1) or
              LAG-3 (lymphocyte activation gene-3), and were capable of making
              IFN-$\gamma$ (interferon-$\gamma$). CD103 expression on CD8 T
              cells was required for the establishment of TRM cells in the skin
              but was dispensable for vitiligo development. CD103+ CD8 TRM
              cells were critical for protection against melanoma rechallenge.
              This work establishes that CD103-dependent TRM cells play a key
              role in perpetuating antitumor immunity.",
  journal  = "Sci Immunol",
  volume   =  2,
  number   =  10,
  month    =  apr,
  year     =  2017,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Konjar2018-ok,
  title    = "Mitochondria maintain controlled activation state of
              epithelial-resident {T} lymphocytes",
  author   = "Konjar, {\v S}pela and Frising, Ulrika C and Ferreira, Cristina
              and Hinterleitner, Reinhard and Mayassi, Toufic and Zhang, Qifeng
              and Blankenhaus, Birte and Haberman, Nejc and Loo, Yunhua and
              Guedes, Joana and Baptista, Marta and Innocentin, Silvia and
              Stange, Joerg and Strathdee, Douglas and Jabri, Bana and
              Veldhoen, Marc",
  abstract = "Epithelial-resident T lymphocytes, such as intraepithelial
              lymphocytes (IELs) located at the intestinal barrier, can offer
              swift protection against invading pathogens. Lymphocyte
              activation is strictly regulated because of its potential harmful
              nature and metabolic cost, and most lymphocytes are maintained in
              a quiescent state. However, IELs are kept in a heightened state
              of activation resembling effector T cells but without cytokine
              production or clonal proliferation. We show that this controlled
              activation state correlates with alterations in the IEL
              mitochondrial membrane, especially the cardiolipin composition.
              Upon inflammation, the cardiolipin composition is altered to
              support IEL proliferation and effector function. Furthermore, we
              show that cardiolipin makeup can particularly restrict swift IEL
              proliferation and effector functions, reducing microbial
              containment capability. These findings uncover an alternative
              mechanism to control cellular activity, special to
              epithelial-resident T cells, and a novel role for mitochondria,
              maintaining cells in a metabolically poised state while enabling
              rapid progression to full functionality.",
  journal  = "Sci Immunol",
  volume   =  3,
  number   =  24,
  month    =  jun,
  year     =  2018,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Nicolai2020-wa,
  title    = "{NK} cells mediate clearance of {CD8+} {T} cell-resistant tumors
              in response to {STING} agonists",
  author   = "Nicolai, Christopher J and Wolf, Natalie and Chang, I-Chang and
              Kirn, Georgia and Marcus, Assaf and Ndubaku, Chudi O and
              McWhirter, Sarah M and Raulet, David H",
  abstract = "Several immunotherapy approaches that mobilize CD8+ T cell
              responses stimulate tumor rejection, and some, such as checkpoint
              blockade, have been approved for several cancer indications and
              show impressive increases in patient survival. However, tumors
              may evade CD8+ T cell recognition via loss of MHC molecules or
              because they contain few or no neoantigens. Therefore, approaches
              are needed to combat CD8+ T cell-resistant cancers.
              STING-activating cyclic dinucleotides (CDNs) are a new class of
              immune-stimulating agents that elicit impressive CD8+ T
              cell-mediated tumor rejection in preclinical tumor models and are
              now being tested in clinical trials. Here, we demonstrate
              powerful CDN-induced, natural killer (NK) cell-mediated tumor
              rejection in numerous tumor models, independent of CD8+ T cells.
              CDNs enhanced NK cell activation, cytotoxicity, and antitumor
              effects in part by inducing type I interferon (IFN). IFN acted in
              part directly on NK cells in vivo and in part indirectly via the
              induction of IL-15 and IL-15 receptors, which were important for
              CDN-induced NK activation and tumor control. After in vivo
              administration of CDNs, dendritic cells (DCs) up-regulated
              IL-15R$\alpha$ in an IFN-dependent manner. Mice lacking the type
              I IFN receptor specifically on DCs had reduced NK cell activation
              and tumor control. Therapeutics that activate NK cells, such as
              CDNs, checkpoint inhibitors, NK cell engagers, and cytokines, may
              represent next-generation approaches to cancer immunotherapy.",
  journal  = "Sci Immunol",
  volume   =  5,
  number   =  45,
  month    =  mar,
  year     =  2020,
  language = "en"
}

@ARTICLE{Gueguen2021-mu,
  title    = "Contribution of resident and circulating precursors to
              tumor-infiltrating {CD8+} {T} cell populations in lung cancer",
  author   = "Gueguen, Paul and Metoikidou, Christina and Dupic, Thomas and
              Lawand, Myriam and Goudot, Christel and Baulande, Sylvain and
              Lameiras, Sonia and Lantz, Olivier and Girard, Nicolas and
              Seguin-Givelet, Agathe and Lefevre, Marine and Mora, Thierry and
              Walczak, Aleksandra M and Waterfall, Joshua J and Amigorena,
              Sebastian",
  abstract = "Tumor-infiltrating lymphocytes (TILs), in general, and especially
              CD8+ TILs, represent a favorable prognostic factor in non-small
              cell lung cancer (NSCLC). The tissue origin, regenerative
              capacities, and differentiation pathways of TIL subpopulations
              remain poorly understood. Using a combination of single-cell RNA
              and T cell receptor (TCR) sequencing, we investigate the
              functional organization of TIL populations in primary NSCLC. We
              identify two CD8+ TIL subpopulations expressing memory-like gene
              modules: one is also present in blood (circulating precursors)
              and the other one in juxtatumor tissue (tissue-resident
              precursors). In tumors, these two precursor populations converge
              through a unique transitional state into terminally
              differentiated cells, often referred to as dysfunctional or
              exhausted. Differentiation is associated with TCR expansion, and
              transition from precursor to late-differentiated states
              correlates with intratumor T cell cycling. These results provide
              a coherent working model for TIL origin, ontogeny, and functional
              organization in primary NSCLC.",
  journal  = "Sci Immunol",
  volume   =  6,
  number   =  55,
  month    =  jan,
  year     =  2021,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Gomez2020-wa,
  title       = "Breast cancer--associated macrophages promote tumorigenesis by
                 suppressing succinate dehydrogenase in tumor cells",
  author      = "G{\'o}mez, Valent{\'\i} and Eykyn, Thomas R and Mustapha, Rami
                 and Flores-Borja, Fabi{\'a}n and Male, Victoria and Barber,
                 Paul R and Patsialou, Antonia and Green, Ryan and Panagaki,
                 Fani and Li, Chun W and Fruhwirth, Gilbert O and Ros, Susana
                 and Brindle, Kevin M and Ng, Tony",
  abstract    = "Macrophage-secreted TGF-$\beta$ promotes glycolysis in tumor
                 cells to support angiogenesis and immunosuppression.
                 Macrophages in the tumor microenvironment [called
                 tumor-associated macrophages (TAMs)] often support tumor
                 growth and metastatic progression. Using a mix of in vivo and
                 coculture work with primary macrophages, Gomez et al. found
                 that secretion of the cytokine TGF-$\beta$ from
                 anti-inflammatory TAMs suppressed the abundance of succinate
                 dehydrogenase in breast cancer cells. The loss of this
                 metabolic enzyme promoted glycolysis, thereby enhancing tumor
                 growth, angiogenesis, and immunosuppression. Depleting
                 anti-inflammatory TAMs or blocking TGF-$\beta$ suppressed
                 these effects in vivo. The findings reveal a metabolic
                 mechanism underlying the protumorigenic roles of TAMs.
                 Tumor-associated macrophages (TAMs) can exist in pro- and
                 anti-inflammatory states. Anti-inflammatory TAMs (also
                 referred to as M2-polarized) generally suppress antitumor
                 immune responses and enhance the metastatic progression of
                 cancer. To explore the mechanisms behind this phenomenon, we
                 isolated macrophages from mice and humans, polarized them ex
                 vivo, and examined their functional interaction with breast
                 cancer cells in culture and in mice. We found that
                 anti-inflammatory TAMs promoted a metabolic state in breast
                 cancer cells that supported various protumorigenic phenotypes.
                 Anti-inflammatory TAMs secreted the cytokine TGF-$\beta$ that,
                 upon engagement of its receptors in breast cancer cells,
                 suppressed the abundance of the transcription factor STAT1
                 and, consequently, decreased that of the metabolic enzyme
                 succinate dehydrogenase (SDH) in the tumor cells. The decrease
                 in SDH levels in tumor cells resulted in an accumulation of
                 succinate, which enhanced the stability of the transcription
                 factor HIF1$\alpha$ and reprogrammed cell metabolism to a
                 glycolytic state. TAM depletion-repletion experiments in a 4T1
                 mouse model additionally revealed that anti-inflammatory
                 macrophages promoted HIF-associated vascularization and
                 expression of the immunosuppressive protein PD-L1 in tumors.
                 The findings suggest that anti-inflammatory TAMs promote
                 tumor-associated angiogenesis and immunosuppression by
                 altering metabolism in breast cancer cells.",
  journal     = "Sci. Signal.",
  volume      =  13,
  number      =  652,
  pages       = "eaax4585",
  year        =  2020,
  original_id = "10455c67-8fef-0fe4-b8b6-959fb645965e"
}

@ARTICLE{Zhang2022-dt,
  title    = "{CECR2} drives breast cancer metastasis by promoting
              {NF-$\kappa$B} signaling and macrophage-mediated immune
              suppression",
  author   = "Zhang, Meiling and Liu, Zongzhi Z and Aoshima, Keisuke and Cai,
              Wesley L and Sun, Hongyin and Xu, Tianrui and Zhang, Yangyi and
              An, Yongyan and Chen, Jocelyn F and Chan, Lok Hei and Aoshima,
              Asako and Lang, Sabine M and Tang, Zhenwei and Che, Xuanlin and
              Li, Yao and Rutter, Sara J and Bossuyt, Veerle and Chen, Xiang
              and Morrow, Jon S and Pusztai, Lajos and Rimm, David L and Yin,
              Mingzhu and Yan, Qin",
  abstract = "Metastasis is the major cause of cancer-related deaths due to the
              lack of effective therapies. Emerging evidence suggests that
              certain epigenetic and transcriptional regulators drive cancer
              metastasis and could be targeted for metastasis treatment. To
              identify epigenetic regulators of breast cancer metastasis, we
              profiled the transcriptomes of matched pairs of primary breast
              tumors and metastases from human patients. We found that distant
              metastases are more immune inert with increased M2 macrophages
              compared to their matched primary tumors. The acetyl-lysine
              reader, cat eye syndrome chromosome region candidate 2 (CECR2),
              was the top up-regulated epigenetic regulator in metastases
              associated with an increased abundance of M2 macrophages and
              worse metastasis-free survival. CECR2 was required for breast
              cancer metastasis in multiple mouse models, with more profound
              effect in the immunocompetent setting. Mechanistically, the
              nuclear factor $\kappa$B (NF-$\kappa$B) family member v-rel avian
              reticuloendotheliosis viral oncogene homolog A (RELA) recruits
              CECR2 to increase chromatin accessibility and activate the
              expression of their target genes. These target genes include
              multiple metastasis-promoting genes, such as TNC, MMP2, and
              VEGFA, and cytokine genes CSF1 and CXCL1, which are critical for
              immunosuppression at metastatic sites. Consistent with these
              results, pharmacological inhibition of CECR2 bromodomain impeded
              NF-$\kappa$B-mediated immune suppression by macrophages and
              inhibited breast cancer metastasis. These results reveal that
              targeting CECR2 may be a strategy to treat metastatic breast
              cancer.",
  journal  = "Sci. Transl. Med.",
  volume   =  14,
  number   =  630,
  pages    = "eabf5473",
  month    =  feb,
  year     =  2022,
  language = "en"
}

@ARTICLE{Hewavisenti2020-du,
  title    = "{CD103+} tumor-resident {CD8+} {T} cell numbers underlie improved
              patient survival in oropharyngeal squamous cell carcinoma",
  author   = "Hewavisenti, Rehana and Ferguson, Angela and Wang, Kevin and
              Jones, Deanna and Gebhardt, Thomas and Edwards, Jarem and Zhang,
              Mei and Britton, Warwick and Yang, Jean and Hong, Angela and
              Palendira, Umaimainthan",
  abstract = "BACKGROUND: Human Papillomavirus (HPV) associated oropharyngeal
              squamous cell carcinoma (OPSCC) is one of the fastest growing
              cancers in the Western world. When compared to OPSCCs induced by
              smoking or alcohol, patients with HPV+ OPSCC, have better
              survival and the mechanisms remain unclear. METHODS: The Cancer
              Genome Atlas (TCGA) database was examined for genes associated
              with tissue-resident CD8+ T cells. Multiplex immunohistochemistry
              (IHC) staining was performed on tumor specimen taken from 35 HPV+
              and 27 HPV- OPSCC patients. RESULTS: TCGA database revealed that
              the expression of genes encoding CD103 and CD69 were
              significantly higher in HPV+ head and neck SCCs (HNSCC) than in
              HPV- HNSCC. Higher expression levels of these two genes were also
              associated with better overall survival. IHC staining showed that
              the proportion of CD103+ tumor-resident CD8+ T cells were
              significantly higher in HPV+ OPSCCs when compared to HPV- OPSCC.
              This higher level was also associated with both lower risk of
              loco-regional failure, and better overall survival. Importantly,
              patients with HPV- OPSCC who had comparable levels of CD103+
              tumor-resident CD8+ T cells to those with HPV+ OPSCC demonstrated
              similar survival as those with HPV+OPSCC. CONCLUSION: Our results
              show that CD103+ tumor-resident CD8+ T cells are critical for
              protective immunity in both types of OPSCCs. Our data further
              suggest that the enhanced local protective immunity provided by
              tumor-resident T cell responses is the underlying factor driving
              favorable clinical outcomes in HPV+ OPSCCs over HPV- OPSCCs.",
  journal  = "J Immunother Cancer",
  volume   =  8,
  number   =  1,
  month    =  jun,
  year     =  2020,
  keywords = "immunology; tumors;Human study",
  language = "en"
}

@ARTICLE{Banchereau2021-tg,
  title    = "Intratumoral {CD103+} {CD8+} {T} cells predict response to
              {PD-L1} blockade",
  author   = "Banchereau, Romain and Chitre, Avantika S and Scherl, Alexis and
              Wu, Thomas D and Patil, Namrata S and de Almeida, Patricia and
              Kadel, Iii, Edward E and Madireddi, Shravan and Au-Yeung, Amelia
              and Takahashi, Chikara and Chen, Ying-Jiun and Modrusan, Zora and
              McBride, Jacqueline and Nersesian, Rhea and El-Gabry, Ehab A and
              Robida, Mark D and Hung, Jeffrey C and Kowanetz, Marcin and Zou,
              Wei and McCleland, Mark and Caplazi, Patrick and Eshgi, Shadi
              Toghi and Koeppen, Hartmut and Hegde, Priti S and Mellman, Ira
              and Mathews, W Rodney and Powles, Thomas and Mariathasan, Sanjeev
              and Grogan, Jane and O'Gorman, William E",
  abstract = "BACKGROUND: CD8+ tissue-resident memory T (TRM) cells, marked by
              CD103 (ITGAE) expression, are thought to actively suppress cancer
              progression, leading to the hypothesis that their presence in
              tumors may predict response to immunotherapy. METHODS: Here, we
              test this by combining high-dimensional single-cell modalities
              with bulk tumor transcriptomics from 1868 patients enrolled in
              lung and bladder cancer clinical trials of atezolizumab
              (anti-programmed cell death ligand 1 (PD-L1)). RESULTS: ITGAE was
              identified as the most significantly upregulated gene in inflamed
              tumors. Tumor CD103+ CD8+ TRM cells exhibited a complex phenotype
              defined by the expression of checkpoint regulators, cytotoxic
              proteins, and increased clonal expansion. CONCLUSIONS: Our
              analyses indeed demonstrate that the presence of CD103+ CD8+ TRM
              cells, quantified by tracking intratumoral CD103 expression, can
              predict treatment outcome, suggesting that patients who respond
              to PD-1/PD-L1 blockade are those who exhibit an ongoing antitumor
              T-cell response.",
  journal  = "J Immunother Cancer",
  volume   =  9,
  number   =  4,
  month    =  apr,
  year     =  2021,
  keywords = "CD8-positive T-lymphocytes; biomarkers; gene expression
              profiling; immunotherapy; lymphocytes; tumor;
              tumor-infiltrating;Human study",
  language = "en"
}

@ARTICLE{Muthuswamy2021-qh,
  title    = "{CXCR6} by increasing retention of memory {CD8+} {T} cells in the
              ovarian tumor microenvironment promotes immunosurveillance and
              control of ovarian cancer",
  author   = "Muthuswamy, Ravikumar and McGray, Aj Robert and Battaglia,
              Sebastiano and He, Wenjun and Miliotto, Anthony and Eppolito,
              Cheryl and Matsuzaki, Junko and Takemasa, Tsuji and Koya, Richard
              and Chodon, Thinle and Lichty, Brian D and Shrikant, Protul and
              Odunsi, Kunle",
  abstract = "PURPOSE: Resident memory CD8 T cells, owing to their ability to
              reside and persist in peripheral tissues, impart adaptive
              sentinel activity and amplify local immune response, and have
              beneficial implications for tumor surveillance and control. The
              current study aimed to clarify the less known chemotactic
              mechanisms that govern the localization, retention, and residency
              of memory CD8 T cells in the ovarian tumor microenvironment.
              EXPERIMENTAL DESIGN: RNA and protein expressions of chemokine
              receptors in CD8+ resident memory T cells in human ovarian
              tumor-infiltrating CD8+ T cells and their association with
              survival were analyzed. The role of CXCR6 on antitumor T cells
              was investigated using prophylactic vaccine models in murine
              ovarian cancer. RESULTS: Chemokine receptor profiling of
              CD8+CD103+ resident memory tumor-infiltrating lymphocytes in
              patients with ovarian cancer revealed high expression of CXCR6.
              Analysis of The Cancer Genome Atlas (TCGA) (ovarian cancer
              database revealed CXCR6 to be associated with CD103 and increased
              patient survival. Functional studies in mouse models of ovarian
              cancer revealed that CXCR6 is a marker of resident, but not
              circulatory, tumor-specific memory CD8+ T cells. CXCR6-deficient
              tumor-specific CD8+ T cells showed reduced retention in tumor
              tissues, leading to diminished resident memory responses and poor
              control of ovarian cancer. CONCLUSIONS: CXCR6, by promoting
              retention in tumor tissues, serves a critical role in resident
              memory T cell-mediated immunosurveillance and control of ovarian
              cancer. Future studies warrant exploiting CXCR6 to promote
              resident memory responses in cancers.",
  journal  = "J Immunother Cancer",
  volume   =  9,
  number   =  10,
  month    =  oct,
  year     =  2021,
  keywords = "adoptive; immunological memory; immunotherapy; lymphocytes; tumor
              microenvironment; tumor-infiltrating;Human study",
  language = "en"
}

@ARTICLE{Corgnac2022-tn,
  title    = "Cancer stem-like cells evade {CD8+CD103+} tumor-resident memory
              {T} ({TRM}) lymphocytes by initiating an
              epithelial-to-mesenchymal transition program in a human lung
              tumor model",
  author   = "Corgnac, St{\'e}phanie and Damei, Isabelle and Gros, Gwendoline
              and Caidi, Aziza and Terry, St{\'e}phane and Chouaib, Salem and
              Deloger, Marc and Mami-Chouaib, Fathia",
  abstract = "BACKGROUND: Cancer stem cells (CSC) define a population of rare
              malignant cells endowed with 'stemness' properties, such as
              self-renewing, multipotency and tumorigenicity. They are
              responsible for tumor initiation and progression, and could be
              associated with resistance to immunotherapies by negatively
              regulating antitumor immune response and acquiring molecular
              features enabling escape from CD8 T-cell immunity. However, the
              immunological hallmarks of human lung CSC and their potential
              interactions with resident memory T (TRM) cells within the tumor
              microenvironment have not been investigated. METHODS: We
              generated a non-small cell lung cancer model, including CSC line
              and clones, and autologous CD8+CD103+ TRM and CD8+CD103- non-TRM
              clones, to dissect out immune properties of CSC and their
              susceptibility to specific T-cell-mediated cytotoxic activity.
              RESULTS: Unlike their parental tumor cells, lung CSC are
              characterized by the initiation of an epithelial-to-mesenchymal
              transition program defined by upregulation of the SNAIL1
              transcription factor and downregulation of
              phosphorylated-GSK-3$\beta$ and cell surface E-cadherin.
              Acquisition of a CSC profile results in partial resistance to
              TRM-cell-mediated cytotoxicity, which correlates with decreased
              surface expression of the CD103 ligand E-cadherin and human
              leukocyte antigen-A2-neoepitope complexes. On the other hand, CSC
              gained expression of intercellular adhesion molecule (ICAM)-1 and
              thereby sensitivity to leukocyte function-associated antigen
              (LFA)-1-dependent non-TRM-cell-mediated killing. Cytotoxicity is
              inhibited by anti-ICAM-1 and anti-major histocompatibility
              complex class I neutralizing antibodies further emphasizing the
              role of LFA-1/ICAM-1 interaction in T-cell receptor-dependent
              lytic function. CONCLUSION: Our data support the rational design
              of immunotherapeutic strategies targeting CSC to optimize their
              responsiveness to local CD8+CD103+ TRM cells for more efficient
              anticancer treatments.",
  journal  = "J Immunother Cancer",
  volume   =  10,
  number   =  4,
  month    =  apr,
  year     =  2022,
  keywords = "CD8-positive T-lymphocytes; immune evation; immunity;
              lymphocytes, tumor-infiltrating; tumor microenvironment;Mouse
              study",
  language = "en"
}

@ARTICLE{Attrill2022-vr,
  title    = "Higher proportions of {CD39+} tumor-resident cytotoxic {T} cells
              predict recurrence-free survival in patients with stage {III}
              melanoma treated with adjuvant immunotherapy",
  author   = "Attrill, Grace Heloise and Owen, Carina N and Ahmed, Tasnia and
              Vergara, Ismael A and Colebatch, Andrew J and Conway, Jordan W
              and Nahar, Kazi J and Thompson, John F and Pires da Silva, Ines
              and Carlino, Matteo S and Menzies, Alexander M and Lo, Serigne
              and Palendira, Umaimainthan and Scolyer, Richard A and Long,
              Georgina V and Wilmott, James S",
  abstract = "BACKGROUND: Adjuvant immune checkpoint inhibitor (ICI)
              immunotherapies have significantly reduced the recurrence rate in
              high-risk patients with stage III melanoma compared with surgery
              alone. However, 48\% of anti-PD-1-treated patients will develop
              recurrent disease within 4 years. There is a need to identify
              biomarkers of recurrence after adjuvant ICI to enable
              identification of patients in need of alternative treatment
              strategies. As cytotoxic T cells are critical for the antitumor
              response to anti-PD-1, we sought to determine whether specific
              subsets were predictive of recurrence in anti-PD-1-treated
              high-risk patients with stage III melanoma. METHODS: Associations
              with recurrence in patients with stage III melanoma were sought
              by analyzing resection specimens (n=103) taken prior to adjuvant
              nivolumab/pembrolizumab$\pm$low-dose/low-interval ipilimumab.
              Multiplex immunohistochemistry was used to quantify intratumoral
              CD8+ T-cell populations using phenotypical markers CD39, CD103,
              and PD-1. RESULTS: With a median follow-up of 19.3 months, 37/103
              (36\%) of patients had a recurrence. Two CD8+ T-cell
              subpopulations were significantly associated with recurrence.
              First, CD39+ tumor-resident memory cells (CD39+CD103+PD-1+CD8+
              (CD39+ Trm)) comprised a significantly higher proportion of CD8+
              T cells in recurrence-free patients (p=0.0004). Conversely,
              bystander T cells (CD39-CD103-PD-1-CD8+) comprised a
              significantly greater proportion of T cells in patients who
              developed recurrence (p=0.0002). Spatial analysis identified that
              CD39+ Trms localized significantly closer to melanoma cells than
              bystander T cells. Multivariable analysis confirmed significantly
              improved recurrence-free survival (RFS) in patients with a high
              proportion of intratumoral CD39+ Trms (1-year RFS high 78.1\% vs
              low 49.9\%, HR 0.32, 95\% CI 0.15 to 0.69), no complete lymph
              node dissection performed, and less advanced disease stage (HR
              2.85, 95\% CI 1.13 to 7.19, and HR 1.29, 95\% CI 0.59 to 2.82).
              The final Cox regression model identified patients who developed
              recurrence with an area under the curve of 75.9\% in the
              discovery cohort and 69.5\% in a separate validation cohort
              (n=33) to predict recurrence status at 1 year. CONCLUSIONS:
              Adjuvant immunotherapy-treated patients with a high proportion of
              CD39+ Trms in their baseline melanoma resection have a
              significantly reduced risk of melanoma recurrence. This
              population of T cells may not only represent a biomarker of RFS
              following anti-PD-1 therapy, but may also be an avenue for
              therapeutic manipulation and enhancing outcomes for
              immunotherapy-treated patients with cancer.",
  journal  = "J Immunother Cancer",
  volume   =  10,
  number   =  6,
  month    =  jun,
  year     =  2022,
  keywords = "CD8-positive T-lymphocytes; immunotherapy; melanoma; tumor
              microenvironment;Human study",
  language = "en"
}

@ARTICLE{Webb2014-wa,
  title    = "Tumor-infiltrating lymphocytes expressing the tissue resident
              memory marker {CD103} are associated with increased survival in
              high-grade serous ovarian cancer",
  author   = "Webb, John R and Milne, Katy and Watson, Peter and Deleeuw,
              Ronald J and Nelson, Brad H",
  abstract = "BACKGROUND: The presence of CD8(+) tumor-infiltrating lymphocytes
              (TIL) is associated with prolonged survival in high-grade serous
              ovarian cancer (HGSC) and other epithelial cancers. Survival is
              most strongly associated with intraepithelial versus intrastromal
              CD8(+) TILs; however, the mechanisms that promote the
              intraepithelial localization of TILs remain poorly understood. We
              hypothesized that intraepithelial CD8(+) TILs, like normal
              mucosal intraepithelial lymphocytes, might express CD103, a
              subunit of $\alpha$E/$\beta$7 integrin, which binds E-cadherin on
              epithelial cells. METHODS: A large collection of primary ovarian
              tumors (HGSC, endometrioid, mucinous, and clear cell) was
              analyzed by immunohistochemistry for the presence of
              TIL-expressing CD103. The activation and differentiation status
              of CD103(+) TILs were assessed by flow cytometry. The prognostic
              significance of TIL subsets was evaluated by Kaplan-Meier
              analysis. RESULTS: CD103(+) TILs were present in all major
              ovarian cancer subtypes and were most abundant in HGSC. CD103(+)
              TILs were preferentially localized to epithelial regions of
              tumors and were comprised predominantly of CD8(+) T cells
              expressing activation (HLA-DR, Ki-67, PD-1) and cytolytic (TIA-1)
              markers, as well as CD56(+) NK cells. Tumor infiltration by
              CD103(+) TILs was strongly associated with patient survival in
              HGSC. Tumors containing CD8(+) TILs that were CD103(-) showed
              poor prognosis equivalent to tumors lacking CD8(+) TILs
              altogether. CONCLUSIONS: CD103(+) TILs comprise intraepithelial,
              activated CD8(+) T cells, and NK cells and are strongly
              associated with patient survival in HGSC. CD103 may serve as a
              useful marker for enriching the most beneficial subsets of TILs
              for immunotherapy.",
  journal  = "Clin. Cancer Res.",
  volume   =  20,
  number   =  2,
  pages    = "434--444",
  month    =  jan,
  year     =  2014,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Edwards2018-nr,
  title    = "{CD103+} {Tumor-Resident} {CD8+} {T} Cells Are Associated with
              Improved Survival in {Immunotherapy-Na{\"\i}ve} Melanoma Patients
              and Expand Significantly During {Anti-PD-1} Treatment",
  author   = "Edwards, Jarem and Wilmott, James S and Madore, Jason and Gide,
              Tuba Nur and Quek, Camelia and Tasker, Annie and Ferguson, Angela
              and Chen, Jinbiao and Hewavisenti, Rehana and Hersey, Peter and
              Gebhardt, Thomas and Weninger, Wolfgang and Britton, Warwick J
              and Saw, Robyn P M and Thompson, John F and Menzies, Alexander M
              and Long, Georgina V and Scolyer, Richard A and Palendira,
              Umaimainthan",
  abstract = "Purpose: Therapeutic blockade of immune checkpoints has
              revolutionized cancer treatment. Durable responses, however,
              occur in less than half of those treated, and efforts to improve
              treatment efficacy are confounded by a lack of understanding of
              the characteristics of the cells that initiate antitumor immune
              response.Patients and Methods: We performed multiparameter flow
              cytometry and quantitative multiplex immunofluorescence staining
              on tumor specimens from immunotherapy-na{\"\i}ve melanoma
              patients and longitudinal biopsy specimen obtained from patients
              undergoing anti-PD-1 therapy.Results: Increased numbers of
              CD69+CD103+ tumor-resident CD8+ T cells were associated with
              improved melanoma-specific survival in immunotherapy-na{\"\i}ve
              melanoma patients. Local IL15 expression levels strongly
              correlated with these tumor-resident T-cell numbers. The
              expression of several immune checkpoints including PD-1 and LAG3
              was highly enriched in this subset, and these cells significantly
              expanded early during anti-PD-1 immunotherapy.Conclusions:
              Tumor-resident CD8+ T-cell numbers are more prognostic than total
              CD8+ T cells in metastatic melanoma. In addition, they are likely
              to initiate response to anti-PD-1 and anti-LAG-3 treatments. We
              propose that the immune profile of these cells prior to treatment
              could inform strategies for immune checkpoint blockade. Clin
              Cancer Res; 24(13); 3036-45. \copyright{}2018 AACR.",
  journal  = "Clin. Cancer Res.",
  volume   =  24,
  number   =  13,
  pages    = "3036--3045",
  month    =  jul,
  year     =  2018,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Feng2014-vw,
  title    = "Epithelial-to-mesenchymal transition activates
              {PERK-eIF2$\alpha$} and sensitizes cells to endoplasmic reticulum
              stress",
  author   = "Feng, Yu-Xiong and Sokol, Ethan S and Del Vecchio, Catherine A
              and Sanduja, Sandhya and Claessen, Jasper H L and Proia, Theresa
              A and Jin, Dexter X and Reinhardt, Ferenc and Ploegh, Hidde L and
              Wang, Qiu and Gupta, Piyush B",
  abstract = "UNLABELLED: Epithelial-to-mesenchymal transition (EMT) promotes
              both tumor progression and drug resistance, yet few
              vulnerabilities of this state have been identified. Using
              selective small molecules as cellular probes, we show that
              induction of EMT greatly sensitizes cells to agents that perturb
              endoplasmic reticulum (ER) function. This sensitivity to ER
              perturbations is caused by the synthesis and secretion of large
              quantities of extracellular matrix (ECM) proteins by EMT cells.
              Consistent with their increased secretory output, EMT cells
              display a branched ER morphology and constitutively activate the
              PERK-eIF2$\alpha$ axis of the unfolded protein response (UPR).
              Protein kinase RNA-like ER kinase (PERK) activation is also
              required for EMT cells to invade and metastasize. In human tumor
              tissues, EMT gene expression correlates strongly with both ECM
              and PERK-eIF2$\alpha$ genes, but not with other branches of the
              UPR. Taken together, our findings identify a novel vulnerability
              of EMT cells, and demonstrate that the PERK branch of the UPR is
              required for their malignancy. SIGNIFICANCE: EMT drives tumor
              metastasis and drug resistance, highlighting the need for
              therapies that target this malignant subpopulation. Our findings
              identify a previously unrecognized vulnerability of cancer cells
              that have undergone an EMT: sensitivity to ER stress. We also
              find that PERK-eIF2$\alpha$ signaling, which is required to
              maintain ER homeostasis, is also indispensable for EMT cells to
              invade and metastasize.",
  journal  = "Cancer Discov.",
  volume   =  4,
  number   =  6,
  pages    = "702--715",
  month    =  jun,
  year     =  2014,
  language = "en"
}

@ARTICLE{Swierczak2014-pb,
  title       = "The promotion of breast cancer metastasis caused by inhibition
                 of {CSF-1R/CSF-1} signaling is blocked by targeting the
                 {G-CSF} receptor",
  author      = "Swierczak, Agnieszka and Cook, Andrew D and Lenzo, Jason C and
                 Restall, Christina M and Doherty, Judy P and Anderson, Robin L
                 and Hamilton, John A",
  abstract    = "Treatment options are limited for patients with breast cancer
                 presenting with metastatic disease. Targeting of
                 tumor-associated macrophages through the inhibition of
                 colony-stimulating factor-1 receptor (CSF-1R), a key
                 macrophage signaling pathway, has been reported to reduce
                 tumor growth and metastasis, and these treatments are now in
                 clinical trials. Here, we report that, surprisingly, treatment
                 with neutralizing anti-CSF-1R and anti-CSF-1 antibodies, or
                 with two different small-molecule inhibitors of CSF-1R, could
                 actually increase spontaneous metastasis without altering
                 primary tumor growth in mice bearing two independently derived
                 mammary tumors. The blockade of CSF-1R or CSF-1 led to
                 increased levels of serum G-CSF, increased frequency of
                 neutrophils in the primary tumor and in the
                 metastasis-associated lung, as well as increased numbers of
                 neutrophils and Ly6C(hi) monocytes in the peripheral blood.
                 Neutralizing antibody against the G-CSF receptor, which
                 regulates neutrophil development and function, reduced the
                 enhanced metastasis and neutrophil numbers that resulted from
                 CSF-1R blockade. These results indicate that the role of the
                 CSF-1R/CSF-1 system in breast cancer is far more complex than
                 originally proposed, and requires further investigation as a
                 therapeutic target.",
  journal     = "Cancer Immunol Res",
  volume      =  2,
  number      =  8,
  pages       = "765--776",
  month       =  aug,
  year        =  2014,
  language    = "en",
  original_id = "bf10b763-391d-0ae7-920e-f94cf7bcdd43"
}

@ARTICLE{Lin2020-hl,
  title    = "Fatty Acid Oxidation Controls {CD8+} {Tissue-Resident} Memory
              T-cell Survival in Gastric Adenocarcinoma",
  author   = "Lin, Run and Zhang, Hui and Yuan, Yujie and He, Qiong and Zhou,
              Jianwen and Li, Shuhua and Sun, Yu and Li, Daniel Y and Qiu,
              Hai-Bo and Wang, Wei and Zhuang, Zhehong and Chen, Bin and Huang,
              Yonghui and Liu, Chuwei and Wang, Yingzhao and Cai, Shirong and
              Ke, Zunfu and He, Weiling",
  abstract = "The success of checkpoint inhibitors in cancer treatment is
              associated with the infiltration of tissue-resident memory T
              (Trm) cells. In this study, we found that about 30\% of
              tumor-infiltrating lymphocytes (TIL) in the tumor
              microenvironment of gastric adenocarcinoma were CD69+CD103+ Trm
              cells. Trm cells were low in patients with metastasis, and the
              presence of Trm cells was associated with better prognosis in
              patients with gastric adenocarcinoma. Trm cells expressed high
              PD-1, TIGIT, and CD39 and represented tumor-reactive TILs.
              Instead of utilizing glucose, Trm cells relied on fatty acid
              oxidation for cell survival. Deprivation of fatty acid resulted
              in Trm cell death. In a tumor cell-T-cell coculture system,
              gastric adenocarcinoma cells outcompeted Trm cells for lipid
              uptake and induced Trm cell death. Targeting PD-L1 decreased
              fatty acid binding protein (Fabp) 4 and Fabp5 expression in tumor
              cells of gastric adenocarcinoma. In contrast, the blockade of
              PD-L1 increased Fabp4/5 expression in Trm cells, promoting lipid
              uptake by Trm cells and resulting in better survival of Trm cells
              in vitro and in vivo. PD-L1 blockade unleashed Trm cells
              specifically in the patient-derived xenograft (PDX) mice. PDX
              mice that did not respond to PD-L1 blockade had less Trm cells
              than responders. Together, these data demonstrated that Trm cells
              represent a subset of TILs in the antitumor immune response and
              that metabolic reprogramming could be a promising way to prolong
              the longevity of Trm cells and enhance antitumor immunity in
              gastric adenocarcinoma.",
  journal  = "Cancer Immunol Res",
  volume   =  8,
  number   =  4,
  pages    = "479--492",
  month    =  apr,
  year     =  2020,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Milling2022-ay,
  title    = "Neoadjuvant {STING} Activation, Extended Half-life {IL2}, and
              Checkpoint Blockade Promote Metastasis Clearance via Sustained
              {NK-cell} Activation",
  author   = "Milling, Lauren E and Garafola, Daniel and Agarwal, Yash and Wu,
              Shengwei and Thomas, Ayush and Donahue, Nathan and Adams, Josetta
              and Thai, Nikki and Suh, Heikyung and Irvine, Darrell J",
  abstract = "Combination immunotherapy treatments that recruit both innate and
              adaptive immunity have the potential to increase cancer response
              rates by engaging a more complete repertoire of effector
              mechanisms. Here, we combined intratumoral STimulator of
              INterferon Genes (STING) agonist therapy with systemically
              injected extended half-life IL2 and anti-PD-1 checkpoint blockade
              (hereafter CIP therapy) to drive innate and adaptive antitumor
              immunity in models of triple-negative breast cancer. Unlike
              treatment with the individual components, this trivalent
              immunotherapy halted primary tumor progression and led to
              long-term remission for a majority of animals in two
              spontaneously metastasizing orthotopic breast tumor models,
              though only as a neoadjuvant therapy but not adjuvant therapy.
              CIP therapy induced antitumor T-cell responses, but protection
              from metastatic relapse depended on natural killer (NK) cells.
              The combination of STING agonists with IL2/anti-PD-1 synergized
              to stimulate sustained granzyme and cytokine expression by
              lung-infiltrating NK cells. Type I IFNs generated as a result of
              STING agonism, combined with IL2, acted in a positive-feedback
              loop by enhancing the expression of IFNAR-1 and CD25 on lung NK
              cells. These results suggest that NK cells can be therapeutically
              targeted to effectively eliminate tumor metastases.See related
              Spotlight by Demaria, p. 3.",
  journal  = "Cancer Immunol Res",
  volume   =  10,
  number   =  1,
  pages    = "26--39",
  month    =  jan,
  year     =  2022,
  language = "en"
}

@ARTICLE{Liikanen2021-hz,
  title    = "Hypoxia-inducible factor activity promotes antitumor effector
              function and tissue residency by {CD8+} {T} cells",
  author   = "Liikanen, Ilkka and Lauhan, Colette and Quon, Sara and Omilusik,
              Kyla and Phan, Anthony T and Bartrol{\'\i}, Laura Barcel{\'o} and
              Ferry, Amir and Goulding, John and Chen, Joyce and Scott-Browne,
              James P and Yustein, Jason T and Scharping, Nicole E and
              Witherden, Deborah A and Goldrath, Ananda W",
  abstract = "Adoptive T cell therapies (ACTs) hold great promise in cancer
              treatment, but low overall response rates in patients with solid
              tumors underscore remaining challenges in realizing the potential
              of this cellular immunotherapy approach. Promoting CD8+ T cell
              adaptation to tissue residency represents an underutilized but
              promising strategy to improve tumor-infiltrating lymphocyte (TIL)
              function. Here, we report that deletion of the HIF negative
              regulator von Hippel-Lindau (VHL) in CD8+ T cells induced
              HIF-1$\alpha$/HIF-2$\alpha$-dependent differentiation of
              tissue-resident memory-like (Trm-like) TILs in mouse models of
              malignancy. VHL-deficient TILs accumulated in tumors and
              exhibited a core Trm signature despite an exhaustion-associated
              phenotype, which led to retained polyfunctionality and response
              to $\alpha$PD-1 immunotherapy, resulting in tumor eradication and
              protective tissue-resident memory. VHL deficiency similarly
              facilitated enhanced accumulation of chimeric antigen receptor
              (CAR) T cells with a Trm-like phenotype in tumors. Thus, HIF
              activity in CD8+ TILs promotes accumulation and antitumor
              activity, providing a new strategy to enhance the efficacy of
              ACTs.",
  journal  = "J. Clin. Invest.",
  volume   =  131,
  number   =  7,
  month    =  apr,
  year     =  2021,
  keywords = "Adaptive immunity; Immunology; Immunotherapy; T cells;
              Therapeutics;Mouse study",
  language = "en"
}

@ARTICLE{You2021-gf,
  title    = "Active surveillance characterizes human intratumoral {T} cell
              exhaustion",
  author   = "You, Ran and Artichoker, Jordan and Fries, Adam and Edwards,
              Austin W and Combes, Alexis J and Reeder, Gabriella C and Samad,
              Bushra and Krummel, Matthew F",
  abstract = "Intratumoral T cells that might otherwise control tumors are
              often identified in an ``exhausted'' state, defined by specific
              epigenetic modifications and upregulation of genes such as CD38,
              cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and
              programmed cell death 1 (PD1). Although the term might imply
              inactivity, there has been little study of this state at the
              phenotypic level in tumors to understand the extent of their
              incapacitation. Starting with the observation that T cells move
              more quickly through mouse tumors the longer they reside there
              and progress toward exhaustion, we developed a nonstimulatory,
              live-biopsy method for the real-time study of T cell behavior
              within individual patient tumors. Using 2-photon microscopy, we
              studied native CD8+ T cell interaction with antigen-presenting
              cells (APCs) and cancer cells in different microniches of human
              tumors and found that T cell speed was variable by region and by
              patient and was inversely correlated with local tumor density.
              Across a range of tumor types, we found a strong relationship
              between CD8+ T cell motility and the exhausted T cell state that
              corresponded with our observations made in mouse models in which
              exhausted T cells moved faster. Our study demonstrates T cell
              dynamic states in individual human tumors and supports the
              existence of an active program in ``exhausted'' T cells that
              extends beyond incapacitating them.",
  journal  = "J. Clin. Invest.",
  volume   =  131,
  number   =  18,
  month    =  sep,
  year     =  2021,
  keywords = "Cancer; Immunology; Oncology; T cells;Human study",
  language = "en"
}

@ARTICLE{Egelston2019-qw,
  title    = "Resident memory {CD8+} {T} cells within cancer islands mediate
              survival in breast cancer patients",
  author   = "Egelston, Colt A and Avalos, Christian and Tu, Travis Y and
              Rosario, Anthony and Wang, Roger and Solomon, Shawn and
              Srinivasan, Gayathri and Nelson, Michael S and Huang, Yinghui and
              Lim, Min Hui and Simons, Diana L and He, Ting-Fang and Yim, John
              H and Kruper, Laura and Mortimer, Joanne and Yost, Susan and Guo,
              Weihua and Ruel, Christopher and Frankel, Paul H and Yuan, Yuan
              and Lee, Peter P",
  abstract = "CD8+ tumor-infiltrating lymphocytes (TILs) correlate with
              relapse-free survival (RFS) in most cancer types, including
              breast cancer. However, subset composition, functional status,
              and spatial location of CD8+ TILs in relation to RFS in human
              breast tumors remain unclear. Spatial tissue analysis via
              quantitative immunofluorescence showed that infiltration of CD8+
              T cells into cancer islands was more significantly associated
              with RFS than CD8+ T cell infiltration into either tumor stroma
              or total tumor. Localization into cancer islands within tumors is
              mediated by expression of the integrin CD103, which is a marker
              for tissue-resident memory T cells (TRMs). Analysis of fresh
              tumor samples revealed that CD8+ TRMs are functionally similar to
              other CD8+ TILs, suggesting that the basis of their protective
              effect is their spatial distribution rather than functional
              differences. Indeed, CD103+ TRMs, as compared with CD103-CD8+
              TILs, are enriched within cancer islands, and CD8+ TRM proximity
              to cancer cells drives the association of CD8+ TIL densities with
              RFS. Together, these findings reveal the importance of cancer
              island-localized CD8+ TRMs in surveillance of the breast tumor
              microenvironment and as a critical determinant of RFS in patients
              with breast cancer.",
  journal  = "JCI Insight",
  volume   =  4,
  number   =  19,
  month    =  oct,
  year     =  2019,
  keywords = "Breast cancer; Immunology; Oncology; T cells;Human study",
  language = "en"
}

@ARTICLE{Hasan2021-la,
  title    = "Hypoxia acts as an environmental cue for the human
              tissue-resident memory {T} cell differentiation program",
  author   = "Hasan, Farah and Chiu, Yulun and Shaw, Rebecca M and Wang, Junmei
              and Yee, Cassian",
  abstract = "Tissue-resident memory T cells (TRM) provide frontline defense
              against infectious diseases and contribute to antitumor immunity;
              however, aside from the necessity of TGF-$\beta$, knowledge
              regarding TRM-inductive cues remains incomplete, particularly for
              human cells. Oxygen tension is an environmental cue that
              distinguishes peripheral tissues from the circulation, and here,
              we demonstrate that differentiation of human CD8+ T cells in the
              presence of hypoxia and TGF-$\beta$1 led to the development of a
              TRM phenotype, characterized by a greater than 5-fold increase in
              CD69+CD103+ cells expressing human TRM hallmarks and enrichment
              for endogenous human TRM gene signatures, including increased
              adhesion molecule expression and decreased expression of genes
              involved in recirculation. Hypoxia and TGF-$\beta$1 synergized to
              produce a significantly larger population of TRM phenotype cells
              than either condition alone, and comparison of these cells from
              the individual and combination conditions revealed distinct
              phenotypic and transcriptional profiles, indicating a programming
              response to milieu rather than a mere expansion. Our findings
              identify a likely previously unreported cue for the TRM
              differentiation program and can enable facile generation of human
              TRM phenotype cells in vitro for basic studies and translational
              applications such as adoptive cellular therapy.",
  journal  = "JCI Insight",
  volume   =  6,
  number   =  10,
  month    =  may,
  year     =  2021,
  keywords = "Hypoxia; Immunology; T cells;Human study",
  language = "en"
}

@ARTICLE{Boddupalli2016-yf,
  title    = "Interlesional diversity of {T} cell receptors in melanoma with
              immune checkpoints enriched in tissue-resident memory {T} cells",
  author   = "Boddupalli, Chandra Sekhar and Bar, Noffar and Kadaveru, Krishna
              and Krauthammer, Michael and Pornputtapong, Natopol and Mai,
              Zifeng and Ariyan, Stephan and Narayan, Deepak and Kluger,
              Harriet and Deng, Yanhong and Verma, Rakesh and Das, Rituparna
              and Bacchiocchi, Antonella and Halaban, Ruth and Sznol, Mario and
              Dhodapkar, Madhav V and Dhodapkar, Kavita M",
  abstract = "Heterogeneity of tumor cells and their microenvironment can
              affect outcome in cancer. Blockade of immune checkpoints (ICPs)
              expressed only on a subset of immune cells leads to durable
              responses in advanced melanoma. Tissue-resident memory T (TRM)
              cells have recently emerged as a distinct subset of memory T
              cells in nonlymphoid tissues. Here, we show that functional
              properties and expression of ICPs within tumor-infiltrating
              lymphocytes (TILs) differ from those of blood T cells. TILs
              secrete less IL-2, IFN-$\gamma$, and TNF-$\alpha$ compared with
              circulating counterparts, and expression of VEGF correlated with
              reduced TIL infiltration. Within tumors, ICPs are particularly
              enriched within T cells with phenotype and genomic features of
              TRM cells and the CD16+ subset of myeloid cells. Concurrent T
              cell receptor (TCR) and tumor exome sequencing of individual
              metastases in the same patient revealed that interlesional
              diversity of TCRs exceeded differences in mutation/neoantigen
              load in tumor cells. These findings suggest that the TRM subset
              of TILs may be the major target of ICP blockade and illustrate
              interlesional diversity of tissue-resident TCRs within individual
              metastases, which did not equilibrate between metastases and may
              differentially affect the outcome of immune therapy at each site.",
  journal  = "JCI Insight",
  volume   =  1,
  number   =  21,
  pages    = "e88955",
  month    =  dec,
  year     =  2016,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Boldajipour2016-iu,
  title    = "Tumor-infiltrating lymphocytes are dynamically desensitized to
              antigen but are maintained by homeostatic cytokine",
  author   = "Boldajipour, Bijan and Nelson, Amanda and Krummel, Matthew F",
  abstract = "T cells that enter tumors are largely tolerized, but how that
              process is choreographed and how the ensuing ``dysfunctional''
              tumor-infiltrating lymphocytes (TILs) are maintained are poorly
              understood and are difficult to assess in spontaneous disease. We
              exploited an autochthonous model of breast cancer for
              high-resolution imaging of the early and later stages of tumor
              residence to understand the relationships between cellular
              behaviors and cellular phenotypes. ``Dysfunctional''
              differentiation began within the first days of tumor residence
              with an initial phase in which T cells arrest, largely on
              tumor-associated macrophages. Within 10 days, cellular motility
              increased and resembled a random walk, suggesting a relative
              absence of TCR signaling. We then studied the concurrent and
              apparently contradictory phenomenon that many of these cells
              express molecular markers of activation and were visualized
              undergoing active cell division. We found that whereas
              proliferation did not require ongoing TCR/ZAP70 signaling,
              instead this is driven in part by intratumoral IL-15 cytokine.
              Thus, TILs undergo sequential reprogramming by the tumor
              microenvironment and are actively retained, even while being
              antigen insensitive. We conclude that this program effectively
              fills the niche with ineffective yet cytokine-dependent TILs, and
              we propose that these might compete with new clones, when they
              arise.",
  journal  = "JCI Insight",
  volume   =  1,
  number   =  20,
  pages    = "e89289",
  month    =  dec,
  year     =  2016,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Bosiljcic2019-en,
  title       = "Targeting myeloid-derived suppressor cells in combination with
                 primary mammary tumor resection reduces metastatic growth in
                 the lungs",
  author      = "Bosiljcic, Momir and Cederberg, Rachel A and Hamilton, Melisa
                 J and LePard, Nancy E and Harbourne, Bryant T and Collier,
                 Jenna L and Halvorsen, Elizabeth C and Shi, Rocky and Franks,
                 S Elizabeth and Kim, Ada Y and Ban{\'a}th, Judit P and Hamer,
                 Mark and Rossi, Fabio M and Bennewith, Kevin L",
  abstract    = "BACKGROUND: Solid tumors produce proteins that can induce the
                 accumulation of bone marrow-derived cells in various tissues,
                 and these cells can enhance metastatic tumor growth by several
                 mechanisms. 4T1 murine mammary tumors are known to produce
                 granulocyte colony-stimulating factor (G-CSF) and increase the
                 numbers of immunosuppressive CD11b+Gr1+ myeloid-derived
                 suppressor cells (MDSCs) in tissues such as the spleen and
                 lungs of tumor-bearing mice. While surgical resection of
                 primary tumors decreases MDSC levels in the spleen, the
                 longevity and impact of MDSCs and other immune cells in the
                 lungs after tumor resection have been less studied. METHODS:
                 We used mass cytometry time of flight (CyTOF) and flow
                 cytometry to quantify MDSCs in the spleen, peripheral blood,
                 and lungs of mice bearing orthotopic murine mammary tumors. We
                 also tested the effect of primary tumor resection and/or
                 gemcitabine treatment on the levels of MDSCs, other immune
                 suppressor and effector cells, and metastatic tumor cells in
                 the lungs. RESULTS: We have found that, similar to mice with
                 4T1 tumors, mice bearing metastatic 4T07 tumors also exhibit
                 accumulation of CD11b+Gr1+ MDSCs in the spleen and lungs,
                 while tissues of mice with non-metastatic 67NR tumors do not
                 contain MDSCs. Mice with orthotopically implanted 4T1 tumors
                 have increased granulocytic (G-) MDSCs, monocytic (M-) MDSCs,
                 macrophages, eosinophils, and NK cells in the lungs. Resection
                 of primary 4T1 tumors decreases G-MDSCs, M-MDSCs, and
                 macrophages in the lungs within 48 h, but significant numbers
                 of functional immunosuppressive G-MDSCs persist in the lungs
                 for 2 weeks after tumor resection, indicative of an
                 environment that can promote metastatic tumor growth. The
                 chemotherapeutic agent gemcitabine depletes G-MDSCs, M-MDSCs,
                 macrophages, and eosinophils in the lungs of 4T1 tumor-bearing
                 mice, and we found that treating mice with gemcitabine after
                 primary tumor resection decreases residual G-MDSCs in the
                 lungs and decreases subsequent metastatic growth. CONCLUSIONS:
                 Our data support the development of therapeutic strategies to
                 target MDSCs and to monitor MDSC levels before and after
                 primary tumor resection to enhance the effectiveness of
                 immune-based therapies and improve the treatment of metastatic
                 breast cancer in the clinic.",
  journal     = "Breast Cancer Res.",
  volume      =  21,
  number      =  1,
  pages       = "103",
  month       =  sep,
  year        =  2019,
  keywords    = "4T07; 4T1; 67NR; Eosinophils; Gemcitabine; Macrophages;
                 Metastasis; Myeloid-derived suppressor cells; Tumor resection",
  language    = "en",
  original_id = "a01259cc-9eec-0efc-b67e-2b396d3afe6b"
}

@ARTICLE{Komdeur2016-sb,
  title    = "{CD103+} intraepithelial {T} cells in high-grade serous ovarian
              cancer are phenotypically diverse {TCR$\alpha$$\beta$+}
              {CD8$\alpha$$\beta$+} {T} cells that can be targeted for cancer
              immunotherapy",
  author   = "Komdeur, Fenne L and Wouters, Maartje C A and Workel, Hagma H and
              Tijans, Aline M and Terwindt, Anouk L J and Brunekreeft, Kim L
              and Plat, Annechien and Klip, Harry G and Eggink, Florine A and
              Leffers, Ninke and Helfrich, Wijnand and Samplonius, Douwe F and
              Bremer, Edwin and Wisman, G Bea A and Daemen, Toos and Duiker,
              Evelien W and Hollema, Harry and Nijman, Hans W and de Bruyn,
              Marco",
  abstract = "CD103+ tumor-infiltrating lymphocytes (TIL) have been linked to
              specific epithelial infiltration and a prolonged survival in
              high-grade serous epithelial ovarian cancer (HGSC). However,
              whether these cells are induced as part of an ongoing anti-HGSC
              immune response or represent non-specifically expanded resident
              or mucosal lymphocytes remains largely unknown. In this study, we
              first confirmed that CD103+ TIL from HGSC were predominantly
              localized in the cancer epithelium and were strongly correlated
              with an improved prognosis. We further demonstrate that CD103+
              TIL were almost exclusively CD3+ TCR$\alpha$$\beta$+
              CD8$\alpha$$\beta$+ CD4- T cells, but heterogeneously expressed T
              cell memory and differentiation markers. Activation of peripheral
              T cells in the presence of HGSC was sufficient to trigger
              induction of CD103 in over 90\% of all CD8+ cells in a T cell
              receptor (TCR)- and TGF$\beta$R1-dependent manner. Finally,
              CD103+ TIL isolated from primary HGSC showed signs of recent
              activation and dominantly co-expressed key immunotherapeutic
              targets PD-1 and CD27. Taken together, our data indicate CD103+
              TIL in HGSC are formed as the result of an adaptive anti-tumor
              immune response that might be reactivated by (dual) checkpoint
              inhibition.",
  journal  = "Oncotarget",
  volume   =  7,
  number   =  46,
  pages    = "75130--75144",
  month    =  nov,
  year     =  2016,
  keywords = "CD103; TGF-$\beta$; cancer immunotherapy; high-grade serous
              ovarian cancer; tumor-infiltrating lymphocytes;Human study",
  language = "en"
}

@ARTICLE{Koh2017-qk,
  title    = "Prognostic implications of intratumoral {CD103+}
              tumor-infiltrating lymphocytes in pulmonary squamous cell
              carcinoma",
  author   = "Koh, Jaemoon and Kim, Sehui and Kim, Moon-Young and Go,
              Heounjeong and Jeon, Yoon Kyung and Chung, Doo Hyun",
  abstract = "CD103 is the $\alpha$E subunit of $\alpha$E$\beta$7 integrin that
              is expressed in tissue-resident memory T cells, where it promotes
              cytotoxic T cell responses against tumors. However, little is
              known about its expression or clinicopathological implications in
              non-small cell lung cancer (NSCLC). This study investigated the
              prognostic implications of CD103+ tumor-infiltrating lymphocytes
              (TILs) in NSCLC. We established two cohorts: patients with
              resected NSCLC (n = 132) and patients with pulmonary squamous
              cell carcinoma (pSCC), a subset of NSCLC (n = 378), to estimate
              the prognostic significance of CD103+ TILs. The numbers of CD103+
              TILs in the intratumoral (i.e., intraepithelial) and stromal
              regions of NSCLC were estimated using immunohistochemistry and
              automated image analysis. In the NSCLC cohort, high numbers of
              intratumoral CD103+ TILs were significantly associated with
              prolonged disease-free survival (DFS) and overall survival (OS)
              in patients with pSCC but not in those with pulmonary
              adenocarcinoma. In the pSCC cohort, a positive correlation was
              observed between the numbers of intratumoral CD103+ and CD8+ TILs
              (correlation coefficient = 0.736, P < 0.001). The ratio of
              intratumoral/stromal CD103+ TILs was higher in pSCC with high
              compared to low E-cadherin expression (P = 0.021). According to
              Kaplan-Meier analysis, high intratumoral but not stromal CD103+
              TILs were associated with prolonged DFS and OS in patients with
              resected pSCC (P = 0.021 and 0.002, respectively). Multivariate
              analysis revealed that a high number of intratumoral CD103+ TILs
              is an independent predictor of a more favorable DFS (P = 0.021).
              Thus, a high number of intratumoral CD103+ TILs is a favorable
              prognostic indicator in patients with pSCC.",
  journal  = "Oncotarget",
  volume   =  8,
  number   =  8,
  pages    = "13762--13769",
  month    =  feb,
  year     =  2017,
  keywords = "CD103; cancer immunotherapy; prognosis; pulmonary squamous cell
              carcinoma; tumor-infiltrating lymphocytes;Human study",
  language = "en"
}

@ARTICLE{Vella2021-jf,
  title    = "Dendritic cells maintain anti-tumor immunity by positioning {CD8}
              skin-resident memory {T} cells",
  author   = "Vella, Jennifer L and Molodtsov, Aleksey and Angeles, Christina V
              and Branchini, Bruce R and Turk, Mary Jo and Huang, Yina H",
  abstract = "Tissue-resident memory (TRM) T cells are emerging as critical
              components of the immune response to cancer; yet, requirements
              for their ongoing function and maintenance remain unclear. APCs
              promote TRM cell differentiation and re-activation but have not
              been implicated in sustaining TRM cell responses. Here, we
              identified a novel role for dendritic cells in supporting TRM to
              melanoma. We showed that CD8 TRM cells remain in close proximity
              to dendritic cells in the skin. Depletion of CD11c+ cells results
              in rapid disaggregation and eventual loss of melanoma-specific
              TRM cells. In addition, we determined that TRM migration and/or
              persistence requires chemotaxis and adhesion mediated by the
              CXCR6/CXCL16 axis. The interaction between CXCR6-expressing TRM
              cells and CXCL16-expressing APCs was found to be critical for
              sustaining TRM cell-mediated tumor protection. These findings
              substantially expand our knowledge of APC functions in TRM T-cell
              homeostasis and longevity.",
  journal  = "Life Sci Alliance",
  volume   =  4,
  number   =  10,
  month    =  oct,
  year     =  2021,
  keywords = "Mouse study",
  language = "en"
}

@ARTICLE{Murray2016-gl,
  title    = "Very Late Antigen-1 Marks Functional {Tumor-Resident} {CD8} {T}
              Cells and Correlates with Survival of Melanoma Patients",
  author   = "Murray, Timothy and Fuertes Marraco, Silvia A and Baumgaertner,
              Petra and Bordry, Natacha and Cagnon, Laur{\`e}ne and Donda,
              Alena and Romero, Pedro and Verdeil, Gr{\'e}gory and Speiser,
              Daniel E",
  abstract = "A major limiting factor in the success of immunotherapy is tumor
              infiltration by CD8+ T cells, a process that remains poorly
              understood. In the present study, we characterized homing
              receptors expressed by human melanoma-specific CD8+ T cells. Our
              data reveal that P-selectin binding and expression of the
              retention integrin, very late antigen (VLA)-1, by vaccine-induced
              T cells correlate with longer patient survival. Furthermore, we
              demonstrate that CD8+VLA-1+ tumor-infiltrating lymphocytes (TILs)
              are highly enriched in melanoma metastases in diverse tissues.
              VLA-1-expressing TIL frequently co-express CD69 and CD103,
              indicating tissue-resident memory T cells (TRM) differentiation.
              We employed a mouse model of melanoma to further characterize
              VLA-1-expressing TIL. Our data show that VLA-1+ TRM develop in
              murine tumors within 2 weeks, where they exhibit increased
              activation status, as well as superior effector functions. In
              addition, in vivo blockade of either VLA-1 or CD103 significantly
              impaired control of subcutaneous tumors. Together, our data
              indicate that VLA-1+ TRM develop in tumors and play an important
              role in tumor immunity, presenting novel targets for the
              optimization of cancer immunotherapy.",
  journal  = "Front. Immunol.",
  volume   =  7,
  pages    = "573",
  month    =  dec,
  year     =  2016,
  keywords = "CD103; VLA-1; cancer vaccines; melanoma; tissue-resident memory T
              cells;Human study",
  language = "en"
}

@ARTICLE{Smith2018-ti,
  title    = "Regulation of cytokine production by the unfolded protein
              response; Implications for infection and autoimmunity",
  author   = "Smith, Judith A",
  abstract = "Protein folding in the endoplasmic reticulum (ER) is an essential
              cell function. To safeguard this process in the face of
              environmental threats and internal stressors, cells mount an
              evolutionarily conserved response known as the unfolded protein
              response (UPR). Invading pathogens induce cellular stress that
              impacts protein folding, thus the UPR is well situated to sense
              danger and contribute to immune responses. Cytokines
              (inflammatory cytokines and interferons) critically mediate host
              defense against pathogens, but when aberrantly produced, may also
              drive pathologic inflammation. The UPR influences cytokine
              production on multiple levels, from stimulation of pattern
              recognition receptors, to modulation of inflammatory signaling
              pathways, and the regulation of cytokine transcription factors.
              This review will focus on the mechanisms underlying cytokine
              regulation by the UPR, and the repercussions of this relationship
              for infection and autoimmune/autoinflammatory diseases.
              Interrogation of viral and bacterial infections has revealed
              increasing numbers of examples where pathogens induce or modulate
              the UPR and implicated UPR-modulated cytokines in host response.
              The flip side of this coin, the UPR/ER stress responses have been
              increasingly recognized in a variety of autoimmune and
              inflammatory diseases. Examples include monogenic disorders of ER
              function, diseases linked to misfolding protein (HLA-B27 and
              spondyloarthritis), diseases directly implicating UPR and
              autophagy genes (inflammatory bowel disease), and autoimmune
              diseases targeting highly secretory cells (e.g., diabetes). Given
              the burgeoning interest in pharmacologically targeting the UPR,
              greater discernment is needed regarding how the UPR regulates
              cytokine production during specific infections and autoimmune
              processes, and the relative place of this interaction in
              pathogenesis.",
  journal  = "Front. Immunol.",
  volume   =  9,
  pages    = "422",
  month    =  mar,
  year     =  2018,
  keywords = "autoimmunity; autoinflammatory disease; bacteria; cytokine
              regulation; endoplasmic reticulum stress; infection; unfolded
              protein response; virus",
  language = "en"
}

@ARTICLE{Stackowicz2019-gb,
  title       = "Mouse Models and Tools for the in vivo Study of Neutrophils",
  author      = "Stackowicz, Julien and J{\"o}nsson, Friederike and Reber,
                 Laurent L",
  abstract    = "Neutrophils are the most abundant leukocytes in human blood
                 and critical actors of the immune system. Many neutrophil
                 functions and facets of their activity in vivo were revealed
                 by studying genetically modified mice or by tracking
                 fluorescent neutrophils in animals using imaging approaches.
                 Assessing the roles of neutrophils can be challenging,
                 especially when exact molecular pathways are questioned or
                 disease states are interrogated that alter normal neutrophil
                 homeostasis. This review discusses the main in vivo models for
                 the study of neutrophils, their advantages and limitations.
                 The side-by-side comparison underlines the necessity to
                 carefully choose the right model(s) to answer a given
                 scientific question, and exhibit caveats that need to be taken
                 into account when designing experimental procedures.
                 Collectively, this review suggests that at least two models
                 should be employed to legitimately conclude on neutrophil
                 functions.",
  journal     = "Front. Immunol.",
  volume      =  10,
  pages       = "3130",
  year        =  2019,
  keywords    = "Cre-recombinase; Gfi-1; NETosis; depletion; diphtheria toxin;
                 mouse models; neutrophils",
  language    = "en",
  original_id = "473ad5f7-b127-0bf0-bf45-c1287dd4427b"
}

@ARTICLE{Gitto2021-mm,
  title    = "The Emerging Interplay Between Recirculating and
              {Tissue-Resident} Memory {T} Cells in Cancer Immunity: Lessons
              Learned From {PD-1/PD-L1} Blockade Therapy and Remaining Gaps",
  author   = "Gitto, Silvia and Natalini, Ambra and Antonangeli, Fabrizio and
              Di Rosa, Francesca",
  abstract = "Remarkable progress has been made in the field of anti-tumor
              immunity, nevertheless many questions are still open. Thus, even
              though memory T cells have been implicated in long-term
              anti-tumor protection, particularly in prevention of cancer
              recurrence, the bases of their variable effectiveness in tumor
              patients are poorly understood. Two types of memory T cells have
              been described according to their traffic pathways: recirculating
              and tissue-resident memory T cells. Recirculating tumor-specific
              memory T cells are found in the cell infiltrate of solid tumors,
              in the lymph and in the peripheral blood, and they constantly
              migrate in and out of lymph nodes, spleen, and bone marrow.
              Tissue-resident tumor-specific memory T cells (TRM) permanently
              reside in the tumor, providing local protection. Anti-PD-1/PD-L1,
              a type of immune checkpoint blockade (ICB) therapy, can
              considerably re-invigorate T cell response and lead to successful
              tumor control, even in patients at advanced stages. Indeed, ICB
              has led to unprecedented successes against many types of cancers,
              starting a ground-breaking revolution in tumor therapy.
              Unfortunately, not all patients are responsive to such treatment,
              thus further improvements are urgently needed. The mechanisms
              underlying resistance to ICB are still largely unknown. A better
              knowledge of the dynamics of the immune response driven by the
              two types of memory T cells before and after anti-PD-1/PD-L1
              would provide important insights on the variability of the
              outcomes. This would be instrumental to design new treatments to
              overcome resistance. Here we provide an overview of T cell
              contribution to immunity against solid tumors, focusing on memory
              T cells. We summarize recent evidence on the involvement of
              recirculating memory T cells and TRM in anti-PD-1/PD-L1-elicited
              antitumor immunity, outline the open questions in the field, and
              propose that a synergic action of the two types of memory T cells
              is required to achieve a full response. We argue that a T-centric
              vision focused on the specific roles and the possible interplay
              between TRM and recirculating memory T cells will lead to a
              better understanding of anti-PD-1/PD-L1 mechanism of action, and
              provide new tools for improving ICB therapeutic strategy.",
  journal  = "Front. Immunol.",
  volume   =  12,
  pages    = "755304",
  month    =  nov,
  year     =  2021,
  keywords = "TRM; anti-tumor immunity; bone marrow; immune checkpoint
              blockade; memory T cells;Review",
  language = "en"
}

@ARTICLE{Cotechini2021-zr,
  title    = "{Tissue-Resident} and Recruited Macrophages in Primary Tumor and
              Metastatic Microenvironments: Potential Targets in Cancer Therapy",
  author   = "Cotechini, Tiziana and Atallah, Aline and Grossman, Arielle",
  abstract = "Macrophages within solid tumors and metastatic sites are
              heterogenous populations with different developmental origins and
              substantially contribute to tumor progression. A number of
              tumor-promoting phenotypes associated with both tumor- and
              metastasis-associated macrophages are similar to innate programs
              of embryonic-derived tissue-resident macrophages. In contrast to
              recruited macrophages originating from marrow precursors,
              tissue-resident macrophages are seeded before birth and function
              to coordinate tissue remodeling and maintain tissue integrity and
              homeostasis. Both recruited and tissue-resident macrophage
              populations contribute to tumor growth and metastasis and are
              important mediators of resistance to chemotherapy, radiation
              therapy, and immune checkpoint blockade. Thus, targeting various
              macrophage populations and their tumor-promoting phenotypes holds
              therapeutic promise. Here, we discuss various macrophage
              populations as regulators of tumor progression, immunity, and
              immunotherapy. We provide an overview of macrophage targeting
              strategies, including therapeutics designed to induce macrophage
              depletion, impair recruitment, and induce repolarization. We also
              provide a perspective on the therapeutic potential for
              macrophage-specific acquisition of trained immunity as an
              anti-cancer agent and discuss the therapeutic potential of
              exploiting macrophages and their traits to reduce tumor burden.",
  journal  = "Cells",
  volume   =  10,
  number   =  4,
  month    =  apr,
  year     =  2021,
  keywords = "cancer; depletion; immune therapy; metastasis-associated
              macrophage; monocyte; recruitment; repolarization;
              tissue-resident macrophages; trained immunity; tumor
              microenvironment; tumor-associated macrophages",
  language = "en"
}

@ARTICLE{Djenidi2015-pt,
  title    = "{CD8+CD103+} tumor-infiltrating lymphocytes are tumor-specific
              tissue-resident memory {T} cells and a prognostic factor for
              survival in lung cancer patients",
  author   = "Djenidi, Fay{\c c}al and Adam, Julien and Goubar, A{\"\i}cha and
              Durgeau, Aur{\'e}lie and Meurice, Guillaume and de
              Montpr{\'e}ville, Vincent and Validire, Pierre and Besse,
              Benjamin and Mami-Chouaib, Fathia",
  abstract = "We had previously demonstrated the role of CD103 integrin on lung
              tumor-infiltrating lymphocyte (TIL) clones in promoting specific
              TCR-mediated epithelial tumor cell cytotoxicity. However, the
              contribution of CD103 on intratumoral T cell distribution and
              functions and the prognosis significance of TIL subpopulations in
              non-small cell lung carcinoma (NSCLC) have thus far not been
              systematically addressed. In this study, we show that an enhanced
              CD103(+) TIL subset correlates with improved early stage NSCLC
              patient survival and increased intraepithelial lymphocyte
              infiltration. Moreover, our results indicate that CD8(+)CD103(+)
              TIL, freshly isolated from NSCLC specimens, display
              transcriptomic and phenotypic signatures characteristic of
              tissue-resident memory T cells and frequently express PD-1 and
              Tim-3 checkpoint receptors. This TIL subset also displays
              increased activation-induced cell death and mediates specific
              cytolytic activity toward autologous tumor cells upon blockade of
              the PD-1-PD-L1 interaction. These findings emphasize the role of
              CD8(+)CD103(+) tissue-resident memory T cells in promoting
              intratumoral CTL responses and support the rationale for using
              anti-PD-1 blocking Ab to reverse tumor-induced T cell exhaustion
              in NSCLC patients.",
  journal  = "J. Immunol.",
  volume   =  194,
  number   =  7,
  pages    = "3475--3486",
  month    =  apr,
  year     =  2015,
  keywords = "Human study",
  language = "en"
}

@ARTICLE{Emmanuilidis2001-hu,
  title    = "Critical role of Kupffer cell-derived {IL-10} for host defense in
              septic peritonitis",
  author   = "Emmanuilidis, K and Weighardt, H and Maier, S and Gerauer, K and
              Fleischmann, T and Zheng, X X and Hancock, W W and Holzmann, B
              and Heidecke, C D",
  abstract = "Intra-abdominal infection in patients following major visceral
              surgery is associated with high mortality. Using a macrophage
              depletion technique, we demonstrate that in murine septic
              peritonitis, Kupffer cells are a major source of systemic IL-10
              levels. Kupffer cell-depleted mice were highly susceptible to the
              lethal effects of septic peritonitis and exhibited an increased
              bacterial load. Kupffer cell-depleted mice were protected by the
              administration of an IL-10-Fc fusion protein. Loss of Kupffer
              cell-derived IL-10 was associated with a weak increase in serum
              IL-12 levels, whereas TNF, IL-1alpha, and IL-18 levels were not
              significantly elevated, suggesting that the loss of Kupffer
              cell-derived IL-10 did not result in a toxic cytokine release
              syndrome. Instead, loss of Kupffer cell-derived IL-10 was
              associated with a reduced splenocyte production of IFN-gamma that
              is required for immune protection in murine septic peritonitis.
              Therefore, the results suggest that the protective function of
              IL-10 in septic peritonitis may not be restricted to the
              anti-inflammatory activities of IL-10.",
  journal  = "J. Immunol.",
  volume   =  167,
  number   =  7,
  pages    = "3919--3927",
  month    =  oct,
  year     =  2001,
  language = "en"
}

@ARTICLE{Sunderkotter2004-bj,
  title    = "Subpopulations of mouse blood monocytes differ in maturation
              stage and inflammatory response",
  author   = "Sunderk{\"o}tter, Cord and Nikolic, Tatjana and Dillon, Marilyn J
              and Van Rooijen, Nico and Stehling, Martin and Drevets, Douglas A
              and Leenen, Pieter J M",
  abstract = "Blood monocytes are well-characterized precursors for macrophages
              and dendritic cells. Subsets of human monocytes with differential
              representation in various disease states are well known. In
              contrast, mouse monocyte subsets have been characterized
              minimally. In this study we identify three subpopulations of
              mouse monocytes that can be distinguished by differential
              expression of Ly-6C, CD43, CD11c, MBR, and CD62L. The subsets
              share the characteristics of extensive phagocytosis, similar
              expression of M-CSF receptor (CD115), and development into
              macrophages upon M-CSF stimulation. By eliminating blood
              monocytes with dichloromethylene-bisphosphonate-loaded liposomes
              and monitoring their repopulation, we showed a developmental
              relationship between the subsets. Monocytes were maximally
              depleted 18 h after liposome application and subsequently
              reappeared in the circulation. These cells were exclusively of
              the Ly-6C(high) subset, resembling bone marrow monocytes. Serial
              flow cytometric analyses of newly released Ly-6C(high) monocytes
              showed that Ly-6C expression on these cells was down-regulated
              while in circulation. Under inflammatory conditions elicited
              either by acute infection with Listeria monocytogenes or chronic
              infection with Leishmania major, there was a significant increase
              in immature Ly-6C(high) monocytes, resembling the inflammatory
              left shift of granulocytes. In addition, acute peritoneal
              inflammation recruited preferentially Ly-6C(med-high) monocytes.
              Taken together, these data identify distinct subpopulations of
              mouse blood monocytes that differ in maturation stage and
              capacity to become recruited to inflammatory sites.",
  journal  = "J. Immunol.",
  volume   =  172,
  number   =  7,
  pages    = "4410--4417",
  month    =  apr,
  year     =  2004,
  language = "en"
}

@ARTICLE{Ran2019-qk,
  title     = "{YIPF5} is essential for innate immunity to {DNA} virus and
               facilitates {COPII-dependent} {STING} trafficking",
  author    = "Ran, Yong and Xiong, Mei-Guang and Xu, Zhi-Sheng and Luo,
               Wei-Wei and Wang, Su-Yun and Wang, Yan-Yi",
  abstract  = "STING plays central roles in the innate immune response to
               pathogens that contain DNA. Sensing cytoplasmic DNA by cyclic
               GMP-AMP synthase produces cyclic GMP-AMP, which binds to and
               activates STING and induces STING translocation from the
               endoplasmic reticulum to the perinuclear microsome. However,
               this trafficking process has not been fully elucidated yet. In
               this study, we identified YIPF5 as a positive regulator of STING
               trafficking. YIPF5 is essential for DNA virus- or intracellular
               DNA-triggered production of type I IFNs. Consistently, knockdown
               of YIPF5 impairs cellular antiviral responses to DNA virus.
               Mechanistically, YIPF5 interacts with both STING and components
               of COPII, facilitating STING recruitment to COPII in the
               presence of cytoplasmic dsDNA. Furthermore, knockdown of
               components of COPII inhibits DNA virus-triggered production of
               type I IFNs, suggesting that COPII is involved in innate immune
               responses to DNA viruses. Collectively, our findings demonstrate
               that YIPF5 positively regulates STING-mediated innate immune
               responses by recruiting STING to COPII-coated vesicles and
               facilitating STING trafficking from the endoplasmic reticulum to
               Golgi, providing important insights into the molecular
               mechanisms of intracellular DNA-stimulated STING trafficking and
               activation.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  203,
  number    =  6,
  pages     = "1560--1570",
  month     =  sep,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Sundaram2017-rd,
  title    = "The Sec61 translocon limits {IRE1$\alpha$} signaling during the
              unfolded protein response",
  author   = "Sundaram, Arunkumar and Plumb, Rachel and Appathurai, Suhila and
              Mariappan, Malaiyalam",
  abstract = "IRE1$\alpha$ is an endoplasmic reticulum (ER) localized
              endonuclease activated by misfolded proteins in the ER.
              Previously, we demonstrated that IRE1$\alpha$ forms a complex
              with the Sec61 translocon, to which its substrate XBP1u mRNA is
              recruited for cleavage during ER stress (Plumb et al., 2015).
              Here, we probe IRE1$\alpha$ complexes in cells with blue native
              PAGE immunoblotting. We find that IRE1$\alpha$ forms a
              hetero-oligomeric complex with the Sec61 translocon that is
              activated upon ER stress with little change in the complex. In
              addition, IRE1$\alpha$ oligomerization, activation, and
              inactivation during ER stress are regulated by Sec61. Loss of the
              IRE1$\alpha$-Sec61 translocon interaction as well as severe ER
              stress conditions causes IRE1$\alpha$ to form higher-order
              oligomers that exhibit continuous activation and extended
              cleavage of XBP1u mRNA. Thus, we propose that the
              Sec61-IRE1$\alpha$ complex defines the extent of IRE1$\alpha$
              activity and may determine cell fate decisions during ER stress
              conditions.",
  journal  = "Elife",
  volume   =  6,
  month    =  may,
  year     =  2017,
  keywords = "ER stress; cell biology; endoplasmic reticulum; none; unfolded
              protein response",
  language = "en"
}

@ARTICLE{Dexter1978-nt,
  title    = "Heterogeneity of tumor cells from a single mouse mammary tumor",
  author   = "Dexter, D L and Kowalski, H M and Blazar, B A and Fligiel, Z and
              Vogel, R and Heppner, G H",
  abstract = "By the use of a variety of cell culture and separation methods,
              four cell lines were isolated from a single autochthonous
              BALB/cfC3H mammary tumor. These lines differ markedly from each
              other in culture morphology, various in vitro growth properties,
              expression of murine mammary tumor virus antigen, and karyotype,
              yet all four lines are tumorigenic in normal, syngeneic hosts,
              yielding tumors of generally similar histology, although distinct
              from the original neoplasm. Three of the four lines have been
              cloned from soft agar. The clones exhibit the same growth
              properties as the lines from which they were derived. Karyotypic
              analysis of the parent tumor revealed the presence of cells with
              heterogeneous numbers of chromosomes similar to those seen in the
              isolated lines, suggesting both the presence of these distinct
              cell types in the original neoplasm and a genetic origin of the
              diversity.",
  journal  = "Cancer Res.",
  volume   =  38,
  number   =  10,
  pages    = "3174--3181",
  month    =  oct,
  year     =  1978,
  language = "en"
}

@ARTICLE{noauthor_undated-qv,
  title       = "{ADA454757.pdf}",
  original_id = "801691e9-2d37-0866-9271-ba82ce4e52c4"
}

@MISC{noauthor_undated-uh,
  title        = "Granulocyte-colony stimulating factor promotes lung
                  metastasis through mobilization of {Ly6G+Ly6C+} granulocytes",
  booktitle    = "{PNAS}",
  abstract     = "Priming of the organ-specific premetastatic sites is thought
                  to be an important yet incompletely understood step during
                  metastasis. In this study, we ...",
  howpublished = "\url{https://www.pnas.org/doi/full/10.1073/pnas.1015855107}",
  note         = "Accessed: 2022-5-15",
  language     = "en",
  original_id  = "f640c65a-4cc9-08ce-8379-32bee988c95a"
}
